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PO01-01
LAPAROSCOPIC HEPATECTOMY FOR
HEPATOCELLULAR CARCINOMA
Kuohsin Chen, Jain-Ming Wu, Shian-dian Chen, Ying-
Da Chen, Shu-Yi Huang and Kuo-Hsiang Cheng
Far-Eastern Memorial Hospital, Taiwan
Introduction: Despite its technical challenges, laparo-
scopic hepatectomy (LH) has been advocated more fre-
quently. However, LH for hepatocellular carcinoma
(HCC) was reported only in small cohort studies. Long
term results were still unclear. In this study, we
reviewed the perioperative results and long term follow-
up of HCC patients receiving LH in our institute.
Method: From Feb 2002 to Jun 2013, total 355
patients received laparoscopic hepatectomy in our insti-
tute. Curative laparoscopic hepatectomy was attempted
in 186 HCC patients. Fifteen patients needed open con-
version. Patients with combined local ablation treat-
ment, incomplete follow-up data and concurrent other
malignancies were excluded. Total 130 patients were
enrolled in this retrospective review. Operative parame-
ters, perioperative results, and follow-up data were
assessed.
Results: There were 98 male and 32 female aged from
37 to 86 y/o (mean 55.8).
Surgical procedures included wedge resection in 38
patients, 1 ~ 3 segments in 52, more than three seg-
ments in 11, left lateral sectionectomy in 11, left hepa-
tectomy in 4 and right hepatectomy in 18. Surgical
approaches included pure laparoscopic in 77 patients,
hand assisted in two, hybrid in 38 and robotic in 13.
Tumor location included S1 in 6 patients, S23 in 17, S4
in 13, S5 in 21, S6 in 31, S7 in19 and S8 in 22. Margin
free resection was achieved in all patients. Mean post-
operative hospital stay was 7.6 days (3 ~ 46). Compli-
cations developed in 35 patients (27%) and 1 patient
died of liver failure. Disease free survival and overall
survival at 1, 3, and 5 years were 86%, 65%, 57% and
96%, 83% and 78%.
Conclusions: Laparoscopic hepatectomy is feasible with
acceptable perioperative results. The follow-up survival
data was comparable to that after open hepatectomy.
However, large randomized control studies are still
needed to confirm the potential benefits.
PO01-02
LAPAROSCOPIC ANATOMICAL
HEPATIC RESECTION WITH
GLISSONIAN PEDICLE TRANSECTION
Yuji Iimuro, Toshihiro Okada, Seikan Hai, Shogo
Tanaka, Yuichi Kondo, Ikuo Nakamura, Kazuhiro
Suzumura, Yasukane Asano, Tadamichi Hirano and
Jiro Fujimoto
Hyogo College of Medicine, Japan
Introduction: Anatomical hepatic resection is now
believed to be preferable procedure for surgical treat-
ment of hepatocellular carcinoma (HCC), if the liver
function is preserved. Recently, we have performed this
procedure with Glissonian pedicle transection even in
pure laparoscopic hepatectomy.
Method: HCC occupying segments 3, 4, 5, 6, 2 + 3,
6 + 7 have been good subjects for this procedure. Left
or right decubitus position has been employed for the
right-side or left-side segmentectomy as appropriate.
Right-side segmentectomy: After cholecystectomy, Glis-
sonian pedicles of right-paramedian and right-posterior
sections are identified. For identification of more distal
branches, preoperative 3-D simulation and intraopera-
tive ultrasonography are useful. Left-side segmentecto-
my: Glissonian pedicle transection can be basically
performed from each side of the umbilical portion.
After the isolation of targeted branch, test clamp is per-
formed and accuracy of the demarcation line is esti-
mated comparing with preoperative simulation data.
After this method, the targeted Glissonian branch is
dissected using auto-staplers or clips. Parenchymal
resection is performed using BiClamp and LCS or scis-
sors. CUSA is also used as appropriate.
Results: Twenty patients underwent this procedure from
Jan 2012 and August 2013. Operation time:
261  119 min., Intraoperative blood loss:
121  190 mL, Postoperative hospital stay: 9  2 days.
No morbidity or mortality was observed in this series.
Conclusions: Anatomical hepatic resection with Glisso-
nian pedicle transection for HCC can be safely per-
formed even in pure laparoscopic surgery. Selected
patients with preserved liver function and preferable
tumor site are considered to be good candidates for this
procedure. Preoperative 3D-simulation and intraopera-
tive ultrasonography are useful modalities for this
method.
PO01-03
LAPAROSCOPIC ROBOT-ASSISTED
MAJOR HEPATECTOMY
Fabio Caniglia, Fabio Vistoli, Stefano Signori,
Francesca Costa, Mario Antonio Belluomini, NelideDe
Lio and Ugo Boggi
University of Pisa, Pisa, Italy
Introduction: Major hepatectomy (MH) remains one of
the last frontiers of laparoscopy because of the unique
technical challenge of controlling hemorrhage from
major vessels, avoiding gas embolism, limiting post-
operative complications, and ensuring margin-free
tumor resection. The daVinci Surgical System improves
surgeon’s dexterity during laparoscopic operations and
could be meaningfully employed in challenging opera-
tions such as MH.
Method: Patients requiring MH were considered for
possible robot-assisted surgery when there were no gen-
eral contraindications to prolonged pneumoperitoneum,
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American Society of Anesthesiologists classification did
not exceed grade three, and liver reserve was deemed
appropriate. Both symptomatic benign lesions and
malignant liver tumors were accepted, when otherwise
resectable, irrespective of tumor diameter but avoiding
lesions extensively reaching liver capsule. Previous
abdominal operations, and/or necessity for simulta-
neous intra-abdominal procedures were not considered
absolute contraindications. Hilar cholangiocarcinoma
was excluded.
Results: Between July 2010 and May 2013, 18 patients
underwent robot-assisted MH. Overall there were 11
right hepatectomies, one extended right hepatectomy,
three left hepatectomies, three en-bloc resection of mul-
tiple liver segments not classifiable into a classic MH.
There were nine males and nine females, mean age was
63.5 years (39–80). Pathology demonstrated malignancy
in 13 patients (8 CRLM, 2 HCC, 3 intrahepatic cholan-
giocarcinoma) and bening disease in five (four heman-
gioma, one solitary bile duct cyst). Three patients
underwent associated procedures (right nephrectomy,
enucleation of renal tumor, left colectomy). One patient
was converted to open surgery (5.5%) because of diffi-
cult dissection of hilar vessels. Mean operative time
(SD) was 428  117.2 min. Mean hospital stay was
10  3.8 days. No patient required repeated surgery
and none developed grade V complications, according
to the Clavien scale.
Conclusions: Our experience confirms that laparoscopic
robot-assisted MH is safely feasible in selected patients.
The real benefits of either laparoscopy or robotic-assis-
tance, as compared to open resection, require further
experience and prospective randomized comparison.
PO01-04
PROSPECTIVE AND RANDOMIZED
STUDY TO ANALYZE THE
INFLAMATORY RESPONSE OF THE
LIVER RESECTION AFTER
LAPAROSCOPIC AND OPEN SURGERY
IN PATIENTS WITH COLORECTAL
LIVER METASTASIS
Ricardo Robles1, Beatriz Abellan2, Ana Garcia1,
Asuncion Lopez Conesa1, Roberto Brusadin1, Carmen
Botella1, Rocio Alvarez1, Victor Lopez1 and Pilar
Jimeno1
1Virgen de la Arrixaca University Hospital, Spain;
2Reina Sofia University hospital, Murcia (Spain), Spain
Introduction: Laparoscopic surgery (LS) is less aggres-
sive and results in a lower immune response than open
surgery (OS). The patients with colorectal liver metas-
tasis (CRLM) need adjuvant chemotherapy after liver
resection, so it is important a fast recovery and lower
postoperative immune response.Our objective was ana-
lyze the inflammatory response after hepatic resection
in CRLM comparing LS with OS.
Method: A prospective randomized study including 40
patients was conducted: 20 patients was operated on by
LS and 20 by OS. Exclusion criteria: inability to per-
form laparoscopic surgery, perioperative transfusion
and postoperative complications. LS and OS groups
were homogeneous. In the LS group we used the hand-
assisted technique (HALS) described by our Depart-
ment and in the OS we used a subcostal laparotomy.
We determined levels of IL-6, IL-10 and TNF-alpha at
three moments: time 0 (the day before surgery), time 1
(day 3 after surgery) and time 2 (day 30 after surgery).
Results: In LS group preoperative levels of IL-6 was
10.88  10.8, increasing at third postoperative day
(33.30  23.45) (p < 0.001), and returning to normal
level a month after surgery (13.33  12.26). In the OS
group preoperative levels of IL-6 was 8.87  9.41,
increasing at the third postoperative day
(35.05  40.26) (p < 0.013), and returning to normal
level a month after surgery (11.17  12.04). There was
no significant difference regarding IL-10 and TNFalpha
levels at any time in both group. We found no differ-
ences comparing the LS and OS groups respect to IL-6,
IL-10 and TNF-alpha.
Conclusions: There are no difference between the
inflammatory response that occurs after hepatic resec-
tion CRLM, comparing OS with the LS by HALS.
PO01-05
OPEN LIVER RESECTION FOR
COLORECTAL METASTASES INDUCED
A SIGNIFICANT INCREASE IN
INTERLEUKIN-6 AS COMPARED TO
LAPAROSCOPIC TECHNIQUE
Aasmund Avdem Fretland1, Andrey Sokolov1, Nadya
Postriganova1, Airazat M. Kazaryan2, Bard I. Røsok1,
Bjørn A Bjørnbeth1, Tom E Mollnes1 and Bjørn
Edwin1
1Oslo University Hospital, Norway; 2Telemark Hospital
Trust, Norway
Introduction: The Oslo CoMet-study is an open, ran-
domized, controlled trial comparing open and laparo-
scopic resection for colorectal liver metastases
(CRLM). The primary end point is complication rate.
The aim of this sub-study was to explore differences in
activation of the cytokine network, as judged by Inter-
leukin-6 (IL-6), between the two techniques.
Method: The first 45 patients in the trial were included
in the sub-study. All patients were operated with local
resection of one or more CRLM, liver parenchyma was
mostly divided using LigaSure, assisted by the Sono-
Surg Aspirator or Endo-GIA. Blood samples were
obtained preoperatively, after anesthesia, at set time
points during surgery and 2, 6 and 24 hours after sur-
gery. EDTA-plasma was snap-frozen at 80°C and
analysed for IL-6 using luminex technique. Two
patients, one in each group, had to be excluded because
of technical problems with the blood samples, while
one patient withdrew from the study after randomiza-
tion.
Results: In the open group, IL-6 increased significantly
from 27.7 pg/mL from time point before operation, to
a maximum of 72.0 pg/mL at the end of surgery and
declined to 42 pg/mL 24 hours postoperatively
(n = 21). In contrast, IL-6 remained stable from start
of operation (24.5 pg/mL) during the observation per-
iod with a slight increase to 27 pg/mL at the end of
surgery in the laparoscopic group (n = 21). The differ-
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ence between the groups at the end of surgery was sta-
tistically significant (p = 0.004).
Conclusions: These data indicate that open liver resec-
tion for CRLM induces a more pronounced inflamma-
tory response than the laparoscopic technique.
PO02-01
TRIPLE POSITIVE TUMOR MARKERS
OF EARLY STAGE HEPATOCELLULAR
CARCINOMA IS A PREDICTOR OF
MICROSCOPIC VASCULAR INVASION
AND SATELLITE NODULES
Masaki Ueno, Masaji Tani, Manabu Kawai, Shinya
Hayami, Seiko Hirono, Kennichi Okada, Atsushi
Shimizu, Yoshinobu Shigekawa and Hiroki Yamaue
Wakayama Medical University, Japan
Introduction: Microscopic vascular invasion (MVI) or
microscopic satellite nodules (MSN) around an early-
stage hepatocellular carcinoma (HCC) nodule have
been revealed to be a prognostic factor. Therefore,
predicting MVI or MSN has become the next con-
cern. Recent development of imaging diagnosis could
depict tumor in detail and made it possible to predict
MVI or MSN. Also measuring tumor markers such
as alpha-fetoprotein (AFP), lens culinaris agglutinin-
reactive fraction of AFP (AFP-L3) and des-gamma-
carboxy prothrombin (DCP) were revealed to be use-
ful for predicting tumor malignancy. In current study
we aimed to investigate the most valuable predictor
for MVI or MSN under the situation that the sur-
veyed population was limited to HCC with 5 cm or
smaller single nodule and without major vessel inva-
sion.
Method: In this study 140 patients were retrospec-
tively analyzed. Data of serum AFP, AFP-L3, and
DCP levels, tumor size, and tumor margin pattern
were gathered and analyzed using univariate and
multivariate logistic analyses to extract MVI or MSN
predictors.
Results: In univariate analysis, each tumor marker
and tumor margin pattern were recognized as potent
predictors. Areas under the receiver operating charac-
teristics curve of AFP, AFP-L3, and DCP were 0.67,
0.61, and 0.69, respectively and revealed not to be
powerful predictors as a continuous variables. In
multivariate analysis, triple positive tumor markers
and tumor margin pattern were significant predictors
for MVI or MSN. The odds ratio (95% confidence
interval) were 14.8 (1.71–128.3) and 2.44 (1.02–5.86),
respectively. The incidence of MVI or MSN was
60% among patients with both positive predictors.
Conclusions: Triple positive status of following three
tumor markers; AFP, AFP-L3, and DCP were clini-
cally most useful for predicting microscopic vascular
invasion or microscopic satellite nodules. This would
be helpful for selecting treatment strategy.
PO02-02
HIGH VASCULAR ENDOTHELIAL
GROWTH FACTOR AND MATRIX
METALLOPROTEINASE-2 PREDICT
INTRAHEPATIC TUMOR RECURRENCE
IN HEPATOCELLULAR CARCINOMA
PATIENTS RECEIVING
RADIOTHERAPY
Yang-Gun Suh, Eun-Jung Lee, Hyejung Cha, Seung-
Hyun Yang and Jinsil Seong
Yonsei University College of Medicine, Korea
Introduction: Hepatocellular carcinoma (HCC) is a
highly vascularized tumor, and it is known that pro-
angiogenic factors such as matrix metalloproteinase
(MMP)-2, MMP-9, or vascular endothelial growth fac-
tor (VEGF) involve tumor growth and metastasis. In
this study, we investigated prognostic and predictive
value of these pro-angiogenic factors in HCC patients
receiving radiotherapy (RT).
Method: Between September 2008 and December 2009,
a total of 50 patients treated with RT were prospec-
tively enrolled. Patients’ serum and urine were collected
before and <1 week after RT. Serum VEGF levels were
analyzed using cytokine bead assay (CBA), and urine
MMP-2 and MMP-9 levels were measured by enzyme-
linked immunosorbent assay (ELISA). Serum VEGF
levels are normalized by the patient’s platelet count to
eliminate VEGF-scavenging effect of platelet. During
RT, concurrent chemotherapy was given intraarterially
in 32 and systemically in three patients, respectively.
Results: Tumor response was shown as complete
response in 1 (2%) and partial response in 34 patients
(68%). After completion of RT, serum VEGF/platelet
levels were significantly increased (p = 0.00). Patients
who experienced intrahepatic tumor recurrence outside
RT field showed higher pre-RT and post-RT VEGF/
platelet compared with patients who did not (p = 0.05),
whereas patients who had intrahepatic tumor recur-
rence inside RT field showed significantly higher pre-
RT MMP-2 (p = 0.04). On multivariate analyses,
patients with combined low pre-RT VEGF and MMP-
2 levels (p = 0.08).
Conclusions: In HCC patients receiving RT, preRT
level of VEGF/platelet and MMP-2 can be useful to
predict treatment outcome. This study also suggests
necessity of anti-angiogenic therapy, since RT might
increase VEGF/platelet and higher levels of VEGF/
platelet and MMP-2 are associated with intrahepatic
tumor recurrence.
PO02-03
THE ROLE OF SURVIVIN EXPRESSION
IN HEPATOCELLULAR CARCINOMA: A
CORRELATION WITH OVERALL
SURVIVAL
John Contis1, Panagis Lykoudis1, Konstantinos
Nastos1, Konstantinos Karapanos1, Dionysis Voros1
and Agathi Kondi-Pafiti2
1University of Athens Medical School, Greece;
2Aretaieion Hospital, Greece
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Introduction: Survivin is a member of the inhibitors of
the apoptosis (IAP) family, involved in cell division
regulation and inhibition of apoptosis. Over expression
of survivin has been found in many human malignan-
cies usually accompanying more aggressive forms fol-
lowed by worse outcomes. This study aimed to assess
the potential prognostic role of survivin expression in
hepatocellular carcinoma surgically treated and to
examine whether established prognostic markers (grade,
vascular invasion, fibrosis score) are confounding fac-
tors in the correlation between survivin expression and
overall survival following hepatectomy for HCC.
Method: We retrospectively studied, patients with
hepatocellular carcinoma treated surgically in our
department. Paraffin-embedded archived tissue and his-
topathology slides were retrieved concerning 99 consec-
utive specimens with hepatocellular carcinoma. A
Ventana automatic immunostain method was applied
for Survivin, with appropriate positive and negative
controls. Patients were stratified according to presence
of positive surviving stain and a Kaplan-Meier analysis
was conducted. A Cox regression analysis was applied
including variables of sex, age, positive resection mar-
gin, tumor grade, F score, vascular invasion existence
of virus hepatitis, postoperative complications, tumor
multicentricity (satellite nodules), and extent of resec-
tion to control for known dismal prognostic factors.
Results: A positive surviving immunostain was
observed in 78 specimens. Survivin correlated with
grade (p = 0.008). According to a Cox regression
analysis, the covariates that had a statistically signifi-
cant relation to survival were the existence of positive
survivin stain, positive resection margins and the extent
of hepatectomy. Survivin expression was found to be
independently a prognostic factor of overall survival by
the log rank test (p < 0.05).
Conclusions: Survivin expression is a prognostic factor
of overall survival in hepatocellular carcinomas treated
by surgical resection and its significance is independent
of expression of established prognostic factors.
PO02-04
DOWN-EXPRESSION OF HERPESVIRUS
ENTRY MEDIATOR IN
HEPATOCELLULAR CARCINOMA IS
ASSOCIATED WITH WORSE SURGICAL
OUTCOMES
Jun Li, Ying Hou, Yong Xia, Dong Wu, Kui Wang,
Lehua Shi, Meng-Chao Wu and Feng Shen
Eastern Hepatobiliary Surgery Hospital, Second
Military Medical University, Shanghai, China
Introduction: Costimulatory molecule herpesvirus entry
mediator (HVEM) is important to regulation of
immune microenvironment. However, its prognostic
role and possible mechanisms in human solid tumor
has not been reported. The purpose of this study was
to investigate the relationship between HVEM expres-
sion and prognosis of patients with hepatocellular car-
cinoma (HCC) following hepatectomy.
Method: A primary and validation cohorts of patients
who underwent curative hepatectomy for HCC at the
Eastern Hepatobiliary Surgery Hospital from 2002 to
2005 and at the First Affiliated Hospital of Fujian
Medical University from September 2001 to March
2009 were studied. HCC and matched peritumoral liver
tissues were semiquantitatively analyzed for HVEM
expression, followed by correlation with clinicopatho-
logical parameters (patient outcomes). Moreover, the
regulation of tumor immunity by HVEM from the
aspect of the activation of cytotoxic lymphocyte (CTL)
and natural killer cell (NK) was explored by immuno-
fluorescent staining and cytotoxic effect assay.
Results: Low expression of HVEM in HCC tissue but
not in peritumoral tissue was associated with poorer
overall survival (OS) and time to recurrence (TTR),
which was further reconfirmed in validation cohort.
Multivariate analysis demonstrated the expression level
of HVEM is an independent risk factor for both DFS
and OS rate (hazard ration, HR = 0.097 for recurrence,
p = 0.002; HR = 0.131 for survival, p = 0.009). Nota-
bly, HVEM low expression contributed to the low level
of MHC-ABC and CTL activity in tumor tissue and
human heptoma cell lines. Moreover, down-regulation
of NK-mediated tumor immunity attributed to the low
level of HVEM in vitro and in vivo.
Conclusions: HVEM low expression in HCC is strongly
correlated with worse surgical outcome, which may
resulted from down-regulation of tumor immunity
mediated by CTL and NK cells. This molecule may be
a potential intervention target.
PO02-05
IMPACT OF EGF SINGLE-NUCLEOTIDE
POLYMORPHISM AND RECEPTOR
EXPRESSION ON RECURRENCE OF
HEPATOCELLULAR CARCINOMA
AFTER HEPATECTOMY
Shohei Yoshiya, Ken Shirabe, Tomohiro Iguchi,
Mizuki Ninomiya, Yo-ichi Yamashita, Toru Ikegami,
Shinji Okano, Tomoharu Yoshizumi, Hirofumi
Kawanaka and Yoshihiko Maehara
Kyushu University, Japan
Introduction: Epidermal growth factor (EGF) gene sin-
gle-nucleotide polymorphism (SNP) is associated with
an increased risk of hepatic tumors. This study aimed
to elucidate the impact of EGF SNP and EGF receptor
(EGFR) expression on the recurrence of hepatocellular
carcinoma (HCC) after hepatectomy.
Method: We retrospectively analyzed 141 HCC patients
with chronic hepatitis C virus infection who underwent
curative hepatectomy.
Results: The EGF *61 GG allele was present in 69
patients (48.9%), AG in 56 (39.7%), and AA in 16
(11.4%). The AA group had a significantly lower rate
of intrahepatic metastasis (0% vs. 16.5%, p = 0.02),
lower serum EGF concentration (26.3  15.9 pg/ml vs.
43.4  30.5 pg/ml, p = 0.02), and lower proportion of
multiple and extrahepatic recurrence (0% vs. 43.9%,
p = 0.006) than the AG/GG group. The AA group had
a significantly higher recurrence-free survival (RFS)
than the AG/GG group (p = 0.04), but there was no
significant difference in overall survival (OS) between
these two groups (p = 0.97). High versus low EGFR
expression in cancer cells was not significantly associ-
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ated with OS (p = 0.37) or RFS (p = 0.39). There was
no significant association between EGFR expression
and EGF genotype (p = 0.46) or serum EGF concen-
tration (p = 0.87).
Conclusions: EGF *61 AA was associated with a lower
risk of recurrence after curative hepatectomy for HCC
in patients with hepatitis C virus infection than other
genotypes, but EGFR expression in cancer cells was
not significantly associated with prognosis.
PO03-01
NEGATIVE IMPACT OF FRESH
FROZEN PLASMA TRANSFUSION ON
PROGNOSIS OF PANCREATIC DUCTAL
ADENOCARCINOMA AFTER
PANCREATIC RESECTION
Hiroaki Shiba, Takeyuki Misawa, Yuki Fujiwara,
Yasuro Futagawa, Tomonori Iida, Kenei Furukawa,
Koichiro Haruki, Ryota Iwase, Yoshihiro Shirai and
Katsuhiko Yanaga
Jikei University School of Medicine, Japan
Introduction: Excessive blood loss and blood transfu-
sion may influence post-operative complications and
prognosis of patients after pancreatic resection. We
evaluated the influence of blood products use on post-
operative recurrence and outcome of patients with pan-
creatic ductal adenocarcinoma.
Method: The subjects were 82 patients who underwent
elective pancreatic resections for pancreatic ductal ade-
nocarcinoma without distant metastasis nor other
malignancies between January 2001 and December
2010. We retrospectively investigated the influence of
the use of peri-operative blood products including red
cell concentration, fresh frozen plasma (FFP), and
albumin preparation, and clinical variables on disease-
free and overall survival.
Result: In disease-free survival, serum carcinoembry-
onic antigen more than 10 ng/mL (p = 0.015), serum
carbohydrate antigen 19-9 (CA19-9) more than 200 U/
mL (p = 0.0032), R1 resection (p = 0.005), and FFP
transfusion were independent risk factor for cancer
recurrence in the Cox proportional regression model.
Pancreaticoduodenectomy (p = 0.057) and advance
tumor stage (p = 0.083) tended to be associated with
poor disease-free survival, but not statistically signifi-
cant. In overall survival, female (p = 0.012), advance
tumor stage (p = 0.005), serum CA19-9 more than
200 U/mL (p < 0.001), and FFP transfusion
(p = 0.003) were positively associated with poor overall
survival in the Cox proportional regression model.
Conclusions: FFP transfusion is associated with poor
therapeutic outcome after elective pancreatic resection
for pancreatic ductal adenocarcinoma.
PO03-02
CORRELATION OF BIPHASIC CECT/
PET FUSION IMAGING AND
ENDOSCOPIC ULTRASOUND IN
PERIAMPULLARY MALIGNANCY WITH
OPERATIVE AND
HISTOPATHOLOGICAL FINDING
Sidharth Garg, Rajesh Gupta, Rajinder Singh and
Deepak K. Basin
PGIMER Chandigarh, India
Introduction: A prospective ongoing study to evaluate
the diagnostic accuracy, tumor staging and resctability
results of Biphasic contrast enhanced Multidetector CT
PET(PET/CECT) hybrid imaging and Endoscopic
Ultrasound in patients of periampullary malignancy
and finally corellating them with per operative findings
and post operative histopathology.
Method: A total of thirty(n = 30) patients of periampul-
lary malignancy proven or suspected with no evidence of
distant metastasis underwent biphasic CECT PET
hybrid imaging and Endoscopic Ultrasound.
The patients (n = 18) who were found to have a resect-
able disease on Biphasic PET -CT scan and EUS were
operated upon at an earliest available date and an opera-
tive and pathological diagnosis was made accordingly.
Results: Out of the total patients (n = 30), 18 (n = 18)
were found to have a resectable disease on PET/CECT
scan and Endoscopic Ultrasound. The patients found
to have unresectable disease in either of the diagnostic
modality (n = 12) were excluded from the study.
The patients with resectable disease (n = 18) underwent
laparotomy. Intra operatively (n = 5) were found to
have unresectable disease. Rest of the patients (n = 13)
underwent pancreatodudenectomy.
Those who underwent resection (n = 13), the resected
specimen was evaluated histopathologically for final
correlation.
Conclusions: PETCTwith intravenous contrast enhance-
ment might have the potential of being established as a
single’ staging investigation in cases of periampullary
malignancies but this will require further validation.
PO03-03
PHASE I/ II STUDY OF CONCURRENT
CHEMORADIOTHERAPY WITH
GEMCITABINE AND S-1 FOR
UNRESECTABLE LOCALLY ADVANCED
PANCREATIC ADENOCARCINOMA
Tatsuya Ioka, Kazuhiro Katayama, Reiko Ashida and
Ryoji Takada
Osaka Medical Center for Cancer and CVD, Japan
Introduction: Survival benefit of chemoradiotherapy for
the unresectable locally advanced panreatic cancer is
not proven with Phase III study, yet.
Purpose: The primary objective of this study is to
assess the efficacy and toxicity of concurrent radiother-
apy with a combination of Gemcitabine (GEM) and S-
1 for unresectable locally advanced pancreatic cancer.
Method: Chemotherapy-naive patients with histologi-
cally or cytologically proven unresectable locally
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advanced pancreatic adenocarcinoma were enrolled to
this trial. The patients received gemcitabine intrave-
nously over 30 min. on days 1 and 8 and S-1 orally b.i.d.
from days 1 to 14. Cycles were repeated every 21 days
until disease progression. Patients were scheduled to
receive gemcitabine (mg/msq/week) and S-1 (mg/msq/
day) at five dose levels: 600/50 (level 1), 600/60 (level 2),
800/60 (level 3), 800/70 (level 4) and 1000/70(level 5).
Radiation therapy was delivered through four fields as a
total dose of 50.4 Gy in 28 fractions over 5.5 weeks, and
no prophylactic nodal irradiation was given. Dose-limit-
ing toxicity (DLT) was defined as grade 4 thrombocyto-
penia, grade 4 neutropenia, or grade 3 non-hematologic
toxicity. Every patients were evaluated for response with
RECIST criteria by a radiologist.
Results: Fifteen patients were enrolled in phase I study
between 05/12 and 07/05. The maximum-tolerated dose
was level 2, Gem 600 mg/ S-1 60 mg. Six patients expe-
rienced DLT (four patients with anorexia and two
patients with Gr4 neutropenia). Fifteen patients were
added to phase II study, and finally 21 patients treated
with the recommended dose of phase I were enrolled to
phase II part. Treatment was well tolerated. Response
rate(RR) was 52% and 1 year survival rate was 76%.
Conclusions: The chemoradiation therapy with a combi-
nation of GEM and S-1 can be one of the most promis-
ing options for unresectable locally advanced pancreatic
cancer.
PO03-04
DETECTION OF PANCREATIC CANCER
BY ATR-FTIR SPECTROSCOPY
Katherine Oliver2, Jorge Paulino1, Eduardo Barroso1,
Graca Soveral3 and Peter Rich2
1Universidade Nova de Lisboa - Hospital Curry Cabral,
Portugal; 2Institute of Structural and Molecular Biology,
University College, London, UK; 3Faculty of Pharmacy,
University of Lisbon, Portugal
Introduction: Pancreatic cancer is the fourth most com-
mon cause of cancer deaths worldwide and has a 5 year
survival rate of <5%. The high mortality rates can, in
part, be attributed to diagnosis only at advanced stage.
A rapid and sensitive diagnostic method, with the
potential to detect presymptomatic disease, is therefore
desirable. Mid-infrared (IR) spectroscopy is a sensitive
analytical technique that exploits absorption of IR
radiation arising from molecular vibrational properties.
It can be used to study a wide range of materials
including complex mixtures and biological samples,
revealing subtle differences between samples or quanti-
tative information on specific components. Attenuated
total reflection (ATR) technology, in combination with
Fourier Transform infrared (FTIR) spectroscopy,
allows samples to be analysed rapidly and with little or
no sample preparation. There is a growing literature on
potential medical diagnostic applications of ATR-FTIR
spectroscopy in many areas including cancer diagnos-
tics. FTIR-spectroscopy has been used already to detect
early-stage and premalignant changes in a number of
cancers including cervical, lymphoid, and oesophageal.
Here, it has been applied to the diagnosis of pancreatic
cancer1.
Method: Twenty eight healthy or tumorous pancreatic
resections were collected during major pancreatic sur-
gery and immediately frozen in dry ice. ATR-FTIR
absorbance spectra were recorded after thawing. After
spectral pre-processing and conversion into second
derivative form, an initial survey was made of potential
distinguishing features.
Results: Several features in the ATR-FTIR absorbance
spectra provided good discrimination between the
healthy and tumour samples, producing clear clustering
of normal and diseased samples in 3D plots.
Conclusions: This preliminary analysis indicates that it
is possible to distinguish normal pancreas tissue from
tumorous tissue using IR spectroscopy, with scope for
applying the method to detection of early stage disease.
References: 1. Movasaghi Z, et al: Fourier Transform
Infrared (FTIR) Spectroscopy of Biological Tissues.
LAPS 43:134-179, 2008.
PO03-05
LONG-TERM SURVIVORS AFTER
PANCREATECTOMY IN PANCREATIC
CANCER
Sung Hwan Lee, Chang Moo Kang, Ho Kyoung
Hwang, Sung Hoon Choi and Woo Jung Lee
Yonsei University College of Medicine, Korea
Introduction: Despite of improvement of diagnostic
techniques and treatment modalities for pancreatic can-
cer, the oncologic outcome after surgical resection has
been still poor compared to other malignancies. The aim
of this study is to evaluate the clinicopathologic charac-
teristics of long-term survivors after pancreatectomy for
pancreatic cancer compared with short-term survivors.
Method: Among 320 patients who were underwent
pancreatectomy for pancreatic cancer from October
1990 to December 2012, thirty-five long-term survivors
who survived more than 5 years after surgery and 110
short-term survivors who died within 2 years following
operation were identified. The clinicopathologic fea-
tures including demographics, perioperative outcomes,
pathologic examination, and postoperative complica-
tions were compared between long-term and short-term
survivors.
Results: There was no significant difference between
two groups concerning demographics and perioperative
factors including neoadjuvant and adjuvant treatment.
In clinicopathologic features, TNM stage (Long-term
vs. Short-term survivor; stage IA 11.8% vs. 0%, IB
8.8% vs. 2.8%, IIA 38.2% vs. 42.6%, IIB 35.3% vs.
51.9%, III 5.9% vs. 0%, IV 0% vs. 2.8%, p < 0.001)
was significant prognostic factor and perineural inva-
sion (26.5% vs. 43.1%, p = 0.082) showed marginally
significant value. More frequent postoperative compli-
cation rates were observed in short-term survivors with
marginally statistical significance (31.4% vs. 49.1%,
p = 0.067). In multivariate overall survival analysis, the
presence of postoperative complication showed signifi-
cant higher hazard ratio (Exp(B) = 1.782, 95% CI:
1.193–2.660, p = 0.005).
Conclusions: Postoperative complications may influence
the oncologic survival outcome of patients who under-
went curative pancreatectomy for pancreatic cancer.
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PO04-01
EVALUATION OF THE SENDAI AND
2012 INTERNATIONAL CONSENSUS
GUIDELINES BASED ON CROSS-
SECTIONAL IMAGING FINDINGS
PERFORMED FOR THE INITIAL
TRIAGE OF MUCINOUS CYSTIC
LESIONS OF THE PANCREAS: A
SINGLE INS
Brian Goh, Choon Hua Thng, Damien Tan, Albert
Low, Peng-Chung Cheow, Jen-San Wong, Pierce
Chow, Alexander Chung, Wai-Keong Wong and
London Ooi
Singapore General Hospital, Singapore
Introduction: The Sendai Consensus Guidelines (SCG)
was formulated in 2006 to guide management of
mucinous cystic lesions of the pancreas (CLP) and this
international consensus guidelines was updated in 2012
(ICG 2012). This study aims to evaluate and compare
the clinical utility of the ICG 2012 with the SCG based
on initial cross-sectional imaging findings performed in
mucinous CLP.
Method: The records of 114 patients with pathologi-
cally proven mucinous CLP were retrospectively
reviewed and classified according to the ICG 2012 as
high risk (HRICG2012), worrisome (WICG2012), low risk
(LRICG2012) and according to the SCG as high risk
(HRSCG) and low risk (LRSCG).
Results: On univariate analysis; the presence of symp-
toms, obstructive jaundice, elevated serum CEA/CA
19-9, presence of solid component and dilated
MPD ≥ 10 mm or ≥5 mm was associated with high
grade dysplasia (HGD)/invasive carcinoma in all
mucinous CLP. Increasing number of HRSCG or HR
ICG2012 features was associated with a significantly
increased likelihood of malignancy. The positive predic-
tive value (PPV) of HRSCG and HRICG2012 for HGD/
invasive carcinoma was 46% and 62.5% respectively.
The presence of elevated serum tumor markers
improved the PPV of HRSCG to 69%, p = .011 and
HRICG2012 to 83%, p = .103. The negative predictive
value of both LRSCG and LRICG2012 was 100%.
Conclusions: Both the SCG and ICG 2012 were useful
in the initial cross-sectional imaging evaluation of
mucinous CLP. The ICG 2012 guidelines were superior
to the SCG.
PO04-02
EXPRESSION OF SOMATOSTATIN
RECEPTOR SUBTYPES IN
PANCREATIC NEUROENDOCRINE
TUMORS
Ki Byung Song, Song Cheol Km, Young-Joo Lee,
Kwang-Min Park, Jae Hoon Lee, Jeong Su Nam, Jong
Hee Yoon, Dong Joo Lee and Jung Woo Lee
Asan Medical Center, Ulsan University, Korea
Introduction: Studies on the expression of somatostatin
receptor (SSTR) subtypes in pancreatic neuroendocrine
tumors (PNETs) are rare. The aim of this study was to
determine the expression of the SSTR subtypes via
immunohistochemistry analyses and assess the correla-
tion between SSTR subtype expression status and prog-
nosis.
Method: We examined 199 patients with PNET under-
went surgical resection between January 1995 and
December 2010 at the Asan Medical Center. For all
cases, medical records, including demographic data,
clinical symptoms, radiological findings, post-operative
treatment outcomes, and expression of SSTR subtypes,
were carefully reviewed.
Results: In total, 37 tumors (18.6%) displayed no
somatostatin receptor immunoreactive staining, and
162 (81.4%) expressed more than one SSTR subtype.
The most commonly expressed subtype was SSTR2
(109/199, 55.9%). Functioning PNET expressed signifi-
cantly more SSTR subtypes, compared to non-func-
tioning PNET. SSTR5 was highly expressed in WHO
grade 1(Gr1) PNET relative to grade 2 or 3 (Gr2 or
Gr3) PNET. The SSTR2(+) and SSTR5 (+) groups had
better prognosis than the SSTR2(-) (p = 0.0436) and
SSTR5(-) groups (p = 0.0266), respectively.
Conclusions: The majority of PNETs expressed more
than one somatostatin receptor subtype. The most
commonly expressed somatostatin subtype in PNETs
was SSTR2. SSTR5 was highly expressed in Gr1 and
functioning PNET. The expression of SSTR 5 was
related with good prognosis of PNET.
PO04-03
DEVELOPMENT OF BIOMARKERS FOR
INTRADUCTAL PAPILLARY
MUCINOUS NEOPLASM OF THE
PANCREAS USING MULTIPLE
REACTION MONITORING
Ikwon Kim1, Jiyoung Yu1, Mee Joo Kang1, Junghyun
Namkung2, Taegyun Yun2, Sangjo Han2, Wooil
Kwon1, Jin-Young Jang1, Sun Whe Kim1 and
Youngsoo Kim1
1Seoul National University College of Medicine, Korea;
2Healthcare group, SK telecom, Korea
Introduction: Intraductal papillary mucinous neoplasm
(IPMN) of the pancreas, which was first described in
the 1980s, is a cystic neoplasm of the pancreas that is
being diagnosed with increasing frequency as an inci-
dental finding on MRI or CT scans of the abdomen
performed for some other indication. Two distinct vari-
ants have been described: main duct and branch duct.
IPMN is a slow-growing tumor that has malignant
potential. For this reason, there is an urgent need for
early and predictive biomarkers for pancreatic cancer.
Method: We adopted multiple reaction monitoring
(MRM) methods to perform targeted quantification of
significantly changed proteins in IPMN. The target
proteins were selected by microarray data and data
mining from previous papers, the Oncomine database,
the Metacore database and the Pathway studio data-
base. Of the total target proteins, over 200 proteins,
which were detected in preliminary MRM, were applied
to individual plasma MRM. Individual plasma MRM
was performed for 99 human plasma samples, which
consisted of 50 controls and 49 IPMN. The 50 control
plasma samples comprised 25 normal control plasma
© 2014 The Authors
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samples (NC) and 25 chronic cholecystitis plasma sam-
ples (CC). Forty-nine IPMN plasma samples consisted
of 31 benign IPMN plasma samples (bIPMN) and 18
malignant IPMN plasma samples (mIPMN). All MRM
analyses were performed using triple quadrupole mass
spectrometry.
Results: We compared MRM data by three means:
(1) NC + CC vs. bIPMN + mIPMN; (2) NC vs.
bIPMN + mIPMN; (3) bIPMN vs. mIPMN. In the three
sets, candidate marker proteins showing area under curve
(AUC) values >0.7, with p-values <0.05, were selected.
Conclusions: Further, a large cohort study is currently
underway using MRM analysis for selected proteins
identified in this study. The number of samples is
approximately 1000, representing various diseases,
including pancreatic cancer and other cancers.
PO04-04
PREDICTORS OF MALIGNANCY IN
INTRADUCTAL PAPILLARY
MUCINOUS NEOPLASM OF THE
PANCREAS (IPMN) - ANALYSIS OF 310
PANCREATIC RESECTION PATIENTS
AT MULTIPLE HIGH VOLUME
CENTERS
Yasuhiro Shimizu1, Hiroki Yamaue2, Hiroyuki
Maguchi3, Kenji Yamao1, Seiko Hirono2, Manabu
Osanai3, Susumu Hijioka1 and Akio Yanagisawa4
1Aichi Cancer Center Hospital, Nagoya, Japan;
2Wakayama Medical University, Wakayama, Japan;
3Teine-Keijinkai Hospital, Sapporo, Japan; 4Kyoto
Prefectural University of Medicine, Kyoto, Japan
Introduction: The present study was a retrospective
investigation of predictors of malignancy in intraductal
papillary mucinous neoplasm of the pancreas (IPMN).
Method: The study population was 310 patients with
IPMN who underwent pancreatic resection at Aichi
Cancer Center Hospital, Wakayama Medical University,
or Teine-Keijinkai Hospital between 1996 and March
2011. The investigation of predictors of malignancy was
done for 10 factors: age at time of surgery, sex, presence
or absence of symptoms, serum amylase, CA19-9, CEA,
tumor location, size of mural nodules (S-MN), diameter
of main pancreatic duct (D-MPD), and cyst size of
branch pancreatic duct (CS-BPD). Endoscopic ultraso-
nography (EUS) measurements were essential for S-MN,
and CT measurement values were used for D-MPD and
CS-BPD. In this study, a central review was conducted
for pathological diagnosis and, patients were categorized
as benign (IPMA and IPMB) or malignant (noninvasive
and invasive IPMC). The significance of each prognostic
factor was assessed by logistic regression analyses. A
receiver operating characteristics (ROC) curve was used
to measure the predictive accuracy of each independent
predictor of malignant IPMN.
Results: Pathological diagnosis was benign IPMN in
150 cases and malignant in 160 (noninvasive carcinoma
100, invasive 60). In univariate analysis age, CA19-9, S-
MN, D-MPD, and CS-BPD were significant factors. In
multivariate analysis, S-MN, D-MPD, and CS-BPD
were independent predictors of malignancy, and in
ROC analysis AUC for these 3 factors was 0.798,
0.643, and 0.601, respectively. With 7 mm taken as the
cutoff value for S-MN, the diagnosis of malignant
IPMN had sensitivity of 74.3% and specificity of
72.7%. Carcinoma without nodules was present in 15
patients (15/160 = 9.4%).
Conclusions: S-MN measured with EUS showed high
predictive ability. However, about 10% of carcinoma
patients did not have nodules, and the handling of the
diagnosis in such cases is a problem for the future.
PO04-05
PROGNOSTIC FACTORS IN A 95
PATIENTS SERIES OF PANCREATIC
NEUROENDOCRINE TUMORS WITH
PANCREATIC RESECTION
Francisco Sanchez-Bueno, Gloria Torres, Maria
Balsalobre, Jose Manuel Rodriguez, Antonio Bernabe,
Rocio Garcia, Pedro Gil, Eduardo Ortiz and Pascual
Parrilla
Hospital Clinico Universitario “Virgen de la Arrixaca”
Murcia, Spain
Introduction: The aim is to show our experience with
95 patients operated on pancreatic neuroendocrine
tumors (PNT) by analyzing the prognosis factors,
which affect the survival.
Method: Medical records of 95 patients with pancreatic
resection were retrospectively reviewed. The variables
studied were: age, sex, form of presentation, (sporadic
/familial tumors), functionality, type of tumor, localiza-
tion, diagnostic tests (analytical/image tests), type of
surgery, tumor size, multifocal tumors and recurrent
rate. It has been used the new WHO classification.
Results: Fourty five were males and 50 women. The
average age was 46.8 years. Regarding on the presenta-
tion form, it was sporadic in 66 patients (69.8%) and 29
cases were familial neuroendocrine tumors (30.2%) in
association with NEM 1 syndrome. 59% of patients suf-
fered from non-functional tumors and 41% were func-
tional: 20 insulinoma, 12 gastrinoma, 4 hypergastrinemia
and 3 glucagonoma. The most popular surgery per-
formed was distal pancreatectomy, followed by tumor
enucleation in 19 patients. There was synchronous liver
metastasis in 28 patients, all of them from the sporadic
group. 10 patients needed liver transplant and metastases
resection was made in 7 cases. According to WHO classi-
fication, 59 patients had a well-differentiated (43
functional and 16 non-functional), 24 with a well-differ-
entiate carcinoma (six functional and 18 non-functional)
and 12 with a poorly-differentiate carcinoma (two func-
tional and 10 non-functional), respectively. The 5-year
survival in well-differentiate tumors was 100%, regard-
less of the functionality. In contrast very poorly-differen-
tiate tumors global survival is less than 5 years. Sporadic
PNT used to be unifocal (p < 0.001), associating liver
metastasis (p < 0,003). After an average follow-up of
84.3 months (range 4–293), disease-free and recurrent
rates were 65.8% and 24% respectively.
Conclusions: In our experience, WHO classification was
an independent prognostic factor in PNT survival. Spo-
radic tumors are usually non-functional with extra-pan-
creatic extension and worse prognosis.
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PO05-01
IMPACT OF A TRANSFUSION FREE
PROGRAM ON PATIENTS
UNDERGOING
PANCREATICODUODENECTOMY
Young Bae Jeon1, Myung Jin Kim1, Sora Park1, Si
Young Ok1, Kyung Yul Hur1 and Dongho Choi2
1Soonchunhyang University College of Medicine, Korea;
2Hanyang University School of Medicine, Korea
Introduction: Despite the improvement of surgical
techniques, patients undergoing pancreaticoduodenec-
tomy (PD) often require transfusion. However, trans-
fusion related complications and decreased blood
donations in Korea encourage us to develop new
strategy for PD patients. Nonetheless the advantage
of transfusion free (TF) PD is recognized, study
results suggesting beneficial effect of transfusion free
PD are lacking. The aim of our study was to demon-
strate the impact of transfusion-free program on PD
patients.
Method: From December 2003 to October 2012, 70
consecutive patients with periampullary lesion under-
went PD at Soonchunhyang University Hospital by
one surgeon. The patients were categorized into 2
groups as follows: 39 PD patients before TF program
(group 1), and 31 PD patients after TF program
(group2). Patients who agreed with TF program were
enrolled before the operation, and the program pro-
ceeded prospectively. Patients in TF group had periop-
erative blood augmentation and intraoperative acute
normovoleminc hemodilution. The perioperative data
including general patient characteristics, postoperative
complications, and the amount of blood transfusion
were compared respectively.
Results: Mean age, sex ratio, co-morbidity, preopera-
tive diagnosis, and the type of operation from clinical
data showed no statistical differences among two
groups. Mean preoperative hemoglobin level was
11.8 g/dl in group 1, and 11.9 g/dl in group 2
(p = 0.710). Mean operative time was 508.0 min. and
477 min. (p = 0.18), mean operative blood loss was
956 ml and 869 ml in group 1 and group 2 (p = 0.468),
respectively. The amount of blood transfusion was sig-
nificantly lower in group 2 (951 mL vs. 165 mL,
p < 0.0001).
Conclusions: TF program has considerably decreased
the amount of perioperative blood transfusion. The
overall perioperative course and complication rate in
TF group was not inferior, compared to other group.
We suggest that TF program is safe and should be con-
sidered in PD patients.
PO05-02
EFFECTS OF THE CLOSING SPEED
OF STAPLER JAWS ON BOVINE
PANCREASES
Akira Chikamoto, Shinya Abe, Daisuke Hashimoto,
Hidetoshi Nitta, Katsunori Imai, Hiromitsu Hayashi,
Takatoshi Ishiko, Toru Beppu and Hideo Baba
Kumamoto University, Japan
Introduction: Division of the pancreatic parenchyma
using a stapler is important in pancreatic surgery, espe-
cially for laparoscopic surgery. However, the procedure
using a stapler has not yet been standardized. Although
several reports have described the use of the stapler
technique in laparoscopic DP, none has focused on the
effects of staple jaw closure speed. We therefore
assessed the correlation between the speed of staple jaw
closure and pressure tightness after the division of
bovine pancreases with a stapler.
Method: We have analyzed the effects of closing speed
of a stapler jaw using five bovine pancreases in each
method. In slow compression method, the stapler jaw
was closed in 10 min., whereas, 5 min. in intermediate
compression method, and 30 seconds in the rapid com-
pression method. Three minutes of holding and 30 sec-
onds of dividing times were the same.
Results: We found that rapid compression method dem-
onstrated high-pressure tolerance compared to the other 2
groups (rapid, 126  49.0 mmHg; intermediate,
55.5  25.8 mmHg; slow, 45.0  15.7 mmHg; p < 0.01),
although the histological findings of the cut end were simi-
lar. The histological findings of pancreatic capsule and
parenchymaafter compression by staple jawwithout firing
werealsosimilar.
Conclusions: Rapid compression may provide an advan-
tage, as measured by pressure tolerance. A small series of
distal pancreatectomy with stapler comparing the speed
of the stapler jaw closing is required to prove the feasibil-
ity of these results after confirmation of the advantages
of rapid compression method under various setting.
PO05-03
SYMPTOM CLUSTERS AFTER
PANCREATODUODENECTOMY FOR
PERIAMPULLARY CANCER
In Woong Han1, Jin-Young Jang2, Mee Joo Kang2, Jae
Woo Park2, Wooil Kwon2, Ye Rim Chang2 and Sun-
Whe Kim2
1Dongguk University Ilsan Hospital, Korea; 2Seoul
National University College of Medicine, Korea
Introduction: Pancreatoduodenectomy (PD) or pylorus-
preserving pancreatoduodentomy (PPPD) is being per-
formed in increasing numbers for malignant diseases of
periampullary region with minimal mortality. The pur-
pose of this study is to find out and cluster the physi-
cal, emotional, and psychosomatic symptoms related
cancer after PD/ PPPD, to figure out the factor affect-
ing symptoms related cancer after PD/ PPPD.
Method: From 2007 to 2011, symptoms were analyzed
in single-center with prospective manner that included
181 patients who underwent PD/PPPD for periampul-
lary malignant diseases. Symptoms were assessed by
European Organization for Research and Treatment of
Cancer QLQ-C30 and PAN-26 module. Follow- up
and data collection were performed preoperative,
‘before discharge’, postoperative 3, 6, and 12 months.
Results: Mean age of patients was 61.5 years. The type
of operation included PD (20/ 181, 11.0%) and PPPD
(161/ 181, 89.0%). There were 4 distinct symptom clus-
ters consisted of ‘Pain-related’, ‘Gastrointestinal (GI)
function-related’, ‘Hepatic’, and ‘Pancreas exocrine
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function-related symptoms’ (The Cronbach a 0.752,
0.720, and 0.757, respectively). Adjuvant treatment was
the risk factor of ‘Pain-related symptoms (50/ 71,
70.4% vs. 60/ 110, 54.5%, p = 0.042)’ and ‘GI func-
tion- related symptoms (48/ 66, 72.7% vs. 62/ 115,
53.9%, p = 0.017)’. No use of postoperative pancreas
enzyme supplement (lipase 25,000 unit, amylase 22,500
unit, protease 1250 unit) was risk factor of ‘Pancreas-
exocrine function- related symptoms (51/ 69, 81.0% vs.
74/ 112, 66.7%, p = 0.044). All symptom clusters was
recovered on postoperative 3 month (hepatic,
p = 0.002; the other clusters, p < 0.001).
Conclusions: Most patients recovered well in aspects of
postoperative symptoms after PD/PPPD for periampul-
lary malignancy at postoperative 3 months after. How-
ever, careful follow-up and supportive management are
needed in the patients with symptom-related risk factor,
such as, adjuvant treatment or no use of enzyme sup-
plement.
PO05-04
THE CORRELATION BETWEEN GRADE
OF PANCREATIC FISTULA AND SHAPE
OF LIQUID STORAGE AROUND
PANCREATIC STUMP AFTER DISTAL
PANCREATECTOMY
Ryosuke Desaki, Hiroyuki Shinchi, Kosei Maemura,
Yuko Mataki, Hiroshi Kurahara, Taisaku Kuwahata,
Masahiko Sakoda, Shinichi Ueno and Sonshin Takao
Kagoshima University, Japan
Introduction: One of the severe morbidity associated
with distal pancreatectomy (DP) is pancreatic fistula
(PF). Recently, the rate of pancreatic resection by using
automatic stuturing device has been increasing with the
spread of laparoscopic pancreatectomy. To improve a
safety to normal pancreas, we have been utilizing the
auto suturing device. We determined the the correlation
between severity of pancreatic fistula and shape of
pancrleatic stump around liquid storage after DP.
Method: Subjects were 39 cases of DP by autosuture
conducted between 2006 and 2013. For confirmation of
the liquid storage around the pancreatic stump, we have
performed CT a week after surgery. PF was defined and
scored based on criteria of the International Study
Group on Pancreatic Fistula. We examined the following
four category, (1) the relationship between the grade of
PF and amylase score in the peritoneal cavity on the first
postoperative day, (2) the change of amylase, (3) the size
and (4) type of peritoneal cavity.
Results: The incidence of PF in all patients were Grade
A: 16 cases (41%), Grade B: 4 cases (10%), Grade C: 0
(0%). We observed fluid collection around pancreatic
stump in 30 cases (77%). The average length of liquid
storage was 20.0 mm in no PF, 39.5 mm in Grade A
and 84.0 mm in Grade B. The difference between the
grade of PF and the size of liquid size was observed
significantly (p = 0.0063). According to the shape in
the fluid accumulation, they was classified in two types,
localized type in 25 cases and diffused type in five
cases. Diffuse type has tended to be observed fre-
quently in Grade B.
Conclusions: Diffuse type and the large size of peripan-
creatic fluid is frequently observed in Grade B of pan-
creatic fistula. The cases with the spread of diffuse fluid
accumulation is necessary for attention to the transition
to pancreatic fistula grade B/C.
PO05-05
THE IMPACT OF LEFT GASTRIC
ARTERY PRESERVING DISTAL
PANCREATECTOMY WITH CELIAC
AXIS EN-BLOC RESECTION ON
DELAYED GASTRIC EMPTYING
Ken-ichi Okada, Hiroki Yamaue, Masaji Tani,
Manabu Kawai, Seiko Hirono, Motoki Miyazawa,
Atsushi Shimizu and Yuji Kitahata
Wakayama Medical University, Japan
Introduction: The incidence of delayed gastric emptying
(DGE) is high in patients undergoing distal pancreatec-
tomy with celiac axis en-bloc resection (DP-CAR).
Method: The medical records of 37 consecutive patients
who underwent DP-CAR, including 23 (62%) left gastric
artery resecting DP-CAR (conventional DP-CAR) and 14
(38%) left gastric artery preserving DP-CAR (modified
DP-CAR), for pancreatic carcinoma were evaluated about
the incidence of DGE based on the severity classification
of the International Study Group of Pancreatic Surgery
(ISGPS) retrospectively. The patients with tumors situated
more than 10 mm away from antecedent branching left
gastric artery underwent modified DP-CAR.
Results: Among the patients who underwent conven-
tional DPCAR, there were nine patients with Stage IIA,
10 with Stage IIB, three with Stage III, and one with
Stage IV pancreatic carcinoma; among the patients
undergoing modified DPCAR, five patients were Stage
IIA, eight with Stage IIB, and one with Stage III. The
rate of antecedent branching of a left gastric artery was
51%. The shortest distance between the left gastric artery
and tumor was 13 mm in patients underwent modified
DP-CAR. The incidence of clinically significant DGE
(Grade B/C) was low in modified DP-CAR compared to
conventional DP-CAR (p = 0.031). ISGPS grading were:
no DGE 43%, grade A = 26%, B = 13%, and C = 17%
in original DP-CAR and no DGE 93%, grade A = 7%
in modified DP-CAR. The R0 rate (79%) was higher in
modified DP-CAR compared to that of conventional
DP-CAR (43%) (p = 0.048).
Conclusions: Modified DP-CAR significantly reduced
the incidence of DGE and with high R0 rate compared
with conventional DP-CAR.
PO06-01
OXALIPLATIN ASSOCIATED LIVER
LESIONS: A COMPARATIVE STUDY
BETWEEN SYSTEMIC AND HEPATIC
ARTERIAL ADMINISTRATION
Marc Antoine Allard1, Mylene Sebagh1, Gaelle Baillie2,
Peggy Dartigues2, Francois Faitot1, Matthieu Faron2,
Dominique Elias2, Rene Adam1, Diane Goere2 and
Antonio Sa Cunha1
1Paul Brousse Hospital, France; 2Institut Gustave
Roussy, France
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Introduction: The presence of severe oxaliplatin-
induced lesion (SOxL) in the non-tumoral liver carries
important risk after hepatectomy for colorectal liver
metastases (CLM). The impact of oxaliplatin adminis-
trated through hepatic arterial infusion (HAI) on the
NTL has not yet been studied. The aim of this study
was to investigate whether oxaliplatin HAI is more
often associated with SOxL.
Method: All patients (n = 135) operated on for CLMs
after oxaliplatin-based regimen only, with or without
targeted therapies between 2004 and 2010 in two insti-
tutions, were included. Chemotherapy was adminis-
tered by either systemic (n = 116) or HAI (n = 19)
route. SOxL were defined by the presence of sinusoi-
dal obstructive syndrome (SOS) grade 2 and 3 and/or
nodular regenerative hyperplasia, and were evaluated
by two expert pathologists, both blinded for clinical
data.
Results: The median number of cycles of oxaliplatin
was higher in the HAI group compared to the sys-
temic group, respectively 11 (3–25) and 6 (3–25).
SOxL were significantly more observed in the HAI
group (13 patients (68%)) compared to the systemic
group (19 patients (16%), p < 0.001). There was a
trend toward less SOxl in patients who received bev-
acizumab compared to those who did not (10% vs.
23%, p = 0.08). Among patients who received six
cycles or less of oxaliplatin, the rate of SOxL was still
significantly higher in the HAI group (100% vs. 13%,
p = 0.02). A number of cycle >6 and HAI administra-
tion were both associated with SOxL on univariate
analysis and on multivariate analysis, HAI administra-
tion was the sole independant predictor of SOxL [RR
9.1 (3.1–25.8)].
Conclusions: HAI of oxaliplatin seems to be associated
with an increased rate of SOxL, compared to systemic
administration. This could encourage to limit the num-
ber of preoperative cycles of oxaliplatin-HAI and to
evaluate optimally the liver function before performing
hepatectomy in these patients.
PO06-02
SIMULTANEOUS OR DELAYED LIVER
SURGERY FOR SYNCHRONOUS
COLORECTAL METASTASES, WHAT IS
THE BEST APPROACH CONCERNING
SHORT AND LONG-TERM OUTCOME?
Alejandro Serrablo, Vicente Borrego, Carlos H€orndler,
Vicente Alonso-Ordu~na and Luis Ligorred
Miguel Servet University Hospital, Spain
Introduction: The optimal surgical strategy for patients
with synchronous colorectal liver metastases (SCLM) is
still unclear. The aim of this study was to compare
simultaneous colorectal and hepatic resection with a
delayed strategy focused on short- and long-term out-
comes in a single- tertiary-institution cohort as well as
in highly comparable case-matched subgroups
Method: Prospective-data from 400 patients (467 liver
resections) for synchronous-metachronous CLM from
2004 were reviewed retrospectively, managed by a mul-
tidisciplinary team in a tertiary hospital. Data were
coded: sociodemographics, CRC-primary, diagnosis-
surgical-treatment LM, extrahepatic-disease (EHD) and
follow-up. Categorical variables were compared by v2-
test, continuous by independent-samples-T-test. Overall
(OS)/disease-free-survival (DFS) at 1–3–5 years after
first hepatectomy were calculated by Kaplan–Meier
method and compared by logrank test. Separate analy-
ses were performed for the total-study-population and
for the case-matched-subgroups. Univariate and multi-
variate-Cox-regression-model analysis were performed
to identify factors significantly related short- (90 -
days-postoperative-morbimortality-Clavien-Dindo clas-
sification) and long-term outcomes (OS-DFS) in both
subgroups. SPSSTM 15.0, p-value <0.05.
Results: Of 200 patients undergoing hepatectomy for
SCLMs, 33 (16.5%) had a simultaneous colorectal resec-
tion and 152 (76%) had delayed hepatectomy. Mortality
rate following hepatectomy was similar in two-groups (0
vs. 2.6% respectively; p = 0.157); cumulative morbidity
was similar in both groups but complications-grades 3–4
Clavien-Dindo-classification was significantly higher in
the simultaneous group (25.4% vs.11% in the delayed
group; p = 0.025). Five-year OS and DFS rates were 47
and 28% respectively in the simultaneous group, com-
pared with 50.3 and 26.1% in the delayed group (overall
survival: p = 0.871; progression-free survival:
p = 0.225). A simultaneous strategy was not an indepen-
dent predictor of survival neither recurrence.
Conclusions: Results of this study suggest that simulta-
neous colorectal-liver resection can be safely performed
at the same time in selected-patients with synchronous
metastases with similar short- and long-term results
that delayed strategy. The benefit of addition major
liver-resections and rectal cancer by this approach is
still controversial.
PO06-03
IS PREHEPATECTOMY
CHEMOTHERAPY NECESSARY FOR
INITIALLY RESECTABLE
COLORECTAL LIVER METASTASIS?
Daisuke Kudo, Hajime Morohashi, Yoshikazu Toyoki,
Akihiko Murata, Motoi Koyama, Keinosuke Ishido,
Yoshiyuki Sakamoto, Norihisa Kimura and Kenichi
Hakamada
Hirosaki University Graduate School of Medicine, Japan
Introduction: Hepatectomy is the only way to provide
curability for patients with colorectal liver metastasis.
It is unclear whether prehepatectomy chemotherapy is
necessary for resectable liver metastasis, or not.
Method: We studied about 115 patients received hepa-
tectomy for colorectal liver metastases form 2005 to
2012.
Results: Ninety two of them had prehepatectomy che-
motherapy, and five year overall survival rate was
50.5%. Interestingly, that of Patients obtained ‘Com-
plete or Partial response’ in CT image by RECIST cri-
teria was 66.0%, on the other hand that of ‘Stable or
Progressive disease’ was 38.9% (p < 0.05). In the whole
patients, number of tumors (less than three) and the
maximum diameter (less than 25 mm) showed prefera-
ble prognosis, but synchronisity, existence of extrahe-
patic disease (all of cases were lung), systematic
© 2014 The Authors
HPB © 2014 Americas Hepato-Pancreato-Biliary Association HPB 2014, 16 (Suppl. 2), 258–316
268 Poster Oral Representation
hepatectomy and postoperative complication did not
affect the survival. We also studied histopathological
non-tumoral liver injury about sinusoidal obstruction
and steatohepatitis. Sinusoidal obstruction was assessed
according to the Rubbia-Brandt criteria and equally or
more than score 2 was considered as sinusoidal
obstruction syndrome. Steatohepatitis was examined by
NAFLD activity score, and that of more than two was
considered as steatosis. In 92 patients, sinusoidal dila-
tion was observed in 27.5% and 38.0% of them had
steatosis/steatohepatitis. Liver injuries did not affect
the postoperative mortality and overall survive. Regi-
men including oxaliplatin occurred sinusoidal obstruc-
tion (55.0%, p < 0.05), and bevacitumab decreased the
liver injury. Patients with obesity (BMI > 25) had
higher rate of steatosis (65%, p < 0.05).
Conclusions: In conclusion, patients had PR or CR
response by prehepatectomy chemotherapy will be ‘long
surviver’, preoperative image assessment should be
more frequent and never miss the best timing for hepa-
tectomy.
PO06-04
UNRESECTABLE COLORECTAL LIVER
METASTASES: THE SAFETY AND
EFFICACY OF CONVERSION THERAPY
USING HEPATIC ARTERIAL INFUSION
IMMUNOCHEMOTHERAPY WITH 5-
FLUOROURACIL AND POLYETHYLENE
GLYCOL-INTERFERON a-2A
Takuya Nakai, Yasuyuki Nakata, Keiko Kamei,
Hajime Ishikawa and Yoshifumi Takeyama
Kinki University, Japan
Introduction: Hepatic arterial infusion (HAI) or sys-
temic chemotherapy has been used to treat unresectable
colorectal liver metastases. The prognosis of the disease
in recent years has been improved because chemother-
apy is performed prior to hepatectomy to reduce tumor
size (conversion therapy). The aim of this study was to
investigate the safety and efficacy of conversion therapy
following HAI immunochemotherapy.
Method: Hepatic arterial infusion of 5-fluorouracil
(5-FU)/polyethylene glycol (PEG)-IFNa-2a was per-
formed in 21 patients. The primary endpoint was the
safety of HAI and hepatectomy. The secondary end-
points were response rate, rate of conversion to hepa-
tectomy, survival rate, and prognostic factors.
Results: With regard to side effects, drugs were discon-
tinued temporarily in one patient because of a decrease
in white blood cell count; however, other patients contin-
ued chemotherapy. The response rate with HAI was
61.9%, and the conversion rate was 38.1%. Hepatec-
tomy was completed successfully without mortality.
Median progression-free survival was 11.5 months (with
and without conversion, 16.7 and 4.8 months, respec-
tively; p = 0.021). Median overall survival was
34.6 months (with and without conversion, 48.4 and
26.6 months, respectively; p = 0.003). Prognosis was
poor when the number of metastatic tumors was ≥10
(PFS: HR 32.21, p = 0.003; OS: HR 9.13, p = 0.07), but
prognosis improved after hepatectomy (OS: HR 0.08,
p = 0.09).
Conclusions: HAI immunochemotherapy with 5-FU/
PEG-IFNa-2a was performed safely without major side
effects. Prognosis is expected to improve after success-
ful conversion to hepatectomy.
PO06-05
LAPAROSCOPIC LIVER RESECTION
COMPARED TO OPEN APPROACH IN
PATIENTS WITH COLORECTAL LIVER
METASTASES IMPROVES FURTHER
RESECABILITY: ONCOLOGICAL
OUTCOMES OF A CASE-CONTROL
MATCHED-PAIRS ANALYSIS
Roberto Montalti1, Giammauro Berardi1, Stephanie
Laurent2, Liesbeth Ferdinande3, Louis J. Libbrecht3,
Peter Smeets4, Xavier Rogiers1, BernardDe
Hemptinne1, Karen Geboes2 and Roberto I. Troisi1
1Hepato-Biliary Surgery, Liver Transplantation Service,
Belgium; 2Oncology, Belgium; 3Pathology, Belgium;
4Radiology, Belgium
Introduction: Liver resection is considered the standard
treatment of colorectal metastases (CRLM). However,
to date, no long term oncological results and data
regarding repeat hepatectomy after laparoscopic
approach are known.
Method: A total of 57 open resections (OR) were
matched with 57 laparoscopic resections (LR) for
CRLM. Matching was based mainly on number of
metastases, tumor size, segmental position of lesions,
type of hepatectomy and type of resection.
Results: Morbidity rate was significantly less in the LR
group (p = 0.002); the length of hospital stay was
6.5  5 days for the LR group and 9.2  4 days for
the OR group (p = 0.005). After a median follow up of
53.7 months for the OR group and 40.9 months for the
LR group, the 5-year overall survival rate was 65%
and 60% respectively (p = 0.36) and the 5-year disease
free survival rate was 38% and 29% respectively
(p = 0.24). More patients in the LR group received a
third hepatectomy for CRLM relapse than in the OR
group (80% vs. 14.3% respectively; p = 0.015).
Conclusions: Laparoscopic resection for CRLM offers
advantages in terms of reduced blood loss, morbidity
rate and hospital stay. It provides comparable long-
term oncological outcomes but can improve further
resecability in patients with recurrent disease.
PO07-01
INFLUENCE OF LIVER TRANSECTION
WITH OR WITHOUT PORTAL VEIN
LIGATION: COMPARATIVE STUDY IN
A RAT EXPERIMENTAL SURGICAL
MODEL
Rocio Garcia Perez1, C.M. Martinez2, Jezabel
Fernandez2, Beatriz Revilla-Nuin2, Francisco Sanchez
Bueno2, Ricardo Robles Campos2 and Pascual Parrilla
Paricio2
1Liver Surgery, Birmingham Children’s Hospital
Steelhouse Ln, Birmingham, United Kingdom;
2Experimental Surgery, Spain
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Introduction: Actually, there is controversy about the
best hepatectomy surgical method for the treatment of
liver metastases for get an optimal liver regeneration in
the shortest post-surgical time. Two of these methods
are the portal vein ligation (PVL) and the liver transec-
tion + PVL (LTP). The aim of this study was to com-
pare the proliferative rates and grade of liver damage
of these two techniques using an experimental rat
model.
Method: We used Sprague Dawley rats (n = 75) which
were divided in three main groups: control (n = 15),
PVL (n = 30) and LTP (n = 30). Animals were sacrified
at 1, 24 and 48 hours post-surgical procedure. Samples
were collected for histopathology and histochemistry,
proliferative index, and molecular biology. Addition-
ally, samples of blood were also collected for biochemi-
cal and clotting.
Results: At 24 and 48 hours a massive hepatocite
necrosis was observed in the right side of the liver. On
the left side, signs of hepatocyte proliferation (mitotic
index) was observed, with a maximum rate at 48 hours
in the LTP group. No histochemical alterations were
observed in any group at the end of the experience.
Proliferative index increased gradually, with a maxi-
mum rate at 48 hours in the LT group. Significative
increase of expression of EGFR, NFK-b1, STAT3,
TGF-b, TNF-a, HGF, HIF1a and VHL genes was
observed at 1 and 48 hours, specially increased in the
LTP group. GOT, GPT and bilirrubin levels were dra-
matically increased in LTP group at 24 hours PSP.
These levels decreased slightly at 48 hours, but still
increased in LTP group. There are no significative
changes in PT and APPT at 48 hours.
Conclusions: In our experimental model, the LTP is a
technique that induces higher hepatic regeneration rate
than PVL, but causes more liver damage, which could
be a major limiting factor for its clinical applicability.
PO07-02
TEMPORARY PORTAL VEIN
EMBOLIZATION: A TOOL FOR SAFER
LIVER SURGERY AND
TRANSPLANTATION? FIRST RESULTS
IN MICE
Andrea Vuck, Emmanuel Melloul, Dimitri A. Raptis,
Rolf Graf, Pierre-Alain Clavien and Mickael Lesurtel
University Hospital Z€urich, Switzerland
Introduction: Portal vein embolization (PVE) and por-
tal vein ligation (PVL) are routinely used to induce
hypertrophy of the future liver remnant before major
hepatectomy. However, temporary PVE may also be of
interest to hypertrophy liver segments while preserving
the occluded segments, for instance in living donor
liver transplantation. The aim of our study was to
hypertrophy liver lobes through temporary portal
embolization while minimizing injury to the occluded
lobes.
Method: C57BL/6 mice (n = 5/group) underwent 70%
portal vein occlusion using powdered absorbable agent
(temporary PVE), embospheres (permanent PVE), or
ligation (PVL). Mice were sacrificed at different time
points until 30 days after portal vein occlusion. Portal
vein recanalization was assessed using magnetic reso-
nance imaging (MRI). Liver lobe volumes were deter-
mined by MRI volumetry. Serum parameters (AST,
ALT, Bilirubin; Albumin) and necrosis assessment were
used to compare liver injury.
Results: Complete revascularization of occluded lobes
after temporary PVE occurred at day 14. Occluded
liver lobes to total liver volume (TLV) ratio at day 30
decreased by 51%  17% after temporary PVE and
81%  5% after permanent PVE (p < 0.001). Non-
occluded lobes to TLV ratio increased at day 30 by
190%  25% after temporary PVE and 243%  15%
after permanent PVE (p > 0.05). AST and ALT serum
levels were lower after temporary embolization at day 1
and 2 after occlusion. Likewise, there was less necrosis
after temporary PVE.
Conclusions: Portal flow recovery after temporary PVE
limits liver lobe atrophy with less tissue injury to the
occluded lobes than after permanent PVE or PVL.
However, liver hypertrophy of the non-occluded lobes
is similar between the three groups. In a next step, we
aim at investigating liver function of the occluded lobes
after revascularization. Temporary PVE may serve as a
tool to increase liver lobe volume without causing irre-
versible damage of occluded liver lobes.
PO07-03
EFFICIENT LIVER REGENERATION
FOLLOWING REPEATED REVERSIBLE
PORTAL VEIN EMBOLIZATION IN THE
RAT
Hadrien Tranchart1, Marcellin Koffi2, Anne Dubart-
Kupperschmitt2, Tuan Nguyen3 and Ibrahim Dagher1
1Antoine Beclere Hospital, France; 2Paul Brousse
Hospital-Villejuif, France; 3Ho^tel Dieu Hospital-Nantes,
France
Introduction: In clinical practice, a non-absorbable
material is generally used for portal vein embolization
(PVE), as it provides effective, permanent vascular
occlusion. Our team has developed an efficient tech-
nique of reversible embolization (RPVE) using gelfoam
powder in an autotransplantation model in primates.
This technique induced a significant hepatocyte prolif-
eration in the non-embolized segments and a 40%
increase in the non-embolized liver volume. The aim of
this study was to evaluate the effect of a repeated
reversible embolization (RRPVE) on hepatocyte prolif-
eration and the subsequent liver hypertrophy.
Method: Fifteen Wistar rats underwent RRPVE of the
left and right anterior portal branches (70% of the liver
volume) using gelfoam powder with a time interval of
14 days. Three control groups of 15 rats underwent
respectively single RPVE, portal ligation or sham pro-
cedure. Portograms were carried out to evaluate the
complete revascularization of the embolized liver.
Hepatocyte proliferation was assessed by immunostain-
ing and Ki67 index measurement. After sacrifice, liver
lobes weight was measured.
Results: Complete revascularization occurred during
the 14 days following RPVE. Serum AST and ALT
levels increased transiently, returning to normal values
14 days after embolization. Repeated RPVE induced
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more hepatocyte proliferation in the non-embolized
segments compared to single RPVE (31% vs. 15%;
p < 0.0001). Repeated RPVE induced more hepatocyte
proliferation in the non-embolized segments compared
to portal ligation (31% vs. 22%; p = 0.003). The ratio
of the posterior sector (non-embolized liver to total
liver weight was similar after RRPVE and portal liga-
tion (66% and 67%, respectively; p = 1.0).
Conclusions: Repeated RPVE efficiently induces liver
regeneration. Repeated RPVE induced more hepatocyte
proliferation compared to portal ligation. Iterative use
of this stimulus could allow progressive atrophy of the
embolized liver and major hypertrophy of the non-em-
bolized segments. This approach could have numerous
applications in clinical practice and liver cells trans-
plantation.
PO07-04
COLONY STIMULATING FACTOR 1
SIGNALLING REGULATES
REGENERATIVE CYTOKINE
EXPRESSION FOLLOWING PARTIAL
HEPATECTOMY IN MICE
Ben Stutchfield1, D. Gow2, D. Hume2, S. Wigmore2
and S. Forbes1
1MRC Centre for Regenerative Medicine, United
Kingdom; 2University of Edinburgh, United Kingdom
Introduction: Initial hepatocyte priming following par-
tial hepatectomy is thought to be related to Kupffer
cell cytokine production in response to gut derived
LPS. We explore whether CSF1 signalling, where recep-
tor expression is restricted to the macrophage lineage,
has a role in this process.
Method: Blockade of the CSF1 receptor was achieved
using the pharmacological agent GW2580 following 2/3
partial hepatectomy (PH) in C57Bl/6 mice and com-
pared to control mice (n = 8 per group). Alternatively
mice were treated with CSF1 or control following par-
tial hepatectomy (n = 8 per group).
Results: Blockade of CSF1 receptor significantly
impaired hepatic regeneration following PH (mean
number of mitotic figures 0.4 versus 4.8 per per 409
field, p < 0.001) also leading to significant elevation in
markers of hepatic injury (ALT 1579 IU/L versus
532 IU/L, p < 0.001; AST 2175 IU/L versus 947 IU/L,
p = 0.002) at Day 2. Hepatocyte growth factor (HGF)
gene expression was unchanged, although HGF recep-
tor (MET) expression was significantly reduced
(p = 0.01) with CSF1 receptor blockade. Proregenera-
tive cytokine oncostatin M gene expression was also
significantly reduced (p = 0.01) with a trend to reduc-
tion in Il6. Both TGFbeta and TGFbeta receptor gene
expression were significantly reduced (p = 0.004,
p = 0.002). Conversely treating mice with CSF1 follow-
ing partial hepatectomy lead to an increase in oncosta-
tin M and Il6 gene expression (p = 0.01, p = 0.03) with
increased hepatocyte proliferation at Day 4 (p < 0.001).
Conclusions: CSF1 plays an important role in hepato-
cyte proliferation following partial hepatectomy
through influence on hepatic cytokine expression.
PO07-05
ENDOGENOUS IL18 SUPPRESSES
LIVER REGENERATION AFTER
HEPATECTOMY IN MICE
Tingbo Liang, Qida Hu, Yibo Zhang, Wei Chen,
Liqiang Hu, Xueli Bai and Tingbo Liang1
Second Affiliated Hospital, Zhejiang University, China
Introduction: IL18 is recognized as an important regu-
lator of innate and acquired immune responses. Some
reported IL18 induces liver injury. However, the com-
prehensive role of IL18 during liver regeneration is
barely studied. In this study, we explored the role of
endogenous IL18 during liver regeneration using IL18
knockout mice. We also tested the effect of IL18 bind-
ing protein (IL18BP), a natural antagonist to IL18, on
liver regeneration using IL18BP-expressing lentivirus in
vivo.
Method: 70% hepatectomy was performed and liver
samples from IL-18 knockout mice (IL-18 KO) and
wild type mice (WT) were collected for evaluation of
liver regeneration at 24 h, 42 h, 3d, and 7d after sur-
gery. Recombinant lentivirus expressing mouse IL18BP
(IL18BP-LV) or negative control lentivirus
(control-LV) was infused into C57BL/6 mice before
hepatectomy. 70% hepatectomy was performed and
liver samples were collected for evaluation of liver
regeneration after surgery.
Results: We found IL18 knockout enhanced the prolif-
eration of hepatocytes as the expression of cyclinD1
and EdU labeling index were much higher in IL18KO
group at 24 h and 42 h post-operatively. Further more,
the liver weight/body weight ratio (LBWR) and Ki-67
proliferation index were significantly higher in IL18KO
group on post-operative day 3 and 7 than in WT
group. Similarly, infusion of IL18BP-LV significantly
promoted liver regeneration in this model. The expres-
sion of cyclinD1, EdU labeling index, LBWR and Ki-
67 proliferation index were much higher in IL18BP-LV
group than those in control-LV group.
Conclusions: Endogenous IL18 inhibited liver regenera-
tion after 70% hepatectomy in mice. IL18BP may be
an effective agent to promote liver regeneration by neu-
tralizing serum IL-18.
PO08-01
SURGICAL TREATMENT FOR HEPATIC
HEMANGIOMA: WHEN AND HOW?
Xing Huang, Han Zhang, Shu-Yang Dai, Yi-Nan
Shen, Shou-Xin Yuan, Tian Yang and Feng Shen
Eastern Hepatobiliary Surgery Hospital, China
Introduction: Hemangioma is the most common benign
neoplasm of the liver. Consensus on the management
of hepatic hemangioma, especially on surgical indica-
tion and operating method, is controversial.
Method: A systematic review was performed with all
studies published from January 2000 to January 2013
using MEDLINE, Embase, the Cochrane Library and
Science Citation Index Expanded (SCI-EXPANDED).
All data regarding surgical indications, approaches,
morbidity, mortality and follow-up were analyzed.
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Results: Twenty-four studies were analyzed and a total
of 977 patients with hepatic hemangioma in these stud-
ies underwent surgical treatment. Tumor size ranged
from 0.2 to 46 cm. Frequently reported surgical indica-
tions include presence of symptoms, uncertain diagno-
sis, rapid enlargement, patient request, prophylactic
surgery for giant lesions and occurrence of life-threat-
ening complications like Kasabach-Merritt syndrome.
Enucleation was adopted by 13 studies with 519
patients, while open hepatic resections, either anatomi-
cal or non-anatomical ones, were adopted by 21 studies
with 458 patients. Detailed comparisons of the two
approaches were conducted in only 4 studies, a meta-
analysis was conducted with the result favoring enucle-
ation in postoperative morbidity during follow-up.
Overall postoperative morbidity and mortality was
14.1% and 0.2%, respectively.
Conclusions: Surgical Indication for hepatic hemangi-
oma far from well defined by now, a worldwide consen-
sus is mandatory. Surgical treatment, either enucleation
or hepatic resection, was reserved as a safe and effec-
tive option for severe hepatic hemangioma. Minimally
invasive approaches may be optimal alternatives, pend-
ing further studies and supportive evidence.
PO08-02
PATIENT REPORTED LONG-TERM
OUTCOMES AFTER LAPAROSCOPIC
FENESTRATION OF NONPARASITIC
LIVER CYSTS
Alex Navarro, Raymond Ho, Yin Tam, Simon
Bramhall, John Isaac, Ravi Marudanayagam, Darius
Mirza, Paolo Muiesan, Keith Roberts and Robert
Sutcliffe
University Hospital Birmingham NHS Foundation Trust,
United Kingdom
Introduction: Laparoscopic fenestration (LF) of non-
parasitic liver cysts provides effective short-term symp-
tomatic relief. However, there are concerns that cyst
recurrence occurs commonly after laparoscopic surgery,
and the long-term durability of this procedure is not
known. The aim of this study was to evaluate long-
term patient related outcomes after laparoscopic liver
cyst fenestration in a large single centre series.
Method: All patients who underwent LF from Jan
2000 to June 2012 were identified from a prospective
database. Exclusion criteria were: conversion to open
surgery, other synchronous procedures (except chole-
cystectomy), and inadequate follow-up (<1 year). Clini-
cal follow-up data were obtained from medical records,
and long-term patient-related outcomes were evaluated
by telephone interview.
Results: 114 patients underwent LF (66 with cholecys-
tectomy). At a median follow-up of 4.5 years (range 1–
13), 52 patients were invited to participate in a tele-
phone interview, 52 were not contactable and 10
patients had died. Consent was obtained from 46/52
patients (89%). 42/46 patients (91%) had significant
improvement or complete resolution of symptoms
immediately after surgery. 6 patients (13%) sought
medical advice for recurrent symptoms at a median of
10 months postoperatively, including one patient who
successfully underwent further surgery after 5 years.
Overall, 45 patients (98%) were satisfied with the
results of surgery, and 45 patients (98%) would recom-
mend the operation to a friend or relative.
Conclusions: Long-lasting symptomatic relief is
achieved in the majority of patients after laparoscopic
liver cyst fenestration performed as an isolated proce-
dure or with cholecystectomy, and is associated with a
high level of patient satisfaction. Laparoscopic fenestra-
tion is the recommended approach in patients with
symptomatic nonparasitic liver cysts.
PO08-03
COMBINED THERAPY OF LIVER
METASTATES FROM
GASTROINTESTINAL STROMAL
TUMOR (GIST)
Marcin Kotulski1, Piotr Rutkowski2, Paweł
Nyckowski1, Bogusław Najnigier1 and Marek
Krawczyk1
1Medical University of Warsaw, Poland;
2M. Sklodowska-Curie Memorial Cancer Center and
Institute of Oncology, Poland
Introduction: The purpose of this study was to analyze
the role of surgery in the management of GIST meta-
static to the liver in the group of c-KIT positive GIST
patients treated in two referral institutions.
Method: Between January 2002 and December 2012 we
found 21 patients (14M/7F, median age 53) treated sur-
gically due to liver metastases (LM) from GIST. In 9
cases liver metastases were found simultaneously with
primary tumors, in other 12 patients LM occurred after
median time of 29 months after primary tumor resec-
tion. 3 patients underwent resection of LM immediately
after their detection and estimation as resectable, the
other 18 patients were treated with imatinib at the dose
of 400 mg daily before liver surgery.
Results: Surgical procedures consisted of nine extensive
liver resections and 10 non-anatomical resections of
LM, in one case only cryoablation and in one case ter-
moablation of LM with resection of intraperitoneal
lesions was performed. All three patients undergoing
surgery of LM without imatinib treatment and two
patients who did not continue imatinib therapy after
liver surgery recurred within 3–11 months after opera-
tion. These relapses were successfully (PR in RECIST)
treated with imatinib. The other 16 patients who under-
went R0/R1 resection of residual disease after PR no
longer responding to imatinib treatment, continued i-
matinib therapy after surgery. We observe progression
(PD in RECIST) in five cases. three patients died due
to disease progression 46, 93 and 94 months after diag-
nosis. We did not observe any serious complications
requiring reoperations or prolongation of hospital stay-
ing after liver surgery due to metastatic GIST.
Conclusions: Surgery in combination with imatinib
treatment is feasible and may result in improved sur-
vival of patients with GIST metastatic to the liver, the
optimal strategy in GIST-LM consists of imatinib ther-
apy, considering surgery of residual disease (if radical
resection is feasible) and continuation of imatinib post-
operatively.
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PO08-04
HEPATOBLASTOMA IN ADULT AGE: A
REPORT OF 15 CASES AND REVIEW OF
LITERATURE
Qiang Wu, Tianqiang Song, Wei Zhang, Ping Chen
and Qiang Li
Tianjin Medical University Cancer Hospital, China
Introduction: To study the clinical features and treat-
ment options for patients with hepatoblastoma in
adults.
Method: Fifteen cases of adult hepatoblastoma, who
had been treated from May 1963 to March 2011 in
Tianjin Cancer Hospital, were reviewed and analyzed.
23 cases of adult hepatoblastoma reported in English
literatures since 1990 were reviewed. Multiple demo-
graphic and clinicopathological paraeters were reviewed
retrospectively and compared between these groups.
Results: The mean ages of patients with hepatoblas-
toma of our hospital were 50 years ranging from 18–
74 years, with the male: female rations of 8:7. Hepatitis
B virus existed in six patients (40%) and no patient
had HCV infection. The average sizes of tumor were
10.8 cm (3–20 cm), AFP was ≥500 ng/ml in six cases
and <500 ng/ml in three cases. Pathologically hepato-
blastoma consisted of two types, and epithelial type
was dominating with epithelial: mixed ratio of 11:4.
Median survival time was 6 months for all (range:
30 days to 240 months) and 12 months for patients
whose tumor was resected. Compared with literature,
patients in the current study are older with smaller
tumors, more patients had HBV infection and tumor of
epithelial type. Survival time were comparable.
Conclusions: Adult hepatoblastoma has features of a
short course, fast progress, high malignancy, a high
rate of misdiagnosis and poor prognosis. Early diagno-
sis, a timely radical resection and close follow-up are
the key essentials that benefit survival. Adjuvant ther-
apy such as ablation and chemotherapy also benefit
survival.
PO08-05
RADICAL SURGERY FOR LIVER
HYDATID CYST: SAFE OPTION IN
SELECTED PATIENTS.
Hadj Omar EL Malki1, Amine Souadka2, Badr Serji2,
Amine Benkabbou2, Raouf Mohsine2, Lahcen Ifrine2,
Redouane Abouqal1 and Abdelkader Belkouchi2
1University Mohammed Vth Souissi, Rabat, Morocco,
Biostatical, clinical research and epidemiological
laboratory LBRCE, Medical School, Morocco; 2University
Mohammed Vth Souissi, Rabat, Morocco, Medical
School, Morocco
Introduction: Surgery remains the basic treatment of
liver hydatid cyst (LHC). Although, conservative
approaches may be easier in endemic countries, radical
procedures [pericystectomy (PK) and hepatic resection
(RS)] can offer better results and outcomes. The aim of
this study was to evaluate, in an endemic country, the
feasibility and safety of both these radical procedures
by comparing their results and surgical outcomes.
Method: From 792 patients with LHC managed and
treated at the surgery department ‘A’ at Ibn Sina Uni-
versity Hospital, Rabat Morocco. One Hundred forty-
four patients underwent radical surgery. Univariate,
multivariate and Kaplan-Meier survival analysis were
used to assess postoperative morbidity, mortality and
recurrences of these patients.
Results: Thirty-two patients (22.3%) had RS and 111
patients (77.7%) had PK. Mortality rate was 1.3%
(n = 2) and occured in patients with liver resections.
There were no statistical differences between PK and
RS group concerning overall morbidtiy 18.9% versus
28.1% (p = 0.26), postoperative haemorrhage 1.8%
versus 3.1% (p = .535), nor specific LHC operative
complications 17.1% versus 28.1% (p = .167). Recur-
rence rate were similar in both groups 6.3% (p = .943),
median duration of follow up of was 103 months
(IQR: 48; 143 months).
Conclusions: Radical surgery for LHC is safe and feasi-
ble in endemic areas. Both PK and RS ensure good
results however each procedure should be performed in
specific indications. Adequate selection of patients is
the warranty of good outcomes.
PO09-01
COMBINATION ADJUVANT CHEMO-
IMMUNOTHERAPY USING
GEMCITABINE AND cd T
LYMPHOCYTES FOR PANCREATIC
CANCER
Taku Aoki, Kazuhiro Kakimi, Hirokazu Matsushita,
Mayumi Hoshikawa, Yoshihiro Sakamoto, Yasuhiko
Sugawara, Kiyoshi Hasegawa and Norihiro Kokudo
The University of Tokyo, Japan
Introduction: The surgical outcome of pancreatic can-
cer patients remains unsatisfactory. Gemcitabine
(GEM) has been reported to improve both recurrence-
free and overall survival outcomes, but our previous
results showed that GEM improved the recurrence-free
but not overall survival. Therefore, we have developed
a combination adjuvant regimen using GEM and cd T
lymphocytes. The aim of the present study was to eval-
uate the safety and efficacy of our regimen.
Method: The study was started in July 2008. The inclu-
sion criteria was (1) pancreatic cancer patients receiving
R0 or R1 resections, (2) PS 0–1, (3) maintained hepatic,
renal, and bone-marrow function. Patients’ peripheral
blood mononuclear cells were stimulated with zoledro-
nate, and harvested cd T cells were given intravenously
every 2 weeks for 12 times. The primary endpoints
were safety of the therapy and recurrence-free survival.
During the same period, 42 patients received adjuvant
GEM monotherapy.
Results: From July 2008 to December 2012, written
informed consent was obtained from 57 patients. Suffi-
cient amount of cd T cells could be obtained from 31
patients, and 29 patients received the combination ther-
apyt. The enrolled patients consisted of 16 males and
13 females, with median age of 64 years. The therapy
was abandoned in 5 patients (4 for recurrence). No
severe adverse event was observed. At the end of July
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2013, 13 patients experienced recurrence, and 5 patients
died. The median recurrence-free survival was
30 months, showing a better outcome when compared
with GEM monotherapy group. Good response was
observed among patients in whom cd T cells were accu-
mulated in the peripheral blood samples during the
treatment.
Conclusions: Immunotherapy using cd T cells may have
additional effect to the adjuvant GEM monotherapy.
Further investigation is needed to find biomarkers to
select good responders and to evaluate the status of
immune-suppression among patients with pancreatic
cancer.
PO09-02
OUTCOME OF NEOADJUVANT
CHEMORADIATION THERAPY WITH
GEMCITABINE, S-1 AND EXTERNAL
BEAM RADIATION FOR LOCALLY
ADVANCED PANCREATIC CANCER
Koichi Taniguchi, Ryusei Matsuyama, Ryutaro Mori,
Kazunori Nojiri, Takafumi Kumamoto, Kazuhisa
Takeda, Michio Ueda, Hirotoshi Akiyama, Kuniya
Tanaka and Itaru Endo
Yokohama City University, Japan
Introduction: The aim of this study is to examine treat-
ment results of neoadjuvant chemoradiation therapy
for locally advanced pancreatic cancer.
Method: 116 patients with locally advanced pancreatic
cancer between 2001 and 2012 showing invasion to the
portal vein or extrapancreatic perineural invasion to
the SMA, CA or CHA by preoperative imaging studies
were enrolled. We have applied neoadjuvant chemora-
diation therapy (NACRT group, GS therapy 2 cycles,
radiation 30 Gy) as the prospective cohort study.
Treatment effect, survival and adverse events of 62
patients underwent NACRT were compared with those
of 54 patients without neoadjuvant therapy (NoNAC
group).
Results: NACRT group showed 19% of response rates
and 94% of disease control rate according to RECIST
criteria. Four cases (6%) developed remote metastasis
after NACRT and micrometastasis was confirmed at
the time of laparotomy or staging laparoscopy in eight
cases (13%). Thus, 50 cases received radical resection
(resection rate: 81%). Grade 3 or 4 of adverse events
were seen in 56% of neutropenia and 40% of leukope-
nia. Portal vein permeation (6%, p < 0.001), lymph
node metastasis (48%, p < 0.001) were significantly
decreased in histologic examination of NACRT group
in comparison with NoNAC group, and the R0 resec-
tion rate was higher in NACRT group (NACRT group
94%: NoNAC group 49%, p < 0.001). Three-year
cumulative survival rate (NACRT group 47%: NoNAC
group 23%, p = 0.004) was higher in NACRT group.
Total lymphocyte count was significantly decreased
after neoadjuvant therapy (Pre-therapy 1591: Post-ther-
apy 860, p < 0.001) and patients with low total lym-
phocyte count after NACRT showed lower 3 year
survival rate (low lymphocyte count (>860) 32%: high
lymphocyte count (<860) 79%, p = 0.029).
Conclusions: NACRT may improve survival of
advanced pancreatic cancer with good local control
and increased R0 resection rate. To enhance further
survival benefit of NACRT, some measures should be
considered such as nutritional supports to improve lym-
phocyte depletion after NACRT.
PO09-03
APPRAISAL FOR NEOADJUVANT
CHEMORADIATION THERAPY IN
BORDERLINE RESECTABLE
PANCREATIC CANCER: SPECIAL
REFERENCE TO ISOLATED VENOUS
VASCULAR INVOLVEMENT
Jin Ho Lee1 and Chang Moo Kang2
1Yonsei University Wonju College of Medicine, Korea;
2Yonsei University College of Medicine, Korea
Introduction: The rationale for neo-adjuvant chemora-
diation therapy (Neo-CRT) and the definition of bor-
derline resectable pancreatic cancer (BRPC) are still
controversial. In particular, surgical treatment of
BRPC with isolated venous vascular involvement
(IVVI) is debatable.
Method: From January 2000 to December 2012, 74
patients diagnosed with BRPC according to NCCN
guidelines were identified, and 61 patients were found
to have BRPC with IVVI. We divided all 61 patients
into three groups: surgery first without Neo-CRT
(Group 1); pancreatectomy following Neo-CRT
(Group 2); and no operation following Neo-CRT
(Group 3). Patient characteristics including oncologic
outcomes were analyzed for each of the three patients
groups.
Results: Thirty-three patients were female and 28 were
male, with a mean age of 61.7  9.5 years. Among 61
patients with BRPC with IVVI, 23 patients (37.7%)
belonged to Group 1, 26 patients (42.6%) to Group 2,
and 12 (19.7%) to Group 3. Pathological tumor size
(p < 0.001), pT stage (p = 0.004), pTNM stage
(p = 0.007), combined vascular resection (p = 0.001),
completeness of adjuvant therapy (p = 0.003) were
found to be significantly different between Group 1
and 2. In addition, disease-free survival (p = 0.022) and
disease-specific survival (p = 0.009) were improved in
Group 2. Interestingly, when comparing disease-specific
survival, there was no statistically significant difference
between Groups 1 and 3 (p = 0.638).
Conclusions: The clinical practice of pancreatectomy
following Neo-CRT in BRPC with IVVI provided
favorable oncologic outcomes. The effect of Neo-CRT
in BRPC with IVVI may be multifactorial, providing
(1) Proper patient selection, (2) complete adjuvant che-
motherapy, and (3) potential therapeutic (down-stag-
ing) effect.
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PO09-04
FACTORS AFFECTING DELAY TO
CHEMOTHERAPY AFTER
PANCREATICODUODENECTOMY FOR
PANCREATIC ADENOCARCINOMA
Rosanna DeSouza, Patrick Casey, Kariem Elhadd,
Zaria Ali, Colin Harris, Elaine Atkinson, David Chang
and Daren Subar
Royal Blackburn Hospital NHS Trust, United Kingdom
Introduction: Pancreatic adenocarcinoma affects
approximately 8400 people in the UK. Surgery offers
the only chance of cure. At the time of presentation
only 20% of patients are suitable for surgical resection.
Post-operative management includes the administration
of adjuvant chemotherapy which has been proven to
improve patient survival. Delay to the start of chemo-
therapy has been demonstrated to affect survival. The
aim of this study was to determine which factors cause
a delay in the commencement of chemotherapy in
patients who have had pancreaticoduodenectomy for
pancreatic adenocarcinoma.
Method: This is a retrospective study of all the
Whipple’s resections undertaken between January
2006 and December 2012 for pancreatic adenocarci-
noma. The primary outcome measure was time to
chemotherapy. Factors assessed included age, sex, co-
morbidities and post-operative complications including
pancreatic fistula, post-operative haemorrhage and
delayed gastric emptying. Statistical significance was
taken at p < 0.05.
Results: 143 patients underwent pancreaticoduodenec-
tomy in the study period of which 68 (47.5%) were
for pancreatic adenocarcinoma. The M:F ratio was
37:31 with a mean age of 65 years (range 39–
84 years). On univariate analysis only delayed gastric
emptying was found to be statistically significant
(p = 0.03). However, due to the small sample size,
factors such as pancreatic fistula and post-operative
bleeds may have been under-represented and hence
their importance in influencing delay to chemotherapy
are inconclusive.
Conclusions: Delayed gastric emptying delays time to
chemotherapy and every effort should be made to
aggressively manage those causes of delayed gastric
emptying which are treatable.
PO09-05
IMPROVED OVERALL SURVIVAL OF
PANCREATIC HEAD
ADENOCARCINOMA FOLLOWING
PANCREATICODUODENECTOMY IN
THE 2000S
Jaehong Jeong, Dong Wook Choi, Seong Ho Choi, Jin
Seok Heo, Dong Hun Kim and Hui Song Lee
Samsung Medical Center, Sungkyunkwan University,
Korea
Introduction: Although the surgical morbidity and mor-
tality of pancreatic resection have decreased over the
past decades, pancreatic cancer still has a dismal prog-
nosis. We hypothesized that survival of resected pan-
creas head cancer have improved recently.
Method: A total of 401 patients underwent surgical
resection for pancreatic adenocarcinoma of head.
Patients who underwent in 1995–2005 (Period 1) were
compared with patients in 2006–2011 (Period 2).
Results: Overall 5-year survival rate of entire 401
patients was 21.4%. The 5-year survival rate of 241
patients in Period 2 was increased from 15.6% to
26.0% compared with that of 160 patients in Period 1
(Median survival 14.0 months vs. 21.0 months,
p = 0.001 by log-rank test). Between two periods, there
was no significant difference in age, sex, T stage, tumor
size, R status and a level of CA 19-9.Whereas N1 dis-
ease, poorly differentiation and adjuvant therapy were
significantly higher rate in Period 2 compared with
those of Period 1. In Period 2, 66.7% of patients were
treated by adjuvant therapy compared with 53.% of
patients in Period 1 (p = 0.016). And by multivariate
analysis, adjuvant therapy as well as tumor size (more
than 2.5 cm), tumor differentiation, and R status were
revealed as independent prognostic factors. On sub-
group analysis, patients with tumor size (more than
2.5 cm), N1 disease, or well to moderately differentia-
tion had a survival improvement by adjuvant therapy.
Conclusions: The survival of pancreatic adenocarci-
noma of head following surgical resection has substan-
tially improved in the 2000s. Adjuvant therapy
increases overall survival in patients who underwent
surgical resection for pancreatic cancer and recently
more frequent use of adjuvant therapy accounts for
survival improvement in part. So, adjuvant therapy
should be considered unless patients have a poor per-
formance status, especially with N1 disease, large
tumor or well to moderately differentiation.
PO10-01
MANAGERMENT OF NECROTIZING
PANCREATITIS ACCORDING TO THE
CLINICAL AND MORPHOLOGY
MODELS
Alexey Shabunin, Andrey Lukin and Dmitriy Shikov
Moscow Pirogov’s state hospital #1, Russia
Introduction: There is wide variation in conceptual and
technical approaches to interventions for necrotizing
pancreatitis. We try to improve the results of treatment
patients with necrotizing pancreatitis using flexible
approach depending on clinical and morphology mod-
els of the disease.
Method: 489 patients with necrotizing pancreatitis
(2006–2012) were retrospectively analyzed.
We compared results of the CT data, intraoperative
locat-dock, the results of histological examination of
biopsy material of 77 cases of necrotizing pacreatitis.
Revealed their fair match.
The main criteria (providing the ability to model) char-
acterizing pancreatic necrosis were volume and localiza-
tion of pancreatic necrosis, the prevalence of
extrapancreatic disease process.
Results: Four clinical and morphological models of pan-
creatic necrosis were created: “Model-1” - 177 patients,
“Model-2” – 153, “Model-3” – 89, “Model-4” - 70.
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Depending on the results of modeling used various
methods of treatment of percutaneus drainage (PCD),
open surgery (OS) and combined step-up approach.
Specific complications in cases managed with PCD
(n = 108) - 7 (6.5%), OS (n = 57) - 3 (5.3%); Com-
bined step-up approach - 15 (8.1%) of all (n = 350) -
25 (7.1%). The greatest number of complications
observed in cases with “Model 3” and “Model-4”.
Mortality: “Model-1” - 4 (2.3%), “Model-2” - 18
(11.8%), “Model-3” - 25 (28.1%), “Model-4” - 22
(31.4%) of (n = 489) - 69 (14.1%).
Conclusions: Clinical management of patients with nec-
rotizing pancreatitis is defined by the location and
extent of pathological changes in retroperitoneum,
depending on the amount, location of pancreatic necro-
sis. Modeling of pancreatic and peripancreatic necrosis
allows in selection of the optimal method of surgery
and reduce the incidence of complications, morbidity
and mortality.
PO10-02
PANCREATIC FLUID CULTURE IN
PATIENTS WITH CHRONIC
PANCREATITIS: A PROSPECTIVE
STUDY
Salil Parida1, Kalayarasan Raja2, Ranjit Vijayahari2,
Lakshmi CP3 and Biju Pottakat2
1Senior resident, Surgical gastroenterology, JIPMER,
India; 2Assistant Professor, India; 3Assistant professor,
India
Introduction: Data regarding bacteriological profile of
pancreatic fluid is limited in literature. Hence this study
was done to analyse the bacteriological profile of pan-
creatic fluid
Method: Patients who underwent elective surgery
(resection or drainage) for chronic pancreatitis over a
period of 20 months from November 2011 were
included in this study. Patients with evidence of sys-
temic sepsis were excluded from the study Intraopera-
tively 2 ml of pancreatic fluid was aspirated using a
22G syringe aseptically and sent for aerobic and anaer-
obic bacterial culture.
Results: Twenty two patients who underwent surgery
for chronic calcific pancreatitis during the study period
were included. Majority of the patients (81.9%, 18/22)
had alcohol related chronic pancreatitis. Ten (45.5%,
10/22) patients had positive pancreatic fluid culture.
Escherichia coli (80%, 8/10) was the most common
organism isolated, Klebsiella pneumonia and Strepto-
coccos pneumoniae were isolated in one patient each.
Five of the 8 (62.5%) patients with positive Escherichia
coli on culture developed superficial surgical site infec-
tion. However, there was no difference in the incidence
of anastomotic leak rate between patients with positive
and negative culture.
Conclusions: A large subset of patients undergoing
elective surgery for chronic pancreatitis, who are clini-
cally free of sepsis, seems to have positive cultures
despite having no history of prior intervention. This
study forms the basis for further large scale studies to
analyze the clinical significance of positive pancreatic
fluid culture.
PO10-03
REVISION SURGERY FOR
OBSTRUCTIVE CHRONIC
PANCREATITIS FOLLOWING
PANCREATICODUODENECTOMY FOR
MALIGNANT INDICATIONS
Himanshu Yadav, Rajan Saxena and Jayanth Reddy
Sanjay Gandhi Postgraduate Institute of Medical
Sciences, India
Introduction: Stenosis of pancreatico-enteric anastomo-
sis following pancreatico-duodenectomy (PD) for
malignant indications can induce obstructive chronic
pancreatitis in the remnant gland. The literature is
sparse and outside of chronic pancreatitis, no study has
addressed patients who were operated primarily for
malignancy. The type of revision surgery and its exact
role in ameliorating symptoms has not been defined.
Method: We retrospectively analysed 650 patients
undergoing pancreatico-duodenectomy between May
1989- August 2013 at our institution from a prospective
database. Patients requiring management for symptoms
suggestive of chronic pancreatitis in the absence of
tumor recurrence on long term follow up where identi-
fied.
Results: Two patients who underwent pylorus preserv-
ing pancreaticoduodenectomy (PPPD) with pancreati-
co-jejunostomy (PJ) for malignant tumors in the year
1995 and 2000 respectively, presented with symptom-
atic PJ stenosis with abdominal pain of pancreatic ori-
gin after a mean 30 months following index surgery.
Investigations (US, CECT, MRCP) revealed a dilated
pancreatic duct in the residual pancreas. Steatorrhea
was documented. The first patient underwent a conver-
sion pancreaticogastrostomy, and the second a revision
PJ – both had an uneventful recovery. The resected
end of the pancreas showed calcification and calculi in
one patient and evidence of fibrosis and changes of
chronic pancreatitis on histopathological examination
in both. Follow up sonography and CECT showed a
3 mm duct in both patients without any calcification.
Both patients are doing well 15 and 10 years following
their revision surgery – pain free and no steatorrhea..
A third patient, referred to us following classical PD
with pancreatico-gastrostomy, declined a second sur-
gery.
Conclusions: Symptomatic pancreatico-enteric stenosis
is rarely reported following pancreatico-duodenectomy
for malignant tumors. Revision resective surgery in
such patients can be performed with excellent results in
high volume pancreatic surgery centres.
PO10-04
RADIOLOGY DIAGNOSTICS OF SOLID-
PSEUDOPAPILLARY PANCREATIC
TUMORS AT THE STAGES OF
SURGICAL TREATMENT
Yulia Stepanova, Natalya Vetsheva, Grigory
Karmazanovsky, Andrey Kriger, David Gorin and
Aleksander Shchegolev
A.V. Vishnevsky Institute of Surgery, Russia
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Introduction: Solid-pseudopapillary pancreatic tumors
(SPPT) are considered as rare and “mysterious” new
growths of a pancreas. Clinical manifestations aren’t
specific, that’s why the definition of possibilities of radi-
ology diagnostics of SPPT is actual.
Method: Twenty six patients (15–77 years) with SPPT
passed radiology inspection from 2004 to 2013. Women
prevailed (92,3%). All patients were operated on with
morphological verification.
Results: The patients divided into three groups.
1 group (completely solid tumors), 11 (42,3%): tumorwith
the wrong form, indistinct equal contours, solid unevenly
loweredechodensity structure.MRIismorepreferable.
2 group (combination of solid sites and hemorrhages), 9
(34,6%): tumor has a roundish form with accurate equal
contours, solid non-uniform with existence of cystic inclu-
sions structure. US, CT andMRI allow to diagnose.
3 groups (extensive hemorrhages and cystic cavities
come to light), 6 (23,1%): tumor had wrong form with
accurate rather equal contours more often, structure is
cystic with existence of slightly expressed solid compo-
nent located mainly on the peripheries. US, CT and
MRI allow to diagnose.
Presurgical verification – 53,9%. The diagnosis wasn’t
made presurgically in 12 cases: carcinoid tumor (five
cases), pancreatic cancer (six cases), pseudocyst (1 case)
were suspected. Immunohistochemical research had a
crucial importance in tumor verification.
The remote results are tracked from 6 to 60 months.
Recurrence was revealed in one case (SPP-carcinoma).
Metastasises - in three (one at the same time with pri-
mary tumor, two in the remote period).
Conclusions: In tumors with the absence of cystic
component and with the insignificant sizes of a tumor
the diagnosis of SPPT (I group) is difficult to make.
In tumors with the presence of cystic component of
this or that degree of expressiveness (II and III
groups) the diagnosis of SPPT is simpler to make.
Radiology signs of SPPT metastasises is similar to pri-
mary tumor.
PO10-05
PANCREATIC NECROSECTOMY
ANALYSIS OF 78 PATIENTS
Rohit Dama, Pradeep Rabela, GV Rao and DN
Reddy
Asian Institute of Gastroenterology, India
Introduction: Pancreatic necrosectomy is a surgery with
high morbidity and mortality. Here we analyse our
results retrospectively
Method: Data of 78 patients who underwent surgical
necrosectomy between august 2004 to august 2013 were
systematically analysed. Necrosectomy was by open,
laparoscopic or retroperitoneal approaches. After
debridement and washes, multiple tube drains for post
operative irrigation were kept. Need for diversion
stoma and feeding jejunostomy was decided on clinical
and intraoperative findings
Results: There were 64 males & 14 female patients.
Mean age was 39.8(22–65 years). Cause of pancreatic
necrosis was alcohol-38, biliary-32, whereas trauma,post
ercp and autoimmune pancreatitis and idiopathic-2 each
66/78 patients underwent open necrosectomy, whereas
the approach was laparoscopic in three pts, retroperito-
neal in six pts, and in three pts laparoscopy was con-
verted to open necrosectomy.
36/78(46%) pts required diversion stoma .41/78(52%)
patients had feeding jejunostomy
Preoperative percutaneous drainage was done in 16/78
pts(20%).
Average time of intervention was 42nd day since onset
of pancreatitis (16–120 day).
Average amount of necrotic material was 52 gms. Cul-
ture and sensitivity showed growth of e.coli in 43 pts,
pseudomonas in 7, klebsiella 12, whereas in 15 pts there
was polymicrobial growth.
Average post op stay 21 days (11–55). Post op pro-
longed ventilation(>48 hrs) required in 15 patients. 8
patients required tracheostomy. 30/78(38%) patients
had high drain fluid amylase beyond 45 days, out of
which 20 (26%) patients required postoperative ERCP
and PD stenting for the fistula to heal. New onset DM
and incisional hernia was seen in 4 patients each. 9/78
(11.5%) patients had mortality.
Conclusions: Delayed Surgical pancreatic necrosectomy
done after 6–7 weeks and by minimally invasive
approach is less morbid. Diversion stoma and feeding
jejunostomy should be done more liberally. ERCP and
PD stenting may be required for prolonged pancreatic
fistulae to heal.
PO11-01
GALLBLADDER CANCER WITH RIGHT
HEPATIC ARTERY INVOLVEMENT:
CAN THE ARTERY BE LIGATED?
Raja Kalayarasan, Amit Javed and Anil Agarwal
GB Pant Hospital & MAM College, India
Introduction: Management of gallbladder cancer (GBC)
with right hepatic artery involvement(RHAI) is contro-
versial. Some consider it as a sign of advanced unresec-
table disease, while others consider it as an indication
for extended hepatectomy. Hepatic artery reconstruc-
tion is recommended whenever parenchyma preserving
resection is performed. We report our experience of
managing GBC patients with RHAI.
Method: Retrospective analysis of clinicopathological
factors and surgical outcomes of GBC patients with
RHAI who underwent parenchyma preserving resection
(segment IVb/V), between August2009 and Septem-
ber2012.
Results: Of 187 GBC patients who underwent curative
resection during the period, nine with RHAI (and unin-
volved portal vein) who underwent parenchyma pre-
serving resection formed the study group. Abdominal
pain(n = 9) was the most common symptom followed
by jaundice(n = 5) & vomiting(n = 1). On preoperative
cholangiography (MRCP/PTC) all with jaundice sec-
ondary to bile duct involvement (n = 5) had infrahilar
block. RHAI (without reconstruction) with CBD exci-
sion was performed in all. Roof of hepatic duct conflu-
ence was preserved in six, ductoplasty (right and left
ducts) was performed in two and two separate anasto-
mosis was performed in one. Extrahepatic adjacent
organ resection was performed in six (distal gastrec-
tomy with proximal duodenectomy (3), Duodenal
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sleeve resection (3), colonic sleeve resection (1)]. Two
developed bile leak in the postoperative period [grade
A (ISGLS) -1 and grade B -1]. All six with roof of
hepatic duct confluence preserved did not have bile
leak. None of them had post-operative liver failure.
Median post-operative stay was 9 (7–21) days. On his-
topathology 7 had adenocarcinoma and 2 adenosqua-
mous carcinoma with R0 resection in all. All except
one had lymph node positive disease. During median
follow up 18 (3–28) months 6 patients are alive without
recurrence.
Conclusions: Hepatic artery ligation without recon-
struction can be safely performed in GBC patients who
undergo parenchyma preserving resection with bile duct
excision.
PO11-02
FEWER THAN FOUR PORTS VERSUS
FOUR PORTS FOR LAPAROSCOPIC
CHOLECYSTECTOMY
Kurinchi Gurusamy1, Michele Rossi2, Jessica Vaughan1
and Brian Davidson1
1University College London and Royal Free Hospital,
United Kingdom; 2Careggi Academic and Regional
Hospital of Florence, Italy
Introduction: Traditionally, laparoscopic cholecystec-
tomy is performed using two 10 mm ports and two
5 mm ports. Reduction in the number of ports has
been suggested to decrease pain and improve cosmesis.
The safety and effectiveness of using fewer than four
ports has not been established.
Method: A systematic review of literature was per-
formed by searching the Cochrane Library, MED-
LINE, EMBASE and Science Citation Index Expanded
for randomised controlled trials reported until Febru-
ary 2013. Two authors independently identified trials
and collected data. Risk ratio (RR) or mean difference
(MD) with 95% confidence intervals (CI) was calcu-
lated based on an intention-to-treat basis using Rev-
Man software.
Results: A total of 531 low anaesthetic risk patients
undergoing elective laparoscopic cholecystectomy were
randomised in six high-bias risk trials to fewer-than-
four-ports or four-ports. There was no mortality in
either group. There was no significant difference in seri-
ous adverse events (RR 4.24; 95% CI 0.74–24.31),
quality of life (SMD 0.18; 95% CI 0.06–0.43), conver-
sion to open cholecystectomy (RR 0.68; 95% CI 0.19–
2.35), operating time (MD 2.24 min.; 95% CI 1.13–
3.36), length of hospital stay (MD 0.02 days; 95% CI
0.18–0.14), day-surgery discharge (RR 0.92; 95% CI
0.70–1.22), in the time taken to return to activity (MD
0.90 days; 95% CI 5.08–3.28), or in cosmesis scores at
12 months (SMD 0.13; 95% CI 0.19–0.46) between the
two groups. The time taken to return to work was
shorter by two days in the fewer-than-four-ports group
compared with four-port laparoscopic cholecystectomy
(MD 2.00 days; 95% CI 3.31–0.69).
Conclusions: The safety profile of using fewer than
four-ports is yet to be established and fewer-than-four-
ports laparoscopic cholecystectomy should be reserved
to well-designed randomised clinical trials.
PO11-03
IDENTIFICATION OF BILIARY
EPITHELIAL STEM/PROGENITOR
CELLS BY USING LGR5
Mitsuo Miyazawa, Masayasu Aikawa, Katsuya Okada,
Yukihiro Watanabe, Kojun Okamoto and Isamu
Koyama
SaitamaMedical University International Medical
Center, Japan
Introduction: Little is known about how the extrahe-
patic bile duct repairs or regenerates after injury. We
established a model in which a bioabsorbable polymer
tube was implanted in the extrahepatic bile duct with
the aim of clarifying the regeneration process (Am J
Transplant 2005, 1541). Histological studies using this
model demonstrated that the immature bile duct epithe-
lium was villous in morphology and had crypts, sug-
gesting the presence of epithelial stem cells there as in
other parts of the digestive tract. We sought to locate
these stem cells using Lgr5 (leucine-rich-repeat-contain-
ing G-protein-coupled receptor 5), a marker for intesti-
nal epithelial stem cells.
Method: An artificial bile duct (ABD) in tubular form
made of a bioabsorbable polymer was prepared for
implantation. Pigs served as ABD recipients. The common
bile duct was cut around the confluence with the cystic
duct, its duodenal end was ligated and its hepatic stump
was anastomosed to the ABD. The remaining end of the
ABD was sutured to the duodenum. Neo-bile ducts were
collected for histology at various time points after implan-
tation. Biliary stem cells stained with the marker Lgr5 were
compared with c-kit positive cells in terms of location.
Results: Lgr5 positive cells were found in accessory
glandular structures seven weeks after ABD implanta-
tion and in the crypts of villous structures as well as in
accessory glandular structures at 12 weeks. The loca-
tion was similar between Lgr5 positive and c-kit posi-
tive cells. There were a number of accessory glandular
structures at seven weeks, while the neo-bile duct
showed a nearly single layer of cuboidal columnar epi-
thelium with accessory glands decreased in number,
looking like the native duct at six months.
Conclusions: In this model of extrahepatic bile duct
regeneration, biliary stem/progenitor cells appeared to
be in accessory glands and in the crypts of villous
structures of the epithelium.
PO11-04
ELEVATED EXPRESSION OF MASPIN
MRNA AS A PREDICTOR OF SURVIVAL
FOR STAGE II AND III GALLBLADDER
CANCER
Kavita Baghel, Hasan Raza Kazmi, Saloni Raj,
Abhijit Chandra and Rajeshwar Nath Srivastava
King George’s Medical University, India
Introduction: Maspin expression is found to be poten-
tial prognostic factor for various malignancies but its
relation with gallbladder cancer is unknown and needs
to be investigated in the area of high endemicity. In
present study, we investigated maspin mRNA expres-
sion in normal, gall stone disease and gallbladder can-
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cer along with its prognostic importance in cancer
patients.
Method: Gallbladder tissue from normal (n = 25), gall
stone disease (n = 25) and cancer patients (n = 38) were
analysed for maspin mRNA expression by semi-quanti-
tative reverse transcriptase PCR and quantitative real
time PCR. Statistical analysis was carried out using stu-
dent t test or ANOVA. Survival analysis was done
according to Kaplan-Meier method. Correlation analy-
sis was performed using Pearson correlation method.
p < 0.05 was considered statistically significant.
Results: Significant increase (p = 0.028) in expression
of maspin mRNA was observed in gallbladder cancer
as compared to gall stone disease, whereas no expres-
sion was found in normal tissues. Significant correla-
tion (Pearson’s coefficient (r) = 0.798, p < 0.0001)
was observed between relative quantification of maspin
mRNA and survival of cancer patients after surgery,
with significantly shorter (p = 0.002) survival in
patients having relative quantification >1.5 as compared
to those having relative quantification ≤1.5. Similarly,
significant difference in patient survival for maspin
mRNA expression was observed for stage II
(p = 0.025) and III (p = 0.011) cancer.
Conclusions: Higher expression of maspin mRNA in
gallbladder cancer has prognostic significance for stage
II and III cancer, which needs to be investigated fur-
ther.
PO11-05
COMPARISON OF EMERGENCY
LAPAROSCOPIC CHOLECYSTECTOMY
FOR ACUTE CHOLECYSTITIS WITHIN
AND BEYOND 72 H OF SYMPTOM
ONSET
Nilesh Doctor1 and Rachel Gomes2
1Jaslok Hospital and Research Centre, India; 2NUSI
Wockhardt Hospital, India
Introduction: The pathological boundary of acute cho-
lecystitis (AC) between early edematous and late
chronic fibrotic inflammation beyond 72 h is well-
described. Early laparoscopic cholecystectomy (ELC) is
safe in AC but the timing still remains controversial.
The aim of this study was to analyze the impact of the
duration of symptoms on clinical severity, pathology
and outcome in patients who underwent laparoscopic
cholecystectomy (LC) for AC during the urgent admis-
sion.
Method: A retrospective analysis of a prospectively col-
lected database of 61 patients who underwent LC for
AC over a 6-month period was performed.
Results: Of 61 patients 21 (34.43%) received ELC at
<72 h and 40 (65.57%) received late LC (LLC) at
>72 h. Clinically in the ELC group the majority were
mild and in the LLC group the majority were moderate
and severe in severity grading as per Tokyo guidelines
(p < 0.001). Surgical findings and histopathology
showed no significant difference in the distribution of
simple, phlegmonous and gangrenous cholecystitis
between both groups (p = 0.94). The majority were
completed by a standard four port technique and only
one required subtotal cholecystectomy. There was no
significant difference between operating time, return to
normal activities or hospital stay between both groups.
There were no conversions to open cholecystectomy, no
wound infections, no intra-abdominal collections, no
biliary tract injury or mortality in either group.
Conclusions: The degree of inflammatory change in AC
is not dependent on time. LC can be safely performed
in AC regardless of timing with a standardized surgical
strategy in experienced units.
PO12-01
ASSESSMENT OF LYMPH NODE
STATUS IN EXTRAHEPATIC
CHOLANGIOCARCINOMA: NUMBER
VERSUS RATIO OF POSITIVE LYMPH
NODES
Jun Sakata, Taku Ohashi, Yuki Hirose, Tomohiro
Katada, Natsuru Sudo, Kazuyasu Takizawa, Kabuto
Takano, Takashi Kobayashi, Masahiro Minagawa and
Toshifumi Wakai
Niigata University Graduate School of Medical and
Dental Sciences, Japan
Introduction: This study aims to compare the utility of
the number of positive nodes with lymph node ratio
(LNR) in predicting survival after resection for extrahe-
patic cholangiocarcinoma.
Method: We conducted a retrospective analysis of 142
consecutive patients undergoing a radical resection for
extrahepatic cholangiocarcinoma. A total of 3656
lymph nodes were retrieved (median, 24 nodes per
patient). Regarding both the number of positive nodes
and LNR, “optimal” cutoff values were determined
based on the v2 scores calculated by the Cox propor-
tional hazards regression model.
Results: Nodal disease was found in 59 (42%) patients.
None of the 18 patients undergoing an R1-2 resection
survived for more than 5 years, and thus these patients
were excluded from subsequent analyses to assess the
impact of nodal status on long-term survival. The
“optimal” cutoff values for the number of positive
nodes and LNR were determined to be one node and
5%, respectively. Univariate analysis identified both the
number of positive nodes (0, 1, or 2 or more;
p < 0.001) and LNR (0%, 0–5%, or >5%; p < 0.001)
as prognostic factors. Multivariate analysis identified
the number of positive nodes as an independent prog-
nostic factor (p < 0.001), whereas LNR failed to
remain as an independent variable. The 5-year survival
rates were 64% for patients with 0 positive nodes, 46%
for patients with 1 positive node, and 21% for patients
with two or more positive nodes (p < 0.001).
Conclusions: The number of positive nodes better pre-
dicts survival after resection than LNR in extrahepatic
cholangiocarcinoma.
© 2014 The Authors
HPB 2014, 16 (Suppl. 2), 258–316 HPB © 2014 Americas Hepato-Pancreato-Biliary Association
Poster Oral Representation 279
PO12-02
EVALUATION OF POSITIVE DUCTAL
MARGINS OF
CHOLANGIOCARCINOMA IN
INTRAOPERATIVE HISTOLOGICAL
EXAMINATION
Junji Ueda, Hiroshi Yoshida, Yasuhiro Mamada,
Nobuhiko Taniai, Masato Yoshioka, Youichi Kawano,
Tetsuya Shimizu, Daisuke Kakinuma, Hideyuki Takata
and Eiji Uchida
Nippon Medical School, Japan
Introduction: Frozen-section analysis remains the only
method to confirm microscopic extension of the cancer
at the ductal resection margins during surgery. How-
ever, several reports have found that prognosis for
patients with a positive bile duct stump does not differ
significantly from that of carcinoma-negative patients,
and some reports have even described long-term sur-
vival of patients with a positive surgical bile duct
stump. In this study, status of the surgical margins and
postoperative course were evaluated in 93 patients with
extrahepatic bile duct carcinoma to elucidate the influ-
ences of remnant carcinoma in situ on postoperative
survival.
Method: All consecutive patients who underwent
curative intent resection for a cholangiocarcinoma at
our institution between January 2004 and May 2012
were identified from a retrospectively collected data-
base. We evaluated the postoperative survival and
disease free survival. We performed immunochisto-
chemical staining targeting Ki 67 and p53 for positive
margin to evaluate the relation of these protein and
prognosis.
Results: We divided these patients into two groups,
margin positive group and negative group. The major
vessel invasion and peeled surface margin positive cases
were significantly higher in positive group than negative
group. We focused on positive group and divided this
group into two groups according to resected margin
status: carcinoma in situ at the bile duct stump and
invasive carcinoma at any surgical margin. There were
no significant differences in clinicopathological findings
between two groups. Recurrence and Survival were sig-
nificantly longer in CIS group than Invasive group. We
performed immunohistochemical staining targeting p53,
Ki 67of positive margin. There were no statistical rela-
tions between CIS, invasive group and expression of
p53 and Ki 67. Moreover there were no statistical rela-
tions between the expression of p53 and Ki 67 and sur-
vival and recurrence.
Conclusions: Resected margin status is the most impor-
tant to postoperative survival and recurrence in cholan-
giocarcinoma.
PO12-03
TECHNICAL KNACKS AND OUTCOMES
OF EXTENDED EXTRAHEPATIC BILE
DUCT RESECTION IN PATIENTS WITH
MID BILE DUCT CANCER
Youngin Yoon, Shin Hwang, Tae-Yong Ha, Ki-Hun
Kim, Chul-Soo Ahn, Deok-Bog Moon, Gi-Won Song,
Dong-Hwan Jung, Gil-Choon Park and Sung-Gyu Lee
Asan Medical Center, Ulsan University, Korea
Introduction: Mid bile duct cancers often involve the
proximal intrapancreatic bile duct, by which resection
of the extrahepatic bile duct (EHBD) can result in
tumor-positive distal resection margin (RM). We
attempted a customized surgical procedure to obtain
tumor-free distal RM during EHBD resection, by
which R0 resection can be achieved without performing
pancreaticoduodenectomy through extended EHBD
resection.
Method: We previously reported the surgical proce-
dures of extended EHBD resection, in which the extent
of intrapancreatic duct excavation resembling a ≥2 cm-
long funnel. This unique procedure was performed in
11 cases of mid bile duct cancer with old age between
70 and 83 years.
Results: The tumor extents were involvement of intra-
pancreatic duct in all cases. Deep pancreatic excavation
per se required about 30–60 min. Cancer-free hepatic
duct RM was obtained in 10 patients. Prolonged leak-
age of pancreatic juice occurred in 2 patients, but all
were controlled with supportive care. Adjuvant thera-
pies were primarily applied to RM-positive or lymph
node-positive patients. Their 1-year and 3-year survival
rates were 90.9% and 60.6%, respectively.
Conclusions: We suggest that this extended EHBD
resection can be performed as a beneficial option to
achieve R0 resection when pancreaticoduodenectomy
should be avoided due to various causes including old
age and expectation of poor outcome.
PO12-04
EARLY DNA DAMAGE RESPONSE IN
RESIDUAL CARCINOMA IN SITU AT
DUCTAL STUMPS AND LOCAL
RECURRENCE IN PATIENTS
UNDERGOING RESECTION FOR
EXTRAHEPATIC
CHOLANGIOCARCINOMA
Toshifumi Wakai, Jun Sakata, Yuki Hirose, Tomohiro
Katada, Natsuru Sudo, Taku Ohashi, Kazuyasu
Takizawa, Kabuto Takano, Takashi Kobayashi and
Masahiro Minagawa
Niigata University Graduate School of Medical and
Dental Sciences, Japan
Introduction: This study aimed to clarify the associa-
tion between the DNA damage response mediated by
p53-binding protein 1 (53BP1) in residual carcinoma in
situ at ductal stumps and local recurrence in patients
undergoing resection for extrahepatic cholangiocarcino-
ma.
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Method: A retrospective analysis was conducted of 11
patients with positive ductal margins with carcinoma in
situ. To evaluate the early DNA damage response, the
nuclear staining pattern of 53BP1 was examined by
immunofluorescence. TUNEL analysis was used to cal-
culate the apoptotic index.
Results: Of the 11 tumor specimens of carcinoma in situ,
seven showed diffuse localization of 53BP1 in nuclei
(53BP1 inactivation) and four showed discrete nuclear
foci of 53BP1 (53BP1 activation); apoptotic index was
significantly decreased in the seven tumor specimens with
53BP1 inactivation compared to the four with 53BP1
activation (median apoptotic index, 1% vs. 22%;
p = 0.003). The overall cumulative survival rates after
resection were 56% at 5 years and 19% at 10 years. The
cumulative probabilities of local recurrence after resec-
tion were 38% at 5 years and 67% at 10 years. The
cumulative survival after resection was significantly
worse in patients with 53BP1 inactivation than in
patients with 53BP1 activation (cumulative 5-year sur-
vival rate, 33% vs. 100%; p = 0.038). The cumulative
probability of local recurrence was significantly higher in
patients with 53BP1 inactivation than in patients with
53BP1 activation (cumulative 5-year local recurrence
rate, 60% vs. 0%; p = 0.019).
Conclusions: Clinically evident local recurrence of
residual carcinoma in situ at ductal stumps is closely
associated with 53BP1 inactivation and decreased apop-
tosis. In contrast, apoptosis associated with early
53BP1-mediated DNA damage response is one of the
molecular biological mechanisms that permit a small
proportion of patients with residual carcinoma in situ
at ductal stumps to survive in the long term with no
evidence of local recurrence.
PO12-05
PANCREATICODUODENECTOMY FOR
SECONDARY PERIAMPULLARY
CANCER FOLLOWING EXTRAHEPATIC
BILE DUCT CANCER RESECTION
Dong Hun Kim, Dong Wook Choi, Seong Ho Choi,
Jin Seok Heo, Jaehong Jeong and Huisong Lee
Samsung Medical Center, Sungkyunkwan University,
Korea
Introduction: This study addressed the feasibility and
effect of surgical treatment of metachronous periampul-
lary carcinoma after resection of the primary extrahe-
patic bile duct cancer. The performance of this
secondary curative surgery is not well-documented.
Method: We reviewed, retrospectively, the medical
records of 10 patients who underwent pancreaticoduo-
denectomy (PD) for secondary periampullary cancer
following extrahepatic bileduct cancer resection from
1995 to 2011, at Samsung Medical Center.
Results: The mean age of the 10 patients at the second
operation was 61 years (range: 45–70 years). The pri-
mary cancers were seven hilar cholangiocarcinomas, two
middle common bile duct cancers, and one cystic duct
cancer. The secondary cancers were eight distal common
bile duct cancers and two carcinomas of the ampulla of
Vater. The second operations were six Whipple proce-
dures and four pylorus-preserving pancreaticoduodenec-
tomies. The mean interval between primary treatment
and metachronous periampullary cancer was
20.6 months (range: 3.4–36.6 months). The distal resec-
tion margin after primary resection was positive for
recurrent disease in one patient. Preoperative endoscopic
biopsy for secondary periampullary cancer was per-
formed and confirmed the recurrent cancer in 6 patients.
Tumor recurrence was confirmed by periampullary
pathology in 8 cases. Four of the 10 patients had delayed
gastric emptying (N = 2) and pancreatic fistula (N = 2)
after reoperation. No deaths occurred in surgery. Med-
ian survival after PD was 44.6 months (range 8.5–120.5).
Conclusions: Based on post-operative survival, PD may
provide an acceptable protocol for resection in patients
with metachronous periampullary cancer after resection
of the extrahepatic bile duct cancer.
PO13-01
IS THERE ANY ROLE FOR HEPATIC
PEDICLE LYMPHADENECTOMY
IN INTRAHEPATIC
CHOLANGIOCARCINOMA? REVIEW
OF A 17-YEARS EXPERIENCE IN A
TERTIARY INSTITUTION
Dong Hun Kim1, Sun Choon Song1, Dong Wook
Choi1, Seong Ho Choi1, Jin Seok Heo1, Jaehong
Jeong1 and Alfred Wei-Chieh Kow2
1Samsung Medical Center, Sungkyunkwan University,
Korea; 2University Surgical Cluster, National University
Health System, Singapore
Introduction: While the role of lymphadectomy for
extrahepatic cholangiocarcinoma is well established,
routine lymphadenectomy in intrahepatic cholangiocar-
cinoma (ICC) remains controversial. In this study, we
examine the prognostic factors for survival in patients
with resected ICC comparing the outcome of hepatic
pedicle lymph node dissection (LND).
Method: The data of 226 patients with ICC who under-
went liver resection over 17 years were retrospectively
collected. These patients were divided into those with
LND performed [LND (+)] and those not [LND (-)].
Results: There were 120 patients (53.1%) in the LND
(+) group and 106 patients (46.9%) in the LND (-)
group. The demographic data were comparable
between the two groups except the presentation of liver
cirrhosis (p = 0.002), carbohydrate antigen (CA) 19-9
(p = 0.002), type of hepatectomy (p < 0.001) and adju-
vant treatment (p < 0.001). The proportion of T stage
(p = 0.001), tumor differentiation (p = 0.049), lympho-
vascular invasion (p = 0.001), perineural invasion
(p = 0.012) and macroscopic growth type (p = 0.001)
were significantly higher in the LND (+) group. There
were no statistically significant difference between LND
(+) and LND (-) groups in terms of overall survival
(p = 0.097) and disease-free survival (p = 0.125).
Lymph node metastasis (p < 0.001) and poorly differ-
entiated histologic grade (p = 0.016) were identified to
the independent prognostic factors of overall survival.
Conclusions: Routine LND did not show survival bene-
fit, however, it seemed to be crucial in nodal staging
and prognostication of the disease, which was essential
for decision on adjuvant treatment.
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PO13-02
INTRAHEPATIC CHEMOTHERAPY
SHOULD BE THE ANSWER FOR
UNRESECTABLE
CHOLANGIOCARCINOMA: REVIEW OF
THE LITERATURE AND PERSONAL
EXPERIENCE
Marco Massani, Roberta Bonariol, Tommaso Stecca,
Luca Fabris, Cesare Ruffolo, Luca Bonariol, Ezio
Caratozzolo and Nicolo’ Bassi
Regional Hospital, Italy
Introduction: Cholangiocarcinoma is a tumor that
arise primarily from the epithelial lining of the intra
and extrahepatic bile duct. Is the second most com-
mon primary liver cancer and accounted for an esti-
mated 15% of primary liver cancer Prognosis of
cholangiocarcinoma is generally poor. Surgery is the
only curative treatment for patients with CC, however
less than one-third of patients are resectable at diag-
nosis. Curative resection provides the best long term
survival. Five years survival rates after resection are
22–44%.The aim of this study was to evaluate the
efficacy of intrahepatic chemotherapy in patients with
intrahepatic cholangiocarcinoma analyzing the out-
come and survival and compare our results with a
review of literature.
Method: From January 2008 to December 2012 we
have observed 630 patients with hepatic lesion; the
group of patients with proven diagnosis of intrahepatic
cholangiocarcinoma consisted of 32 patients of whom
11 judged resectable at the moment of diagnosis while
21 were not resectable. Eleven patients were referred to
systemic chemotherapy or best supportive care due to
extra hepatic diffusion or because not resectable due to
comorbidities. 11 pts were treated with intra-arterial
chemotherapy and are the object of the study
Results: Four had a response of more than 50%, five
had stable disease and two had clear progression. Inter-
estingly three patients who had response to chemother-
apy were resected and in two of them the percentage of
necrosis, at pathological examination, were more than
90%. Two patients, in the group of stable response,
developed extra-hepatic disease, while three are alive
with disease. Two of the resected patients are alive
while the third one died 23 months after surgery.
Conclusions: Our experience, even considering the small
number of patients treated, suggests that intra-arterial
chemotherapy should be considered as an efficacious arm
in the treatment of intra-hepatic cholangiocarcinoma
PO13-03
SURGICAL OUTCOMES OF HILAR
CHOLANGIOCARCINOMA WITH
BISMUTH TYPE III OR IV: EARLY
EXPERIENCES OF NEOADJUVANT
CONCURRENT CHEMORADIATION
THERAPY
Dai Hoon Han, Sung Hoon Choi, Gi Hong Choi,
Kyung Sik Kim and Jin Sub Choi
Severance Hospital, Yonsei University, Korea
Introduction: Although aggressive surgical resection
with negative resection margin (R0 resection) remains
standard treatment for hilar cholangiocarcinoma
(HCCA), systemic recurrence as well as local recurrence
is frequent even after R0 resection. This study aimed to
analyze the prognostic factors after surgical resection
for Bismuth type III or IV HCCA and identify the pos-
sible role of neoadjuvant concurrent chemoradiation
(CCRT) therapy.
Method: From January 2000 to May 2013, 129 consec-
utive patients with Bismuth type III or IV underwent
surgical resection for treatment of HCCA. Among
these patients, 120 patients underwent curative aimed
surgical resection and 16 patients received neoadjuvant
concurrent chemoradiation therapy. Disease-free and
overall survivals after surgical resection were evaluated
and prognostic factors were analyzed. Then, periopera-
tive outcome of the patients with neoadjuvant CCRT
was compared the patients without neoadjuvant
CCRT.
Results: R0 resection was achieved in 102 patients
(85.0%) and perioperative mortality was 14.2%. 5-year
disease-free and overall survivals of 120 patients were
29.7 and 30.2%, respectively. Preoperative CA 19-9
more than 400 U/ml, preoperative serum total bilirubin
more than 2 mg/dL, and presence of microscopically
positive resection margin were worse prognostic factors
for overall survival according to multivariate analysis.
R0 resection was achieved for all patients with neoadju-
vant CCRT even though there was no statistically sig-
nificance. Recurrence rates, especially local recurrence
rate after surgical resection were smaller in the patients
with neoadjuvant CCRT (50.5% vs. 31.3% and 25.5%
vs. 12.5%, respectively) even though there was no sta-
tistically significance.
Conclusions: Radical R0 resection was one of the inde-
pendent prognostic factors for overall survival after
surgical resection in patients with Bismuth type III or
IV HCCA. Neoadjuvant CCRT allowed for R0 resec-
tion in all patients and tended to decrease recurrence
rate and local recurrence. To confirm the effect of neo-
adjuvant CCRT on surgical outcomes, prospective ran-
domized controlled trial is needed.
PO13-04
EXPRESSION PROFILE OF MICRORNA-
200 FAMILY IN
CHOLANGIOCARCINOMA ARISING
FROM CHOLEDOCHAL CYST
Ta-Sen Yeh, Tse-Ching Chen, Chun-Nan Yeh and
Yi-Yin Jan
Chang Gung Memorial Hospital, Chang Gung
University, Taiwan
Introduction: Cholangiocarcinoma arising from choled-
ochal cyst (CC-CC) is well recognized particularly in
Eastern Asia. The long-term outcome of CC-CC after
resection is considered worse than cholangiocarcinoma
caused by other etiologies (CC). Recently, epithelia-
mesenchymal transition (EMT) has been demonstrated
as a critical step for carcinogenesis and metastasis, dur-
ing which microRNA-200 (miR-200) family might play
an important role.
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Method: A total of 16 patients with CC-CC whom had
undergone intended curative resection were recruited.
Meanwhile a total of 254 patients with resected CC
served as demographic controls; of them, 66 were arbi-
trarily selected for miR-200 family and EMT-affiliated
molecules controls. miR-200 family including miR-
200a, 200b, 200c, 141 and 429 were detected using
qPCR; whereas EMT- affiliated molecules (E-cadherin,
ZEB1, vimentin, Twist, Snail, p53, Bmi-1, Igfbp-4)
were determined using immunohistochemistry.
Results: CC-CC were younger and female-predominant
compared to CC; whereas the latter were more associ-
ated with concomitant hepatolithiasis. The expression of
miR-200 family in CC-CC were significantly lower com-
pared with those of CC (p < 0.0001). CC-CC exhibited
more frequently overexpression of ZEB1, Twist, Snail
and vimentin, and aberrant E-cadherin expression, indi-
cating EMT. Further, CC-CC demonstrated more p53
overexpression and stemness factor Bmi1, but reduced
level of metastasis-suppressive protein Igfbp4. In vitro
functional assay demonstrated that installation of pre-
miR 200s upon cholangiocarcinoma cells attenuates their
biological aggressiveness; whereas installation of anti-
miR0 200s enhances biological aggressiveness.
Conclusions: We for the first time demonstrated that
miR-200 family is responsible for the development of
CC-CC via ZEB1-directed EMT activation and Sec23a-
mediated secretome.
PO13-05
SUBSEQUENT BILIARY MALIGNANCY
FOLLOWING CYST EXCISION FOR
CONGENITAL CHOLEDOCHAL CYSTS:
REPORT OF THREE CASES
Tomohiro Katada, Jun Sakata, Taku Ohashi, Yuki
Hirose, Natsuru Sudo, Kazuyasu Takizawa, Kabuto
Takano, Takashi Kobayashi, Masahiro Minagawa and
Toshifumi Wakai
Niigata University Graduate School of Medical and
Dental Sciences, Japan
Introduction: Although cyst excision is the treatment of
choice for congenital choledochal cysts, it has been
reported that subsequent biliary malignancy developed
in the remnant bile duct after cyst excision.
Method: We herein report three cases of subsequent
biliary malignancy following cyst excision for congeni-
tal choledochal cysts and review of the literature to
clarify the clinical features of this condition.
Results: Three patients had subsequent biliary malig-
nancy at 13, 15, and 32 years following cyst excision.
The anatomical sites of these malignancies were the int-
rahepatic (n = 1), hilar (n = 1), and intrapancreatic
(n = 1) bile ducts. Surgical resection procedures included
left trisectionectomy (n = 2) and pancreaticoduodenecto-
my (n = 1). One patient had a tumor showing direct
invasion to the duodenum and pancreas without lymph
node metastases. Another patient had a tumor showing
invasion to the main portal vein without lymph node
metastases. The other patient had a tumor with periaor-
tic lymph node metastases. These three patients died of
disease 9, 15, and 35 months after resection of the subse-
quent biliary malignancy.
In the literature, we found 32 patients with subsequent
biliary malignancy following cyst excision. The anatom-
ical sites of these tumors were the hilar (n = 17), intra-
hepatic (n = 9), and intrapancreatic (n = 6) bile ducts.
The median interval between cyst excision and the
detection of this complication was six (range, 1–34)
years. Twelve patients were treated with supportive
care and 14 patients received either surgical resection
(n = 11), chemoradiotherapy (n = 2) or chemotherapy
(n = 1). There were no 4-year survivors among the 32
patients.
Conclusions: Subsequent biliary malignancy seems to
be found in the long-term even after cyst excision for
congenital choledochal cysts. Despite an aggressive
treatment approach, the subsequent biliary malignancy
following cyst excision shows an unfavorable outcome.
PO14-01
CONCURRENT VERSUS SEQUENTIAL
NEOADJUVANT
CHEMORADIOTHERAPY FOLLOWED
BY SURGERY IN OPERABLE
CARCINOMA GALLBLADDER
PATIENTS: A PILOT STUDY
Ameet Kumar1, Sujoy Pal1, Nihar Ranjan Dash1, Atul
Sharma2, Raju Sharma1, Siddhartha Datta Gupta1,
Bidhu Kalyan Mohanti2, Peush Sahni1 and Tushar
Kanti Chattopadhyay1
1All India Institute of Medical Sciences, India; 2BRA
IRCH, All India Institute of Medical Sciences, India
Introduction: A multimodality approach may improve
the poor survival and high recurrence rates following
curative resections in locally advanced gallbladder can-
cer (LA-GBC). Only one previous study has examined
the role of neoadjuvant chemoradiotherapy (NACRT),
albeit in incidental GBC. This pilot study was done to
evaluate the safety and efficacy of NACRT in resect-
able LA-GBC.
Method: Sixteen patients were alternately allocated to
sequential (arm A: 8) and concurrent (arm B: 8) NAC-
RT. Eligibility criteria included chemo-radiotherapy-
naive patients with cytologically proven, operable GBC
(stage III: 12/IVA: 4, without vascular involvement and
metastasis- excluded by laparoscopy). Arm A received
GEMOX (300 mg/m2/50 mg/m2) weekly for 4 weeks.
Arm B received GEMOX (900 mg/m2/80 mg/m2) on
days 1, 8, 22 and 29. Radiotherapy (35 Gy/15 frac-
tions) was administered in both arms. Following NAC-
RT these patients were reassessed by CT before
surgery. (TRIAL REGISTRATION: CTRI/2011/12/
002264).
Results: In arm A, radiological complete response
(rCR), partial response (rPR) and progressive disease
(rPD) was seen in 1, 2 and 4 patients, respectively and
1 died of severe cholangitis before response assessment.
In arm B, rCR, rPR and stable disease was seen in 1, 6
and 1 patient, respectively. The overall response rates
were significantly better in arm B (8/8 vs. 3/8;
p = 0.03). Grade III toxicity occurred in only 1 patient.
Eight patients (arm A: 2, arm B: 6) underwent surgical
excision with an R0 resection. Pathological CR was
seen in 1 (arm A) and pPR in 7 patients (arm A: 1,
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arm B: 6). At a median follow up of 16.2 months, the
mean overall survival in arms A and B were 9.5 and
14.2 months, respectively (p = 0.5).
Conclusions: Both sequential and concurrent NACRT
were safe and efficacious in LA-GBC. Concurrent
NACRT allowed more frequent R0 surgical resection,
had better response rate and longer overall survival.
PO14-02
SIMPLE VS. EXTENDED
CHOLECYSTECTOMY FOR T1B GB
CANCER
JongHee Yoon, Jeong-su Nam, Jae Hoon Lee, Ki-
byung Song, Kwang-Min Park and Young-Joo Lee
Asan Medical Center, Ulsan University, Korea
Introduction: The purpose of this study was to assess
the effectiveness of simple and extended cholecystec-
tomy for muscularis (T1b) gallbladder cancer by analy-
sis of surgical outcomes at a single institution.
Method: Archived records of 85 patients with patho-
logic stage T1b GB cancer who underwent surgery
between 1997 and 2010 were reviewed.
Results: Among 806 patients of GB cancer that under-
went surgery, 85 (10.5%) were diagnosed as pathologic
stage T1b cancer. Simple and extended cholecystectomy
were performed in 48 (56.5%) and 37 (43.5%) patients,
respectively. 5-year survival rate was 78.2% in simple cho-
lecystectomy and 91.0% in extended (p = 0.108) respec-
tively. There was no statistically significant difference but
it is better tendency in extended cholecystectomy than
simple cholecystectomy. After simple cholecystectomy,
re-resections were performed in 7 cases. There was no sur-
vival benefit. There were recurrences in 6 (7%) patients.
Average period of recurrence is 27 months (range
4 ~ 47). Out of six patients, four patients underwent sim-
ple cholecystectomy and the rest 2 patients extended cho-
lecystectomy. It was higher risk of recurrence rate in
simple cholecystectomy than extended. Out of four
patients, two patients underwent reoperation and are
alive. The rest two patients were dead. Two recurred
patients who underwent extended cholecystectomy were
dead.Majority of recurrence site was lymph node of hepa-
toduodenal ligament.We can’t identify lymph node status
exactly. Because of 65 (76.5%) patients didn’t undergo
lymph node dissection. There was no lymph node metas-
tasis in the rest 20 patients.
Conclusions: If the disease stage is determined to be
T1b, it is concluded that simple cholecystectomy alone
is statistically curative regardless of operational method
(laparoscopic or open). But, extended cholecystectomy
is better tendency of 5-year survival rate and lower risk
of recurrence rate than simple cholecystectomy. And
majority of recurrence site is lymph node of hepatoduo-
denal ligament. In light of these, extended cholecystec-
tomy is recommended in low operative risk patients.
PO14-03
IMPACT OF ADDITIONAL RESECTION
FOR INCIDENTAL GALLBLADDER
CANCER
Hiroki Hayashi1, Fuyuhiko Motoi1, Hiroshi Yoshida1,
Takanori Morikawa1, Takaho Okada1, Kei
Nakagawa2, Takeshi Naitoh1, Yu Katayose2 and
Michiaki Unno2
1Tohoku University Hospital Japan; 2Tohoku University
School of Medichine, Japan
Introduction: In spite of the improvement of diagnostic
imaging system, we sometimes encounter incidental
gallbladder cancer that was undiagnosed before opera-
tion. If gallbladder cancer is suspected during an opera-
tion, it is difficult to change the operative procedure
because there are many different variations on the
operative procedure depending on the cancer spread
and stage. For those patients, surgeons sometimes per-
formed cholecystectomy and made consideration
whether the additional resection is necessary or not on
the basis of histological diagnosis of the cancer depth
and cancer remnant.
Method: Incidental gallbladder cancer patients after
cholecystectomy were enrolled in this study. The progno-
sis of the patients with or without additional secondary
resection was analyzed with respect to the cancer depth.
Results: 38 incidental gallbladder cancer patients (7, 6,
15, 10 patients were T1a, T1b, T2, T3 in the 7th UICC
TNM classification, respectively) were enrolled. 28
patients (2, 5, 12, 9 patients were T1a, T1b, T2, T3,
respectively) underwent secondary resection. There were
no T4 patients in this study. The mean interval of time
between first and second operation was 1.43 months.
None of T1a patients had a recurrence with or without
secondary resection. Two patients with T1b gallbladder
cancer were referred to our hospital due to the recur-
rence during observation without secondary resection.
The prognosis of secondary resected patients with T2
and more were statistically equal to those of the
patients with elective surgery in our institute who were
preoperatively diagnosed as gallbladder cancer.
Conclusions: No additional resection is needed for T1a
patients. Additional resection is necessary to improve
the prognosis of T2 and T3 incidental gallbladder can-
cer patients. Additional resection is also recommended
for T1b patients because of the possibility of infrequent
recurrence. If T1b and more incidental gallbladder can-
cer were detected histologically after cholecystectomy,
additional resection should be done as soon as possible.
PO14-04
STAGING, RESECTABILITY, AND
OUTCOMES IN PATIENTS WITH
GALLBLADDER CARCINOMA
Ahmed Elgendi, Samer Bessa, Mohamed Sharaan and
Maher Elzeini
Alexandria university, Egypt
Introduction: Carcinoma of gallbladder is the most
common biliary tract malignancy. Unfortunately it usu-
ally presents late in an advanced stage. The authors
analyze and assess the management and outcome in
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patients with gallbladder cancer in a single tertiary
referral center.
Method: Between 2009 and 2013, a prospectively main-
tained database for 31 patients with gallbladder cancer
treated at our institution was developed. Patients, who
were unresectable, were treated with chemotherapy and
metallic stent if jaundiced. Curative resections included
extended cholecystectomy (wedge resection of GB bed),
more extensive hepatectomy (segmentectomy IVb and
V or right hepatectomy) and extra-hepatic biliary ducts
excision.
Results: Thirty-one patients were included in the study.
Nearly three quarters (n = 23) of them died due to can-
cer. The median survival time was 10.00
(SE = 2.78) months. Using life-table, the time of the
greatest risk was during the first year (hazard
rate = .06). Hazard rate dropped dramatically during
the second (hazard rate = .01) and the third year (haz-
ard rate = .01). Using log-rank test, the following cova-
riates were found to increase the survival of patients:
surgical resection of the tumor (Χ2 = 21.18, p < .001),
R0 (Χ2 = 18.34, p < .001), absence of lymph-nodal
metastasis (Χ2 = 21.59, p < .001), absence of local inva-
sion (Χ2 = 8.90, p = .003), and incidental discovery of
gall bladder (Χ2 = 14.00, p < .001). Exposure to che-
motherapy was found to significantly improve the sur-
vival of patients who did not undergo surgical
treatment (Χ2 = 15.51, p < .001), but not among the
patients who undergo surgical treatment (Χ2 = 1.63,
p = .202). Using log-rank test for trend, the poorly dif-
ferentiated tumors (Χ2 = 8.90, p = .006) and advancing
in tumor stage (Χ2 = 19.51, p < .001) significantly
decreasing patients survival.
Conclusions: Although much progress has been made
in the diagnosis and management of gallbladder carci-
noma, the long-term outlook for most patients is still
dismal. Only complete tumor resection, including hepa-
tic resection, enables long-term survival for patients.
Chemotherapy has a significant benefit in term of sur-
vival rate compared with no treatment.
PO14-05
INCIDENTAL NON-BENIGN
GALLBLADDER HISTOPATHOLOGY
AFTER ROUTINE CHOLECYSTECTOMY
IN A UK POPULATION
Khaled Dajani, Krashna Patel, Raaj Praseedom,
Neville Jamieson, Asif Jah, Simon Harper and
Emmanuel Huguet
Addenbrooke’s Hospital, United Kingdom
Introduction: Selective histological assessment of
resected gallbladders from routine cholecystectomies is
a growing trend due to rarity of incidental gallbladder
malignancy. We aim to analyse the range of histopa-
thology detected in the largest UK series of routine
cholecystectomy specimens.
Method: Data for all routine cholecystectomy gallblad-
der specimens examined by the histopathology depart-
ment at Addenbrookes University Hospital (Cambridge,
UK) during a 5 year period between March 2008 and
March 2013 was obtained via a computerised database.
This study collected data on all specimens demonstrating
gallbladder pathology other than gallstones or cholecys-
titis. Hospital computer software and patient hardcopy
notes were used to collate demographic, operative and
histopathological parameters.
Results: A total of 4250 gallbladders were examined in
the 5 year period described. The majority (97%) of
specimens exhibited gallstone disease or cholecystitis
related disease. 43 gallbladders (1.01%) demonstrated
polyps, most cholesterol based in nature (41/43). 55
resected gallbladders exhibited dysplastic changes
(1.29%), ranging from low to multifocal high-grade
dysplasia (4/55). A single gallbladder revealed carci-
noma in situ (0.02%) and 8 specimens (0.19%, 6 female
and 2 male) contained incidental primary gallbladder
adenocarcinoma.
Conclusions: This large single centre study demon-
strated a full range of benign and malignant gallblad-
der disease from histological assessment of routine
cholecystectomy specimens. We report 0.19% incidence
of incidental gallbladder malignancy from routine
cholecystectomies. We conclude that routine histologi-
cal evaluation of all elective and emergency cholecystec-
tomies is justified in a UK population. Region based
selective histological evaluation has the potential to
miss serious gallbladder pathology.
PO15-01
INDICATIONS FOR LIMITED
RESECTION IN THE THERAPEUTIC
STRATEGY FOR NEOPLASMS OF THE
AMPULLA OF VATER
Masaru Koizumi, Naohiro Sata, Yukihiro Sanada,
Yuji Kaneda, Yasunao Ishiguro, Atsushi Miki, Hideki
Sasanuma, Yasunaru Sakuma, Alan Lefor and
Yoshikazu Yasuda
Jichi Medical University School of Medicine, Japan
Introduction: We have emphasized the complications
and uncertain pathological evaluation of the resection
margin after endoscopic papillectomy, and have
reported the usefulness of limited surgical resection,
such as transduodenal papillectomy (TDP), transab-
dominal papillectomy (TAP) and pancreas-sparing duo-
denectomy (PSD). The aim of this study is to
determine the indications for limited resection of neo-
plasms of the ampulla of Vater (NPV).
Method: From 1992 to 2013, 90 patients with NPV
underwent resection at Jichi Medical University Hospi-
tal, Tochigi, Japan. Fifteen patients (17%, 13 male and
2 female, mean age 57.6) underwent limited resection
(10 TDP, 4 TAP and 1 PSD).
Results: Endoscopic ultrasonography (EUS) and/or in-
traductal ultrasonography (IDUS) were performed pre-
operatively in all patients and no pancreatic and/or
duodenal invasion was detected. Pathologically, 7 adeno-
mas and 8 adenocarcinomas including 6 mucosal carci-
nomas and 2 od-carcinomas (limited to the sphincter of
Oddi) were confirmed. All adenomas had negative surgi-
cal margins. One mucosal carcinoma had a positive sur-
gical margin in the bile duct and pylorus preserving
pancreatoduodenectomy (PpPD) was subsequently per-
formed. Another od-carcinoma underwent PpPD, as
31% of od-carcinomas had lymph node metastases in
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our previous series. Pathological evaluation showed
residual carcinoma in both cases, but no lymph node
metastases. All patients are alive without recurrence.
Conclusions: NPVs often have mucosal spread into the
biliary and/or the pancreatic ducts, which cannot be
detected by preoperative EUS and/or IDUS. Limited
resection for NPV has the advantage of precise patho-
logical evaluation especially in early stage lesions. A
“step-up” strategy with limited resection as the primary
procedure followed by PpPD after pathological evalua-
tion is feasible for the treatment of early-stage NPV.
PO15-02
FULL-THICKNESS
CHOLECYSTECTOMY WITH LIMITED
LYMPHADENECTOMY FOR
GALLBLADDER CANCER
Tomohiro Katada1, Jun Sakata1, Yuki Hirose1,
Natsuru Sudo1, Kazuyasu Takizawa1, Kabuto
Takano1, Takashi Kobayashi1, Masahiro Minagawa1,
Yoshio Shirai2 and Toshifumi Wakai1
1Niigata University Graduate School of Medical and
Dental Sciences, Japan; 2Niitsu Medical Center
Hospital, Japan
Introduction: Aggressive radical resection is advocated
for gallbladder cancer. However, this is a disease of the
elderly and some patients have comorbid disease(s)
and/or a debilitated condition that may preclude such
an aggressive treatment strategy. This study aimed to
clarify indications for a minimum radical procedure for
gallbladder cancer, termed as “full-thickness cholecys-
tectomy with limited lymphadenectomy”.
Method: From 1992 through 2010, 12 patients under-
went full-thickness cholecystectomy with limited lym-
phadenectomy in the study department. This procedure
involves full-thickness resection of the gallbladder (cho-
lecystectomy combined with removal of the entire cystic
plate) and removal of the first-echelon lymph nodes
(the pericholedochal and cystic duct node groups). We
mainly applied this procedure to patients with
advanced age and/or comorbid disease(s) with tumor
confined to the gallbladder wall and no gross evidence
of distant metastases/nodal disease.
Results: The primary tumor was classified as pathologi-
cal T1a (pT1a) in 6 patients, pT1b in 2, and pT2 in 4
(according to the American Joint Committee on Cancer
Staging Manual, 7th edition). Two patients had lymph
node metastases; one patient had a positive pericholed-
ochal node and the other had a positive cystic duct
node. No in-hospital mortality has been associated with
this procedure and no patients have died of recurrent
disease. In our series, the median overall survival was
229 months with a cumulative 5-year overall survival
rate of 100%. Of note, one of our patients who showed
a positive pericholedochal node survived for more than
5 years.
Conclusions: Full-thickness cholecystectomy with lim-
ited lymphadenectomy is a minimum radical procedure
for gallbladder cancer that is safe and effective for
early-stage tumors. This less invasive procedure can be
applied to patients with advanced age and/or comorbid
disease(s), provided that the tumor is apparently con-
fined to the gallbladder wall and has no gross evidence
of distant metastases/nodal disease.
PO15-03
THE NEOADJUVANT
CHEMORADIATION THERAPY WITH
GEMCITABINE FOR R0-RESECTION OF
POSSIBLY RESECTABLE
CHOLANGIOCARCINOMA
Kei Nakagawa, Yu Katayose, Koji Fukase, Masamichi
Mizuma, Naoaki Sakata, Takaho Okada, Hiroki
Hayashi, Hiroshi Yoshida, Fuyuhiko Motoi and
Michiaki Unno
Tohoku University Graduate School of Medicine, Japan
Introduction: To improve the prognosis of cholangio-
carcinoma patients, we have applied neoadjuvant
chemoradiation therapy (NACRT) followed by conven-
tional resection for possibly resectable cholangiocarci-
noma. We showed that neoadjuvant chemoradiation
with conventional resection was safe and tolerable (He-
patogastroenterology. 2011;58:1866-72). Then, we pro-
ceeded Phase II study (P-2). Here, we evaluated P-2 as
an interim analysis and compared the P-2 group and 99
patients who were operated on using conventional
resection at the same stage and same period as the P-2
group in terms of the perioperative factors and effec-
tiveness.
Method: Regimen of P-2 was 600 mg/m2 of gemcita-
bine (day 1 and 8 9 2 courses) with external beam
radiation therapy (1.8-Gy daily, 45 Gy). Patients with
histologically or cytologically confirmed adenocarci-
noma of the extra- and hilar cholangiocarcinoma were
enrolled from 2008 to June 2012. The primary endpoint
was the R0-resection rate. We thought the R0-resection
rate was 60% referring to our previous data, assumed
that it would increase to 80% with neoadjuvant chemo-
radiation treatment. We determined that the enrollment
should be 40 cases assuming 10% of the patients would
drop out.
Results: As interim analysis, 22 patients were enrolled
in P-2. 21 patients received complete chemoradiation.
19 cases were operated on, and 18 cases were resected.
Three cases were not operated on. Two cases were pro-
gressing disease, and one was heart failure. The R0-
resection rate of the P-2 group and conventional resec-
tion group was 62% (13 cases out of 22 cases) and
36% (36 cases out of 99 cases), respectively (p < 0.05).
Intraoperative bleeding, operative duration and hospi-
tal stay after surgery were not significant and surgical
site infection (SSI) was also not significant.
Conclusions: NACRT with conventional resection
appears to be effective and well tolerated. We are going
to continue to further patient registration, to analyze
the benefits of this regimen.
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PO15-04
INTER-AORTOCAVAL LYMPH NODE
BIOPSY AS PART OF STAGING
LAPAROSCOPY FOR GALLBLADDER
CANCER: A PILOT STUDY
John Mathew, Raja Kalayarasan, Amit Javed and Anil
Agarwal
GB Pant Hospital & MAM College, India
Introduction: Conventional staging laparoscopy (SL)
picks up surface liver metastasis and peritoneal depos-
its. Involvement of inter-aortocaval (IAC) lymph node
in gallbladder cancer (GBC) is a sign of advanced dis-
ease. Traditionally IAC node sampling biopsy is done
at the time of laparotomy before proceeding with radi-
cal resection. Significant proportion of patients there-
fore undergo a non-therapeutic laparotomy, when IAC
lymph node are found to be positive for malignancy on
per-operative frozen section analysis signifying meta-
static disease. Hence this study was done to evaluate
the feasibility and outcome of laparoscopic IAC sam-
pling biopsy as part of SL.
Method: We conducted a pilot study of laparoscopic
sampling biopsy and frozen section examination of
IAC node in selected patients deemed operable on pre-
operative evaluation and initial staging laparoscopy
(SL). The procedure was performed using four ports
(two in incision line) with the patient in the modified
lithotomy position. Early GBC was defined T1/T2 stage
tumors, while T3/T4 tumors were classified as locally
advanced.
Results: Seventeen patients (early GBC–9, locally
advanced GBC-8) deemed operable on preoperative
evaluation were planned for laparoscopic IAC sampling
biopsy. The procedure was successfully completed in 15
(88.2%) patients (study group), whereas in 2 the proce-
dure was converted to open due to suspected adjacent
organ involvement at the time of SL. Median (range)
lymph node yield was 2 (1–3). None of the patients had
complications related to the procedure. Of the 15
patients, one had evidence of metastasis on frozen sec-
tion examination and the procedure was abandoned.
Of the remaining 14 patients, 11 underwent laparo-
scopic radical cholecystectomy and 3 underwent open
radical cholecystectomy.
Conclusions: Laparoscopic IAC sampling biopsy is
technically feasible in selected GBC patients without
adjacent organ involvement. It has the potential to
improve the yield of SL without increasing the morbid-
ity of the procedure. This avoids unnecessary non ther-
apeutic laparotomy.
PO15-05
“EXTENDED” RADICAL
CHOLECYSTECTOMY FOR
GALLBLADDER CANCER
Jun Sakata, Taku Ohashi, Yuki Hirose, Tomohiro
Katada, Natsuru Sudo, Kazuyasu Takizawa, Kabuto
Takano, Takashi Kobayashi, Masahiro Minagawa and
Toshifumi Wakai
Niigata University Graduate School of Medical and
Dental Sciences, Japan
Introduction: Although “extended” radical cholecystec-
tomy was widely used for gallbladder cancer among
Japanese surgeons, indications for this procedure have
not yet been established. This study aimed to delineate
indications and limitations in using extended radical
cholecystectomy for gallbladder cancer.
Method: Of 145 patients who underwent a radical
resection for gallbladder cancer, 52 (36%) had an
extended radical cholecystectomy, which involved en
bloc resection of the gallbladder, gallbladder fossa,
extrahepatic bile duct, and the regional lymph nodes. A
retrospective analysis of the 52 patients was conducted
including at least 5 years of follow up.
Results: Overall survival after resection was 65% at
5 years in all 52 patients. Overall survival differed
according to the pathological T (pT) classification
(p < 0.001) and the nodal status (p = 0.010). All of
three patients with pT1 tumors and most (29 of 36)
patients with pT2 tumors survived for more than
5 years. Of 12 patients with pT3 tumors, eight who had
an R1-2 resection, distant metastasis, or extensive
extrahepatic organ involvement died soon after resec-
tion. Of the remaining four pT3 patients who had
localized hepatic spread through the gallbladder fossa
and underwent an R0 resection, two survived for more
than 5 years and another survived for 4 years
2 months. The only patient with pT4 tumor died of dis-
ease soon after resection. Among 23 node-positive
patients, 11 survived for more than 5 years, and of
these 10 had a modest degree of nodal disease (one or
two positive nodes).
Conclusions: Extended radical cholecystectomy is indi-
cated for pT2 tumors and some pT3 tumors with local-
ized hepatic invasion, provided that the nodal disease is
limited to a modest degree (up to two positive nodes).
Extensive pT3 disease, pT4 disease, or marked nodal
disease appears to be beyond the scope of this radical
procedure.
PO16-01
LIVING DONOR LIVER
TRANSPLANTATION FOR MIXED
HEPATOCELLULAR AND
CHOLANGIOCARCINOMA –
OUTCOMES
Kumar Palaniappan, Mukul Vij, Rajasekhar
Perumalla, Gomathy Narashiman, Vivekandan
Shanmugam, Srinivas Reddy, Thomas Cherian and
Mohamed Rela
Global hostpitals & Health city, Chennai, India
Introduction: Combined Hepatocellular Cholangiocarci-
noma (cHCC-CC) are rare primary liver tumors
accounting for <1% of all liver cancers. Although trans-
plantation has demonstrated survival benefit for patients
with hepatocellular carcinoma (HCC), there is limited
data to support or refute transplantation for combined
hepatocellular-cholangiocarcinoma (cHCC–CC).
Method: Total of 240 patients underwent transplanta-
tion from January 2010 to July 2013. Of these about
160 was living related liver transplantation. Three
patients who were suspected to have HCC, had cHCC-
CC in their explants. All the three patients had local
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ablative therapy - TACE or RFA in the preoperative
period.
Results: Of the three patients, two were females aged
46 & 54 years. Other patient was male aged 56. CECT
was suggestive of hypervascular lesion. Alfa fetoprotein
levels were normal (40–95 iu). Two patients had Allen-
Lisa Type II tumors & other had Type III. One patient
has TACE, before transplantation. Two other patients
had Radio frequency ablation before transplantation.
The size varied between 3 cm to 6.5 cms. The follow-
up varies between 3 to 20 months (Mean of
14.5 months). All patients are alive without disease
recurrence at a median interval of 14.5 months.
Conclusions: Transplantation for localized cHCC–CC
confers a survival benefit similar to transplantation for
HCC. But the number of patients who underwent trans-
plantation are few for cHCC-CC. With survival data that
mimics historic reports of transplant for intrahepatic cho-
langiocarcinoma, this study questions the benefit of trans-
plantation for patients with cHCC–CC & recommends
more follow up & studies for improving outcomes.
PO16-02
HIGH SERUM VASCULAR
ENDOTHELIAL GROWTH FACTOR
LEVELS PREDICT POOR PROGNOSIS
IN PATIENTS UNDERGOING LIVER
TRANSPLANTATION WITH
HEPATOCELLULAR CARCINOMA:
EXPERIENCE OF A SINGLE WESTERN
CENTER
Wei Zhang, Cristiano Quintini, Koji Hashimoto,
Masato Fujiki, Teresa Diago, Dympna Kelly, Bijan
Eghtesad, Charles Miller, John Fung and Federico
Aucejo
Cleveland Clinic Foundation, USA
Introduction: Vascular endothelial growth factor
(VEGF) has an important role in hepatocellular carci-
noma (HCC) development by fostering tumor cell pro-
liferation and new tumor vessel formation. Recent
studies demonstrated the prognostic value of serum
VEGF levels in patients undergoing liver resection or
locoregional therapies for HCC. Most studies have
been generated in Asian countries, and limited data
correlating serum VEGF in the setting of liver trans-
plantation (LT) for HCC is available. This study inves-
tigated the prognostic significance of pre-transplant
serum VEGF levels in patients with HCC undergoing
LT in a large western transplant center.
Method: From January 2007 to December 2011, pre-
LT serum VEGF levels were measured by an enzyme-
linked immunoassay in 113 patients with HCC. Median
VEGF level was used as the cutoff value to determine
high and low serum VEGF levels. Serum VEGF levels
were correlated with clinicopathological characteristics
and overall and recurrence-free post-LT survival.
Results: Pre-LT serum VEGF levels were significantly
associated with multiple tumors (p = 0.021), total
tumor size greater than 5 cm (p = 0.005), vascular inva-
sion (p = 0.000), and beyond Milan criteria (p = 0.004).
Multivariate analyses revealed that serum VEGF level
>35 pg/mL was independently associated with vascular
invasion (p = 0.003). Patients with serum VEGF level
>35 pg/mL had higher tumor recurrence rate, worse
overall and recurrence-free survival compared with
those with serum VEGF level ≤35 pg/mL (p = 0.000,
0.019 and 0.010, respectively). Serum VEGF level and
Milan criteria were identified by multivariate analysis
as independent predictors of both overall and recur-
rence-free survival.
Conclusions: In patients with chronic end stage liver
disease, median pre-LT serum VEGF level >35 pg/mL
appears to be a predictor of vascular invasion and
post-transplant HCC recurrence. Due to the absence of
accurate prognostic biomarkers in the current era
regarding LT in the setting of HCC, further studies are
warranted to confirm this relevant observation.
PO16-03
SYNERGISTIC EFFECTS OF
METFORMIN IN COMBINATION WITH
RAPAMYCIN ON HEPATOCELLULAR
CARCINOMA CELL LINES
Kwang-Woong Lee, Jeong-Moo Lee, Suk-Won Suh,
Tae You, Youngrok Choi, Nam-Jooe Yi and
Kyung-Suk Suh
Seoul National University Hospital, Korea
Introduction: Several studies have shown that metfor-
min had an anti-tumor effect on several cancers, includ-
ing hepatocellular carcinoma (HCC). After liver
transplantation (LT), immunosuppression is needed to
avoid rejection and graft loss, however, it can stimulate
HCC recurrence and progression. The aim of this study
was to evaluate interactions between metformin and
immunosuppressive agents for antitumor activity.
Method: Antiproliferative effects were assessed using
HCC cell line as HepG2, Hep3B, Huh7. Metformin
(10 mM/L) and several immunosuppressive agents such
as Sirolimus (5 ng/mL), Tacrolimus (5 ng/mL), and
MMF (500 ng/mL) were evaluated. Cell viability was
determined using a standard colorimetric 3-(45-dim-
ethylthiazol-2-yl)-2 5-diphenyltetrazolium bromide
(MTT) assay after 48 hours. Western blot analysis was
performed to investigate protein levels in HCC cells.
Results: Metformin and Sirolimus itself had antitumor
effect in all of the HCC cell lines (73% and 66%, HepG2;
84% and 73%, Hep3B; 77% and 66%, Huh7). They also
had significant synergistic antiproliferative effect in all of
the HCC cell lines (68%, HepG2; 57%, Hep3B; 63%,
Huh7), however, there was no synergistic effect with
other immunosuppressive agents. In addition, combina-
tion of metformin, sirolimus and MMF showed some
synergistic antiproliferative effect in Hep3B and Huh7
HCC cell lines (53%, Hep3b; 53%, Huh7).
Conclusions: Metformin had synergistic interactions
with Sirolimus in terms of antitumor effects for HCC
cell lines. These results may provide a foundation for
further studies to evaluate combination therapies for
patients with HCC who underwent LT in clinical era.
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PO16-04
PRETRANSPLANT SERUM ALPHA-
FETOPROTEIN HAS NO PROGNOSTIC
ROLE IN PATIENTS WITH HBV-
ASSOCIATED HEPATOCELLULAR
CARCINOMA WITHOUT VASCULAR
INVASION
Guo-Ying Wang, Shu-Hong Yi, Hua Li, Wei Meng
and Gui-Hua Chen
The Third Affiliated Hospital of Sun Yat-Sen University,
China
Introduction: Alpha-fetoprotein (AFP) has been pro-
posed to correlate with vascular invasion of hepatocel-
lular carcinoma (HCC) and predict tumor recurrence
after liver transplantation (LT). However, the prognos-
tic value of AFP in patients with HCC without vascu-
lar invasion during the waiting list for LT has not been
clearly defined.
Method: We analyzed the outcome of 80 patients who
underwent LT for HBV-associated HCC without vascu-
lar invasion. Vascular invasion was defined as the pres-
ence of tumor emboli within the lobar or segmental
branches of the portal or hepatic veins, which was diag-
nosed or highly suspected by preoperative imaging
examination. Patients were divided into two groups
according to different AFP cut-off level.
Results: The 1-, 3- and 5-year disease-free and overall
survivals were 97.1%, 89.1%, and 79.9%, and 92.1%,
81.5%, and 72.7%, respectively. Ten patients devel-
oped tumor recurrence and 13 patients died during
6 years of follow-up. Univariate analysis revealed that
multiple tumor number was the only preoperative pre-
dictor of disease-free survival (DFS). Surprisingly,
there was no significant difference in DFS with regard
to the tumor size, AFP level, preoperative tumor ther-
apy, histologic grade, Milan criteria, and UCSF crite-
ria. All four patients with tumor size greater than
8 cm had no tumor recurrence during 3 years of fol-
low-up. The 3-, and 5-year DFS for patients with
AFP≤ or >400 ng/mL were 86.8%, 82.4%, and
86.8%, 72.4%, respectively (p > 0.05). The disease-free
and overall survivals were not significantly different
among the five AFP classes (≤20; 21–100; 101–200;
201–400; >400 ng/mL).
Conclusions: Preopertative AFP has no prognostic role
in patients who underwent LT for HCC without vascu-
lar invasion. Although the accuracy and objectivity of
the radiological imaging remains a problem, carefully
studying the radiologic imaging is still regarded as a
first-line test for selecting appropriate candidates for
LT and predicting tumor recurrence following LT in
patients with HCC.
PO16-05
SALVAGE LIVING DONOR LIVER
TRANSPLANTATION AFTER PRIOR
LIVER RESECTION FOR
HEPATOCELLULAR CARCINOMA
Hyung Woo Park, Shin Hwang and SungGyu Lee
Asan Medical Center, Ulsan University, Korea
Introduction: Salvage liver transplantation has been
performed for recurrent hepatocellular carcinoma
(HCC) or deterioration of liver function after primary
hepatectomy. Living-donor liver transplantation
(LDLT) can be performed for salvage purpose. To
assess the technical feasibility and indication of salvage
LDLT for recurrent HCC, we assessed our experience
performing these surgical procedures over 15 years.
Method: From our institutional database of LDLT, we
selected 75 cases of salvage LDLT after prior hepatec-
tomy for HCC. The medical records of 75 patients who
followed up more than 12 months were retrospectively
reviewed.
Results: Male patients were 65. Mean patient age was
53.1  7.4 years. The extents of prior hepatecomy were
sectionectomy or less in 58 and hemihepatectomy or bi-
sectionectomy in 17. Graft types were right liver grafts
in 64, dual-grafts in eight and left grafts in three. Mean
GRWR was 1.09  0.24. Perioperative mortality within
3 months were four (5.3%). The Milan criteria were
met in 48 (64%). Five-year patient survival rates were
88.1% in within-Milan and 38.7% in beyond-Milan
(p < 0.001). Five-year HCC recurrence rates were 7.3%
in within-Milan and 81.8% in beyond-Milan
(p < 0.001). Preoperative alpha-fetoprotein cutoff at
200 ng/mL and microvascular invasion didn’t show
survival difference.
Conclusions: Overall patient survival rates following
salvage LDLT were similar to those following primary
LDLT, especially when the HCC satisfies the Milan cri-
teria. Therefore, we strongly suggest that every combi-
nation of prior hepatectomy and LDLT is feasible for
patients undergoing salvage LDLT and the acceptable
extent of HCC for salvage LDLT is equivalent to that
for primary LDLT.
PO17-01
ASSESSMENT OF PROGNOSIS IN
FULMINANT HEPATIC FAILURE WITH
MELD AND BILIRUBIN-LACTATE-
ETIOLOGY SCORE IN PATIENTS
LISTED FOR EMERGENCY LIVER
TRANSPLANTATION FROM A SINGLE
BRAZILIAN CENTER
Joel Avancini Rocha Filho1, Estela Regina Ramos
Figueira1, Adriana Rochetto Assalin2, Eleazar Chaib1,
Luciana Bertocco Paiva Haddad1, Alberto Queiroz
Farias1, Cinthia Lanchotte1 and Luiz Augusto
Carneiro D’Albuquerque1
1Hospital das Clinicas University of Sao Paulo, Brazil;
2University of Sao Paulo, Brazil
Introduction: Fulminant hepatic failure (FHF) is a
severe life-threatening multisystem disease. Several
authors have proposed prognostic criteria to indicate
LT for patients with little chance of spontaneous recov-
ery. We aimed to evaluate MELD and Bilirubin-Lac-
tate-Etiology (BiLE) scores to determine prognosis of
patients with FHF in the transplantation waiting-list.
Method: We retrospectively evaluated 100 adult
patients with FHF referred to urgent transplantation.
Indication for LT was determined according to KCC.
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We analyzed age, sex, etiology, prioritization-to-LT
time intervals, encephalopathy, bilirubin, creatinine,
lactate, MELD and the BiLE score (bilirubin [mol/L]/
100 + lactate [mmol/L] + etiology). Data were col-
lected at time of prioritization to LT.
Results: Seventy-eight (78%) patients were female with
35.5  14.7 yo. Etiologies were virus in 17% of cases,
drug-induced in 29%, autoimmune in 13%, cryptogenic in
34%and other in 7%. The prioritization-to-LT time inter-
val was 1.5 days (0–9). Thirty-one patients died inwaiting-
list and 69 were submitted to LT. The non-LT patients
showed increased lactate (78.4  48.3vs. 41.8  30.6 mg/
dL), creatinine (2.60  2.34 vs. 1.55  1.54 mg/dL),
MELD(44  8vs. 38  8) andBiLEscore (15.8  5.5 vs.
10.3  4.1) compared toLTpatients (p < 0.05). TheROC
analysis showed that lactate, creatinine, MELD and BiLE
had considerable specificity (76-88%), but only BiLE and
lactate presented higher sensitivities (70% and 80%,
respectively). Area under curve (AUC) for creatinine was
0.696, for lactate 0.763, for MELD 0.697, and for BiLE
0.814.
Conclusions: Brazilian non-acetaminophen FHF
patients not transplanted after fulfillment of KCC,
died. In the waiting-list, creatinine, lactate, and MELD
and BiLE scores, calculated at the moment of LT indi-
cation, could predict poor outcome. BiLE and lactate
presented higher sensitivities. We need more studies to
identify early markers of poor prognosis to enhance the
“window of opportunity” for successful surgery.
PO17-02
VEIN RECONSTRUCTION IN
MODIFIED RIGHT LIVER GRAFT FOR
LIVING DONOR LIVER
TRANSPLANTATION IN MONGOLIA
Batchuluun Pandaan, Sergelen Orgoi, Amgalan
Luvsandorj, Erdene Sandag, Batireeedui Badarch,
Ganzorig Barjargal, Ganbold Lundeg, Chuluunbaatar
Donhim and Davaadorj Duger
Department of Mongolian Liver Transplant Team,
Mongolian Liver Transplant Team, Mongolia
Introduction: Using donor’s liver right lobe with MHV
(extended right lobectomy) is a beneficial approach for
the recipient but there is high risk involved. From 1998
to 2001 Lee et al performed 176 Modified Right Liver
Graft cases using MRLG with S5 and S8 reconstruc-
tions.
Method: These reconstructions were made with Gore-
Tex grafts, recipient’s iliac veins, umbilical veins and
cadaveric iliac arteries and veins. So far over 3500 cases
of A2ALDLT using MRLG have been performed suc-
cessfully in Asan medical center.
Results: From 9th of October, 2011 to September,
2013 Mongolian Liver Transplantation Team per-
formed 11 cases of adult-to-adult LDLT in National
First Clinical Hospital of Mongolia with cooperation
of Asan Medical Center, 10 cases were performed suc-
cessfully by the Associated Team in Asan Medical Cen-
ter. There were nine male (42.8%) and 12 female
(57.1%) patients, ranging from 30 to 61 years old. 12
patients (57.1%) had HBV induced LC from that four
of which (19%) also had HDV. Four patients (19%)
had HCV induced LC. Five patients (23.8%) had HCC
due to HBV. Three patients (14.2%) were C class and
18 (85.7%) patients were B class by Child Pugh classifi-
cation. Their score ranges from was 9 to 20 points by
MELD.
Conclusions: A right liver graft without the MHV
trunk (modified right liver graft) is now commonly used
but can cause severe congestion of the right paramedi-
an sector. Such congestion can lead to severe graft dys-
function and septic complications because hepatic
venous outflow of the right paramedian sector drains
mostly into the MHV. MHV drainage into the recipi-
ent’s venous system can be reconstructed by using vein
grafts. If the venous congestive area is demonstrated to
be so large that the graft volume excluding this area is
thought to be insufficient for postoperative metabolic
demand, venous reconstruction is recommended.
PO17-03
DOES OBESITY IMPACT THE
PATIENTS’ SURVIVAL IN CADAVERIC
LIVER TRANSPLANT RECIPIENTS?
Krzysztof Zieniewicz, Michal Grat, Waldemar
Patkowski, Tadeusz Wroblewski, Rafal Paluszkiewicz,
Piotr Remiszewski, Krzysztof Dudek, Marcin Kotulski,
Karolina Wronka and Marek Krawczyk
Medical University of Warsaw, Poland
Introduction: The prevalence of the obesity continues
to increase in Western populations. Increased mortal-
ity/morbidity is associated with majority of surgical
procedures performed in obese patients. Liver trans-
plantation (LTx) is one of the most technically chal-
lenging surgical interventions and thus in the group of
obese recipients the higher rate of complications and
postoperative deaths have been shown. Aim of the
study was to analyze the impact of BMI on outcomes
of adult cadaveric LTx.
Method: Liver transplant recipients’ medical records
were analyzed retrospectively. 406 patients (259 men,
147 women) operated on in the period 2009–2013 were
included. Retransplantations and ALF patients were
excluded. Consecutive patients’ BMI was calculated.
The data were stratified according to WHO BMI
stages: underweight (<18.5), normal weight (18.6–25.0),
overweight (25.1–30), obese (>30.0). The primary out-
come was patient/graft survival, the secondary-postop-
erative complications and the length of ICU and
hospital stay.
Results: The reference group were normal weight
patients (n = 197), 1-year and 3-year patients and graft
survival was 90.3% and 89.4%, and 87.2% and 85.5%,
respectively. Underweight patients (n = 16) and graft 1-
year and 3-year survival were equally 81.3%, without
statistically significant difference: p = 0.251 and
p = 0.547 - patient and graft survival respectively.
Overweight patients (n = 137) 1-year and 3-year
survival was 86.6% and 85.5% respectively, without
difference to the reference group (p = 0.326). 1-year
and 3-year graft survival in this group was equally
84.9% without difference to the reference group
(p = 0.740). Finally, obese patients (n = 56) survival
was 94.4% and 91.7% 1-year and 3-years respectively,
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p = 0.604. Graft survival in this group was 91.0%
1-year and 88.2% - 3 years, also without the difference
to the reference group, p = 0.635.
Conclusions: There was no difference in patient/graft sur-
vival in our cohort of patients in the subgroups depending
on BMI. However overweight and obese patients have
increased morbidity and longer hospital stay.
PO17-04
LIVER RETRANSPLANTATION
ASSOCIATED WITH KIDNEY
TRANSPLANTATION FOR END STAGE
LIVER GRAFT DISEASE AND RENAL
INSUFFICIENCY: RESULTS OF A
BICENTRIC STUDY
Francois Cauchy1, Eric Vibert2, Denis Castaing2,
Astrid Schielke1, Fabiano Perdigao1, Filomena Conti1,
Yvon Calmus1, Olivier Soubrane1 and Olivier Scatton1
1Saint Antoine Hospital, France; 2Paul Brousse
Hospital, France
Introduction: Renal insufficiency jeopardizes the long-
term outcome of liver transplant recipients. Hence, in
the event of end-stage liver graft disease with chronic
renal insufficiency, liver retransplantation associated
with kidney transplantation (ReLT-KT) might be
required. Yet, the preoperative characteristics, operative
results and long-term outcomes of these patients remain
poorly described.
Method: Among 3060 patients undergoing liver trans-
plantation (LT) at two transplantation units between
1994–2012, 44 (1.4%) underwent ReLT-KT. Their pre-
operative characteristics, operative results and long-
term outcomes were retrospectively analyzed.
Results: The rate of ReLT-KT grew from 0.31% to
2.27% of all LT performed between 1994–1999 and
2007–2012 respectively (p < 0.001). Twenty-nine
patients (65.9%) were males and median age was 53.4
(17–73.7) years. Median time from primary LT to
ReLT-KT was 150 (7.5–283) months. The most fre-
quent indications for liver retransplantation were recur-
rence of the primary liver disease, cholangitis and
chronic rejection in 15 (34.8%), 14 (34.1%) and 11
(25%) cases respectively. Cirrhosis was present in 29
(65.9%) patients and median MELD score was 22 (9–
40). Renal insufficiency was related to calcineurin
inhibitors toxicity in 37 (84.1%) cases. Preoperatively,
the median glomerular filtration rate was 24 (5–72)
mL/mn and 12 (27.3%) patients required dialysis. Ele-
ven (25%) patients died postoperatively, 3 (6.8%)
required kidney graft removal and 1 (2.3%) underwent
super-urgent liver retransplantation. In multivariate
analysis, the only risk factor associated with postopera-
tive mortality was a donor age >42 years (HR: 6.94,
95%CI: 1.28-37.04, p = 0.019). Median follow-up was
47 months. Overall survivals at 1, 3 and 5 years were
72.7%, 70.3% and 63.8% respectively. The only factor
associated with impaired survival was a donor age
>42 years (54.5%, 54.5% and 45.5% vs. 90.9%, 86.4%
and 80.6% at 1, 3 and 5 years, p = 0.027).
Conclusions: Combined liver retransplantation and kid-
ney transplantation is increasingly performed. These
patients should benefit optimal grafts in order to
improve the operative results.
PO17-05
CLINICAL FEATURE AND ETIOLOGY
OF SEVENTH-DAY SYNDROME
FOLLOWING ADULT LIVING DONOR
LIVER TRANSPLANTATION
Shigeyuki Kawachi1, Minoru Tanabe3, Hideaki Obara2,
Masahiro Shinoda2, Osamu Itano2, Naokazu Chiba1,
Kiminori Takano1, Toru Sano1, Yuko Kitagawa2 and
Motohide Shimazu1
1Tokyo Medical University Hachioji Medical Center,
Japan; 2Keio University School of Medicine, Japan;
3Tokyo Medical and Dental University, Japan
Introduction: Seventh-day Syndrome (7DS) is charac-
terized by sudden failure of a liver graft that had been
working normally at about 1 week after transplanta-
tion, without an identifiable cause such as hepatic
artery thrombosis, severe sepsis, or serious technical
complication.The aim of this study is to describe clini-
cal feature and etiology of 7DS occurred after adult liv-
ing donor liver transplantation (ALDLT).
Method: A retrospective analysis of 111 consecutive
ALDLT over a 17-year period revealed that
three patients developed clinical sequences typical of
7DS.
Results: The features included: (a) severe liver failure
with sudden peak of extremely high liver enzymes at
approximately day 7; (b) color Doppler revealed
reduced blood flow in the portal and hepatic vein; (c)
high fever preceded a sudden rise of liver enzyme; (d)
No evidence of vascular thrombosis or stenosis; (e) Ini-
tial liver biopsy findings were different but finally mas-
sive necrosis was observed. All three patients died in
spite of intensive therapies such as a steroid pulse ther-
apy, plasmapheresis, and IV IgG therapy. Although
two of three patients had clinical and pathological fea-
ture of humoral rejection, pathogenesis of one patient
was yet poorly understood.
Conclusions: 7DS is an important complication after
ALDLT, which is associated with a high rate of mor-
tality. Pathogenesis of 7DS is yet fully elucidated, how-
ever, an antibody-mediated immune response might be
one of the causes for 7DS.
PO18-01
CURRENT STATUS OF LDLT IN ASAN
MEDICAL CENTER
DongHwan Jung, SungGyu Lee, Shin Hwang, KiHun
Kim, ChulSoo Ahn, TaeYong Ha, GiWon Song,
GilChun Park, HyungWoo Park and YoHan Park
Asan Medical Center, Ulsan University, Korea
Introduction: First pediatric living donor liver trans-
plantation (LDLT) was performed in 1994. In 1997,
the first successful right-liver LDLT for adults was per-
formed at the Asan Medical Center. The number of
LDLTs has increased annually, with 317 transplanta-
tions performed in 2011.
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Method: From 1994 to September 2012, we performed
more than 3000 LDLT. We reviewed the recent
changes of LDLT during this period.
Results: Most common indication of pediatric LDLT
was biliary atresia and acute liver failure. HBV associ-
ated liver cirrhosis (HBV LC) was most common indi-
cation of adult LDLT. Proportion of HBV LC has
been decreasing from 80% to 67% and alcoholic LC
and HCV LC have been increasing up to 11% and 6%
recently. Recently urgent LDLT decreased due to
national increase of DDLT. Proportion of hepatocellu-
lar carcinoma positive patient in adult LDLT has been
increased up to 52.3%.
The goal of donor evaluation is to determine whether
the donor is medically and psychologically suitable for
living donation. Laparoscopic –assisted, hand-assisted,
or minimal Incision donor hepatectomy has been
increasing.
Major reasons of rejection as suitable live-donors have
been ABO blood group incompatibility, unsafe donor
liver anatomy concerning small remnant liver volume,
small-for-size graft, and the associated donor comor-
bidities. Dual LDLT, donor exchange LDLT, ABO
incompatible LT can expand donor pool in LDLT
field. We performed more than 300 adult dual LDLT
with various types of graft. There were 26 cases donor
exchange for ABO incompatible adult LDLT at AMC
from July 2003 to December 2011. 125 cases ABO
incompatible LDLT from November 2008 to July 2012
have been performed. The proportion of ABO incom-
patible LT was increased to 23.1% of all adult LDLT
in 2012.
Conclusions: LDLT has evolved to become an indis-
pensable surgical strategy of end stage liver disease.
Minimal morbidity and zero mortality of live donors is
utmost requirement of LDLT.
PO18-02
ARTERIAL STEAL SYNDROME AFTER
LIVING DONOR LIVER
TRANSPLANTATION: SINGLE CENTER
EXPERIENCE IN EGYPT
Hossam Eldeen Soliman1, Osama Hegazy1, Sherif
Saleh1, Taha Yassen1, Mohamed Elwarrakey2, Khaled
Yassen2, Khaled Abuellella1, Tarek Ibrahim1 and
Ibrahim Marwan1
1National Liver Institute, Egypt; 2National Liver
Institute, Menoufia Uiversity, Egypt
Introduction: Arterial steal syndrome (ASS) after liver
transplantation has been reported. ASS causes arterial
hypo-perfusion of the liver graft and devastating conse-
quences. However, the diagnosis tends to be delayed.
We present our experience with these cases.
Method: We reviewed the data 210 cases of LDLT per-
formed by our group. And we found two cases of a
gastroduodenal artery (GDASS) steal syndrome and
two cases of splenic artery (SASS) steal syndrome was
diagnosed and treated.
Results: Operative ligation was done in two cases and
embolisation in another cases and no treatement was
done in the remaining case. All the cases had a good
intraoperative arterial flow as detected by Doppler
ultrasound (DUS). Three cases was discovered several
days after transplantation by changes in arterial flow
and wave form while the last case presented after
2 months by multiple biliary cystic lesions. Despite
treatments all the four patients died due to septic
sequalae of biliary complications with subsequent mul-
tiorgan failure.
Conclusions: Arterial steal is a rare but should be con-
sidered after liver transplantation for unexplained bili-
ary complications. Urgent treatment is mandatory to
achieve early clinical improvement before the develop-
ment of irreversible biliary damage. Multidetector CT
angiography may help in early diagnosis of this prob-
lem.
PO18-03
AWARENESS AND ACCEPTANCE OF
LIVING DONOR LIVER
TRANSPLANTATION (LDLT) AMONG
MALAYSIANS: A PROSPECTIVE
SINGLE-CENTER SURVEY
Peng Soon Koh, Jun Xin Ong, Jun Kit Koong, Boon
Koon Yoong and Khoon Leong Ng
University of Malaya, Malaysia
Introduction: Liver transplantation (LT) has been con-
sidered one of the treatment modality for hepatocellu-
lar carcinoma (HCC). Due to shortage of cadaveric
organ donation, living donor organ transplantation
plays an important role. In living donor liver transplan-
tation (LDLT), a healthy individual donates part of
their liver to those with underlying liver disease. How-
ever, awareness among Malaysians with this treatment
modality is lacking.
Method: A prospective single-centre survey of family
members and friends of patient with HCC who received
treatment from our centre from 2011 to 2012 was con-
ducted to gauge their attitude and awareness towards
LDLT. Their awareness and acceptance of LDLT were
evaluated using a validated questionnaire.
Results: A total of 135 subjects were recruited. About
91.1% (n = 123) respondents had never heard about
LDLT. We found 35.6% were willing to donate only to
their relatives, while 31.1% subjects were willing to
donate to recipients who are related or unrelated. How-
ever, 12.6% of the subjects were unwilling donor. The
subject’s gender, educational level, and financial dispo-
sition have shown to have significant bearing on their
attitude and understanding towards LDLT (p < 0.05).
Respondents who believe that LDLT was ethically
acceptable between family members, friends or strang-
ers had more positive attitude or outlook towards liv-
ing organ donation (p < 0.05). A positive attitude
among respondents towards organ donation and LDLT
have also shown to be important (p < 0.05).
Conclusions: Understanding among Malaysian subjects
towards LDLT remained lacking even among those
with close relation to those afflicted with liver diseases
such as HCC. A greater acceptance towards living
organ donation such as LDLT is associated with
respondents who generally have a positive attitude
towards living organ donation. More effort needs to be
taken to improve awareness among Malaysian subjects.
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PO18-04
PORTAL HYPERTENSION
ACCELERATES ANTI-DONOR
RESPONSE AFTER LIVING DONOR
LIVER TRANSPLANTATION BY
IMPAIRING TOLEROGENECITY OF
LIVER SINUSOIDAL ENDOTHELIAL
CELLS
Takashi Onoe1, Shinji Hashimoto2, Yuka Tanaka2 and
Hideki Ohdan2
1National Hospital Organization Kure Medical Center/
Chugoku Cancer Center, Japan; 2Applied Life Sciences,
Institute of Biomedical and Health Sciences, Hiroshima
University, Hiroshima, Japan
Introduction: It has been recently reported portal vein
pressure (PVP) influences survival of patients in liver
transplantation, although the immunological aspect is
unclear. In this study, we investigated the immunologi-
cal impact of PVP after living-donor liver transplanta-
tion (LDLT).
Method: We analyzed postoperative anti-donor
response of consecutive 166 LDLT patients based on
the level of PVP (< or ≥15 mmHg) at the end of sur-
gery using matched-pair method. Further, to investigate
the mechanism, we developed a 70% hepatectomized
mouse model with portal hypertension. Three days
after hepatectomy, digested whole hepatic constituent
cells of mice were co-cultured with allogeneic spleno-
cytes, and allo-immune of T-cells was quantified.
Results: Mixed-lymphocytes reaction assay (MLR)
revealed that the high PVP group had a significantly
higher anti-donor response than the low PVP group, at
2 weeks after LDLT. In addition, acute rejection epi-
sodes within 3 months were significantly higher in the
high PVP group.
In mouse model, accelerated anti-allogeneic response
was induced in hepatectomized mice. However, this
accelerated response was significantly reduced in hepa-
tectomized mice with a shunt. Interestingly, liver sinu-
soidal endothelial cells (LSECs), which suppress
allogeneic T cells via antigen presentation, significantly
down-regulated their MHC class II expression and sup-
pressive function in hepatectomized mice.
Based on these result, we introduced continuous portal
infusion of PGE1 to five LDLT patients with small-for-
size graft (SFSG, GRWR <0.7%) for portal decom-
pression so far. The PGE1 patients demonstrated sig-
nificantly lower postoperative PVP compared with
eight non-PGE1 patients with SFSG as historical con-
trol. Furthermore, MLR revealed that the PGE1
patients with SFSG showed well-suppressed anti-donor
responses and better survival compared with the non-
PGE1 patients with SFSG after LDLT.
Conclusions: This is the first study to prove that post-
operative portal hypertension accelerates anti-donor
responses in recipients after LDLT. Our findings pres-
ent a novel concept for preventing the acceleration of
anti-donor responses by controlling PVP after LDLT.
PO18-05
MATHEMATICAL MODEL OF LIVER
REGENERATION IN HUMAN LIVE
LIVER DONORS
Cataldo Doria and Vipul Periwal
Thomas Jefferson University Hospital, USA
Introduction: Liver regeneration after injury occurs in
many mammals. Rat liver regenerates after partial hep-
atectomy over a period of 2 weeks while human liver
regeneration takes several months. Notwithstanding
this enormous difference in time-scales, with new data
from five human live liver transplant donors, we show
that a mathematical model of rat liver regeneration can
be transferred to human with little change.
Method: The rat model consists of two interacting
modules of ten ordinary differential equations, seven
describing molecular interactions and three for the phe-
nomenological cell cycle. The human model has the
same molecular module as the rat model. The changes
are all in the human phenomenological cell cycle mod-
ule relative to the rat model. Only six phenomenologi-
cal parameters need change, and three of these
parameter changes are rescalings of rate constants by
the ratio of human lifespan to rat lifespan.
Results: Data from three donor subjects with approxi-
mately equal resections were used to fit the three
parameters and the data from the other two donor sub-
jects was used to independently verify the fit.
Conclusions: This model has the potential to become a
better predictor of liver regeneration after live liver
donation or major hepatectomies
PO19-01
SAFE AND ADEQUATE DIVISION
POINT OF LEFT BILE DUCT DURING
LEFT LATERAL DONOR
HEPATECTOMY
YoungRok Choi, Kwang-Woong Lee, Hyeyoung Kim,
Tae Yoo, Suk-Won Suh, Nam-Joon Yi and
Kyung-Suk Suh
Seoul National University Hospital, Korea
Introduction: To evaluate the risk for multiple bile
ducts (BD) openings according to BD type and suggest
the safe and adequate division point of BD during left
lateral donor hepatectomy.
Method:
1) Multiple openings according to BD type: 43 grafts
and the number of its BD openings after left lateral liv-
ing donor hepatectomy from January 2004 to January
2011 were investigated. And Left BD of the donors was
classified into three types; Type I (n = 27): B4 enters
the common trunk of B2 and B3, Type II (n = 12): B2
joins the common channel of B3 and B4 and Type III
(n = 3): tri-confluence of B2, B3, and B4.
2) The risk analysis by the potential division point of left
BD: The chance for right BD injury and the risk for
multiple openings during left lateral sectionectomy were
analyzed by the potential division points with the pre-
operative MR images of another 99 living donors
between January 2012 and December 2012.
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Results:
1) The risk of multiple BD openings: Four grafts with
BD type II (33.3%), two grafts with type I (7.4%) had
multiple BD openings. And no case of multiple open-
ings in BD type III.
2) The division point that has both low chance for
right BD injury and low risk for multiple openings
Optimal division point was 5 mm right away from the
right border of umbilical portion of PV (U) in type I,
8 mm in type II and 12 mm in type III. But, a division
point, where the possibility of injury for donor’s right
BD is less than 5%, was located within 5 mm from U.
Conclusions: Optimal division point can be suggested,
but considering safety of donor’s BD, it is better to
divide the left BD within 5 mm the right border of the
umbilical portion of left portal vein.
PO19-02
LIVER TRANSPLANTATION WITH
MODIFIED CAVOPORTAL
HEMITRASPOSITION IN JAK 2
MUTATION FOR BUDD-CHIARI
SYNDROME COMPLICATED BY
THROMBOSIS OF THE PORTAL-
VENOUS SYSTEM. LONG TERM
FOLLOW UP
Francesco D’amico, Alessandra Bertacco, Alessandro
Vitale, Domenico Bassi, Enrico Gringeri, Daniele Neri,
Giacomo Zanus, Patrizia Boccagni and Umberto Cillo
HPB and Liver Transplant Unit Padova University,
Italy
Introduction: Combined thrombosis of the inferior vena
cava and portal-venous system is a rare and severe type
of Budd Chiari syndrome. This combined thrombosis
can involve both venous systems to a varying extent
and can be either acute or chronic in nature. It is world
wide accepted in the acute forms the use of liver trans-
plantation with cavoportal hemitransposition as life-
saving procedure or multivisceral transplantation.
Method: In this study, the authors describe a case of
chronic myeloproliferative syndrome associatedted to
JAK 2 mutation determining acute liver failure due to
combined thrombosis of the inferior vena cava and
portal-venous system undergoing to liver transplanta-
tion. The authors perform also a systematic review of
the literature on PUBMED.
Results: This case was a 38 year-old woman, diagnosed
with portal vein and spleno-superior mesenteric vein
thrombosis. She was successfully treated using an in
situ split right graft and a modified Tzakis’ hemitrans-
position technique (with also porta-portal end to side
anastomosis). In particular, we restored the outflow of
the portal and mesenteric veins by using Urokinases
bolus in recipient portal vein, and after we performed
an end to side anastomosis on portal vein of the donor.
The pre and post-transplant drug therapy was made
with Oncocarbide and low molecular weight heparin.
The bone marrow biopsy made 12 months after Liver
transplantation evidenced an idiopatic myelofibrosis
with normal blood tests. This patient is alive with func-
tioning graft after 18 months from the transplant (09/
17/11). No bleeding from esophagus varices, no ascites,
no limb edema and no portal thrombosis has been
observed.
Conclusions: In our systematic literature review we
found only seven cases of cavoportal hemitransposition
for the simultaneous thrombosis of the caval and portal
systems due to Budd Chiari syndrome. However, this is
the first case using such a modified technique in this
specific context.
PO19-03
IMPACT OF RECONSTRUCTING
SINGLE HEPATIC ARTERY WITH TWO
ARTERIAL STUMPS ON THE
INCIDENCE OF BILIARY
COMPLICATIONS IN PEDIATRIC
LIVING DONOR LIVER
TRANSPLANTATION
Karan Julka1, Chih-Chi Wang1, Chao-Long Chen1,
Bhavin Vasavada1 and Yu-Fan Cheng2
1Kaohsiung Chung Gung memorial hospital, India;
2Kaohsiung Chang Gung Memoral Hospital, Taiwan
Introduction: Hepatic artery (HA) reconstruction is one
of the most challenging procedures when performing
living donor liver transplantation (LDLT), especially in
pediatric patients. HA thrombosis is the most feared
complications of all. The size discrepancy and presence
of multiple HAs makes HA reconstruction technically
even more demanding. We herein report the impact of
reconstruction single HA on the incidence of biliary
strictures in pediatric patients undergoing LDLT.
Method: From 2002 to 2010, a total of 103 pediatric
patients underwent LDLT in Kaohsiung Chung Gung
Memorial Hospital. All the data were collected pro-
spectively. The study group was divided in three
groups. Group 1 (n = 21): 2 HA stumps with two HAs
reconstruction, Group 2 (n = 22): two HA stumps with
one HA reconstruction and Group 3 (n = 60): 1 HA
stump with one HA reconstruction. All the HA recon-
structions were done using operating microsurgical
techniques. The criterion for reconstructing only one of
the two was presence of good blood backflow and
intra-operative arterial Doppler findings. The incidence
of hepatic artery related complications, biliary compli-
cations and patient survival were compared between
the three groups.
Results: Except for the duration of surgery which was
more in Group 1 as compared to Groups 2 and 3
(p = 0.01), all the other variables were comparable. The
incidence of HA thrombosis (p = 0.91) and biliary
complications (p = 0.24) were similar in all the 3
groups. There was no significant difference in patient
survival and biliary stricture free survival among the
three groups.
Conclusions: Reconstructing single HA does not have
an impact on the incidence of biliary strictures in pedi-
atric living donor liver transplantation with two arterial
stumps in the liver graft.
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PO19-04
EFFECTIVENESS OF LOW-PRESSURE
HIGH-VOLUME GRAFT INFUSION
METHOD FOR RAPID AND COMPLETE
WASHING OUT OF BLOOD FROM
LIVING-DONOR RIGHT LIVER GRAFTS
Yohan Park and Shin Hwang
Asan Medical Center, Ulsan University, Korea
Introduction: To verify the effectiveness of the Effec-
tiveness of low-pressure high-volume graft infusion
method for right liver graft perfusion at the back table.
Method: In this prospective triple-arm study, first two
groups each consisting of 20 right liver grafts under-
went conventional graft perfusion using slow perfusate
dripping using a small-caliber tube or semi-gravita-
tional infusion method that involved gentle spoid drip-
ping, and the third group used a large-caliber tube for
10 right liver grafts. These three graft perfusion meth-
ods were compared in terms of the perfusion time and
washing-out efficiency.
Results: The spoid and large-caliber tube groups had a
shorter graft portal perfusion time for the first 2 L of
histidine-tryptophan-ketoglutarate solution than the
conventional group (5  2 min. and 5  1 min.,
respectively; vs. 11  1 min.; p < 0.001) and a lower
rate of incomplete blood washing-out after the initial
portal perfusion (56% and 58%, respectively; vs. 92%;
p < 0.001). For ABO-incompatible grafts, fewer than
10 minutes were needed to perfuse the first 3 L of per-
fusate in the spoid and large-caliber tube groups; a
much longer time was required in the small-caliber tube
group.
Conclusions: The low-pressure high-flow infusion
method using a surgical spoid or large-caliber tube
appears to be more effective than the conventional slow
perfusate dripping method for right liver graft perfu-
sion at the back table.
PO19-05
DIFFERENT SURGICAL STRATEGIES
FOR THE MANAGEMENT OF HEPATIC
VEINS ANOMALIES DURING
LAPAROSCOPIC LEFT LIVER
SECTIONECTOMY FOR PEDIATRIC
LIVING RELATED LIVER
TRANSPLANTATION
Marco Spada1, Ugo Boggi2, Duilio Pagano1, Sergio Li
Petri1, Davide Cintorino1, Calogero Ricotta1, Pasquale
Bonsignore1, Salvatore Gruttadauria1 and Silvia Riva1
1ISMETT UPMC Italy; 2Azienda Ospedaliera-
Universitaria Pisana, Pisa, Italy
Introduction: Laparoscopic left lateral sectionectomy
(LLLS) is more and more adopted and has been pro-
posed as the gold standard procedure for pediatric liv-
ing donor liver transplantation.
Method: Between 2010–2012 we performed eight con-
secutive LLLS. Donors were 30  7 years-old, with
body weight and BMI of 69  18 kg and of
24.1  3.7, respectively. Four donors presented left
hepatic vein (LHV) anomalies: common trunk draining
the middle (MHV) and the LHV into the vena cava
(n = 1); accessory hepatic vein draining the fourth seg-
ment, located along the hypothetical plane of section
(n = 1); communicating trunk between the LHV and
MHV (n = 1); separate confluence of segment two and
three LHVs into the MHV (n = 1). We also report two
LHVs that draining into a single and very short com-
mon trunk before the entrance into the inferior vena
cava (n = 1).
Results: Length of procedures was 417.4  57.4 min.
and the operation time have been decreased with the
increasing of the procedures: in the subgroup of donors
with LHV anomalies the operational length was
392.25  62.7 min. versus 443  56.6 min. in the
donors without anomalies (p = 0.27). The total ische-
mia time was 40.2  7.2 and the intra-abdominal warm
ischemia time was 5.5  1 min: in LHV anomalies sub-
group it was 36.75  7.9 min., versus. 43.75  6.5 min.
in donors without anomalies (p = 0.22). The total liver
volume was 1485.4  239.5 cc with a graft volume of
280.8  113.44 cc. The donors did not require intensive
care unit statement. No caval complications were expe-
rienced. All of the donors were discharged between 4–
6 days after the operation. About the recipients, there
were no hepatic vein outflow complications, nor arterial
strictures or thrombosys, but just only one case devel-
oped portal vein thrombosis that did not required any
surgical procedures to be corrected. All of the recipi-
ents were discharged between 15–20 days and actually
are alive and well.
Conclusions: The venous outflow requirements apply as
well when anatomic anomalies are present in the setting
of minimally-invasive approaches for living-related liver
donations.
PO20-01
AUXILIARY PARTIAL ORTHOTOPIC
LIVER TRANSPLANTATION IN MICE
Qi Cheng and Xiao-ping Chen
Tongji hospital, China
Introduction: Auxiliary partial orthotopic liver trans-
plantation (APOLT) is a good alternative treatment in
cases of fulminant liver failure and metablic liver disor-
ders.
Method: Here, we describe on a surgical technique for
APOLT and our experience with this model. In brief,
the donor portal vein and hepatic vein are anastomosed
with a cuff and suture technique, respectively, while the
donor bile duct is implanted into recipient duodenum.
Results: For the whole process, the anhepatic phase is
only 5–7mins. The APOLT model we describe is reli-
able, with an 85% (17/20) survival at 2 weeks postoper-
atively. This is the first description of a mouse model
of APOLT.
Conclusions: Compared with orthotopic liver transplan-
tation, an advantage of this model is that the donor
liver and remnant liver are simultaneous. With the
availability of gene-modified mouse strains and mouse-
specific reagents, this model will allow expanded
research and into mechanisms of liver regeneration and
transplantation immunity.
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PO20-02
RESULT OF EXTRACORPOREAL
MEMBRANE OXYGENATION (ECMO)
SUPPORT IN CARDIAC ARREST OF
THE LIVER TRANSPLANTATION
RECIPIENTS
Jeong-Moo Lee, Nam-Joon Yi, Youngrok Choi,
Suk-Won Suh, Tae You, Jose Benjamin Navarro
Burgos, Angelica Garcia, Kwang-Woong Lee and
Kyung-Suk Suh
Seoul National University Hospital, Korea
Introduction: Recipients of the liver transplantation
have many risk factors for the operation. Intraopera-
tive bleeding due to underlying coagulopathy, thrombo-
cytopenia can increase hemodynamic unstability, and
procedures during the operation like IVC clamping,
reperfusion after anastomosis also affect. These condi-
tions can cause some cardiac problems, even cardiac
arrest during the transplantation. We present 3 cases of
survivor after cardiac arrest, and discuss usefulness of
ECMO in this situation.
Method: We reviewed three cases of survivor after car-
diac arrest in 403 cases of living donor liver transplan-
tation from March 2009 to March 2013.
Results: All patients were male and had no previous
cardiac problems. One case had Non B, non C liver
cirrhosis and two cases had hepatitis B related liver
cirrhosis. In all three cases, cardiac arrest was hap-
pened but there is no definite reason. We inserted
ECMO in two cases intraoperative period and postop-
erative 1-day after transplantation in one case. After
ECMO was inserted, vital sign was recovered immedi-
ately, but acute pulmonary edema was found in chest
x-ray. We checked daily echocardiography at immedi-
ate postoperative period in all patients. After checking
recovery of chest x-ray, we weaned ECMO. Cardiac
output also recovered and there is no cardiac compli-
cation after weaning of ECMO. Finally, two cases
had no serious postoperative complication, one case
had cerebral infarction after cardiac resuscitation, but
liver function was normal and all patients survive
now.
Conclusions: Immediate ECMO application could be
useful in the cardiac arrest in liver transplantation.
PO20-03
RESULTS OF LIVER
TRANSPLANTATION DURING
PREGNANCY DUE TO FULMINANT
HEPATIC FAILURE
Felipe Leon, Juan F Guerra, Jean P B€achler, Jose L
Galindo, Alejandro Rojas, Carlos Benıtez, Marco
Arrese, Rosa M Perez-Ayuso, Nicolas Jarufe and Jorge
Martınez
Pontificia Universidad Catolica de Chile, Chile
Introduction: Fulminant hepatic failure (FHF) during
pregnancy represents an unusual life-threatening condi-
tion. In this setting, liver transplantation (LT) is a life-
saving procedure. Few cases have been reported, with
dissimilar maternal and fetal outcomes. The aim of this
study is to present our experience in LT during preg-
nancy due to FHF in four cases.
Method: A retrospective analysis of our LT database
was performed, between 1994 and 2013. Demographic
and perioperative data, recipient (maternal) and fetal
outcomes were analyzed.
Results: During this period, 188 LT were performed, 30
due to FHF. Four pregnant women underwent a LT dur-
ing pregnancy. The median of age was 31 years (range,
16–35) and gestational age (GA) at the time of transplant
was 25 weeks (range, 21–26). Etiologic work-up includ-
ing viruses, auto-immunity, drugs and others was nega-
tive in all but 1 case (B-19 parvovirus infection). All
patients were transplanted. One patient presented pro-
gression of brain edema and died 3 days after surgery,
with multi-organ failure. One patient presented a pri-
mary non-function, requiring emergent re-transplanta-
tion on POD5. Regarding to fetal outcomes, three
patients required a caesarian section: one at 26 weeks of
gestation, immediately before LT due to obstetric rea-
sons, one required fetal extraction during the transplant
due to severe fetal bradycardia and the other one seven
weeks after the transplant (27 weeks GA) due to non-
controllable labor. The remaining patient had an abor-
tion on POD1 (20 weeks GA). One newborn had neuro-
logical deficit due to intracranial hemorrhage and the
others two exhibited normal postnatal courses, achieving
normal developmental milestones. At long-term follow-
up, the three survivor recipients have excellent liver graft
function with no others complications.
Conclusions: Liver transplant due to FHF during the
pregnancy is challenging. Despite of that, favorable
maternal and fetal outcomes can be achieve when it
success. A multidisciplinary team is essential in the
management of these patients.
PO20-04
THE IMPACT OF BLOOD
TRANSFUSION ON THE INCIDENCE OF
REJECTION IN ORTHOTOPIC LIVER
TRANSPLANTATION
Marieke TDe Boer, Aad PVan den Berg, Ton Lisman,
Herman GD Hendriks and Robert J Porte
University Medical center Groningen, Netherlands
Introduction: Improvements in anesthesiological and
surgical techniques have lead to a decrease in the use
of blood products during liver transplantation (LT).
Nowadays several centers describe series of patients
who were transplanted without intraoperative blood
transfusion. Blood transfusion is generally considered
to be harmful, although in kidney transplantation early
reports have suggested a protective effect of RBC
transfusion on the incidence of rejection after kidney
transplantation. Aim of our study was to determine
whether RBC transfusion has a protective effect against
rejection in LT.
Method: Between 1995 and 2004, 292 primary liver
transplantations in adults were performed. Specific rea-
son to select this decade is that at that time it was our
policy to perform a routine liver biopsy within 2 weeks
after LT, if the clinical condition would allow this. This
policy was abandoned after 2004. All patients who
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underwent a biopsy within 2 weeks were included.
Patients who died or were retransplanted <7 days after
LT were excluded. Recipient and donor parameters
and intraoperative transfusion requirements were avail-
able in a prospectively collected database. Uni- and
multivariate analysis was performed to determine the
risk factors for histological graft rejection.
Results: In total, 197 patients had a biopsy within
2 weeks after OLT. Median age was 49 years, 57% of
recipients was male, median MELD score was 16. Fifty
nine (30%) patients did not receive any RBC transfu-
sion during LT. After uni-and multivariate analysis the
following variables were found to be independently
associated with acute rejection (any Banff grade): RBC
transfusion intraoperative (OR 2.811, 95% CI 1.258–
6.280, p-value 0.012), and induction immunosuppres-
sion (OR 2.061. 95% CI 1.085–3.915, p-value 0.027).
Conclusions: This study shows that there is an
increased risk of developing acute rejection after LT
when patients do not receive any RBC transfusion dur-
ing LT.
PO20-05
HISTOLOGICALLY PROVEN
NONALCOHOLIC FATTY LIVER
DISEASE AND CLINICALLY RELATED
FACTORS IN RECIPIENTS AFTER
LIVER TRANSPLANTATION
Hyeyoung Kim, KyoungBun Lee, Kwang-Woong Lee,
Nam-Joon Yi, Hae Won Lee, YoungRok Choi,
Suk-Won Suh, Tae You and Kyung-Suk Suh
Seoul National University College of Medicine, Korea
Introduction: Nonalcoholic fatty liver disease (NA-
FLD) affects a substantial proportion of the general
population in the world, and its prevalence has been
increasing. However, little is known about NAFLD in
liver transplantation (LT) recipients. The study was
aimed at evaluating the prevalence of NAFLD and
peri-transplant risk factors for post-LT NAFLD.
Method: A retrospective review was performed for
adult recipients who underwent late protocol liver
biopsy (>1 year after LT) at our institution between
August 2010 and December 2012. Hepatic steatosis was
reviewed and graded by hepatic pathologists. The peri-
transplant factors were analyzed for relationships to
histologically proven NAFLD.
Results: Total 166 liver biopsies had been performed in
156 adult recipients. NAFLD (micro and macrovesicu-
lar lipid accumulations of more than 5%) were present
in 27.1% of cases at a mean period of 35.4 months
between LT and biopsy, moderate and severe steatosis
(≥ 33%) consisted of 28.9%. In multivariate analysis,
pre-LT alcoholic cirrhosis (odds ratio [OR] 8.031,
p = 0.003), obesity at biopsy (OR 3.873, p = 0.001),
and pre-existing donor graft steatosis (OR 3.147,
p = 0.022) were significant risk factors for post-LT
NALFD. NASH (NAFLD activity score ≥5) was pres-
ent in 8.9%, and metabolic syndrome in 26.7% of the
steatosis group.
Conclusions: NAFLD represented a considerable por-
tion of liver transplant recipients, but this prevalence
was not higher than those reported for general popula-
tions. Risk factors such as pre-LT alcoholic cirrhosis,
obesity at biopsy, and pre-existing donor graft steatosis
were significantly related to histologically proven NA-
FLD after LT. Post-LT recipients with these risk fac-
tors should be monitored for NAFLD. Furthermore,
possible progression to NASH or fibrosis and meta-
bolic syndrome should be considered in future studies.
PO21-01
STEREOTACTIC BODY
RADIOTHERAPY USING ONLINE
FOUR-DIMENSIONAL IMAGE-
GUIDANCE FOR INOPERABLE
PRIMARY LIVER CANCER OR
HEPATIC METASTASES
Wenchang Wong1, Koroush S Haghighi2 and David
Goldstein1
1Prince of Wales Hospital, Australia; 2UNSW, Australia
Introduction: Curative resection of primary liver cancer
and hepatic oligometastatic disease may not always be
possible due to patient and disease factors. Biological
dose escalation through stereotactic body radiotherapy
(SBRT) is emerging as a treatment option to achieve
long term control and potentially cure for those
patients who are not surgical candidates.
Method: We present our case series of patients who
underwent this novel approach using four-dimensional
(4D) image-guided SBRT to account for respiratory
motion. The dose delivered was 40 Gy in five fractions,
treated second daily on a standard linear accelerator.
The malignancies treated include hepatocellular carci-
noma (HCC), cholangiocarcinoma and solitary meta-
static colorectal cancer to the liver. Patients were of
Eastern Cooperative Oncology Group (ECOG) perfor-
mance status 0 or 1.
Results: As of August 2013, we have observed 100%
response rate to SBRT in our sample pilot group
(n = 4) based on progress CT scans and PET/CT scans.
Follow-up was between 3–18 months. Patients were
aged between 23 and 75 years. The size of the lesions
ranged from 3 cm to 9 cm and one patient had multi-
focal recurrent hepatocellular carcinoma. Reasons for i-
noperability include medical comorbidities and locally
advanced disease. For example, a patient with a 3 cm
HCC was in Child-Pugh class C category. Another
patient had a solitary 9 cm 9 8 cm colorectal carci-
noma metastasis involving segment eight of the liver
and was not resectable as the mass had invaded
through the diaphragm and involved the right lower
lobe of the lung. Apart from mild fatigue and nausea,
acute radiotherapy toxicity was rarely seen. Late toxici-
ties have not been observed. Normalisation of tumour
markers such as alpha-fetoprotein (AFP) and carcino-
embryonic antigen (CEA) were also seen post-treat-
ment.
Conclusions: This novel technique employing 4D
image-guided SBRT is feasible and well tolerated with
minimal side effects. It provides long term local control
of inoperable lesions.
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PO21-02
ANATOMICAL HEPATECTOMY USING
ICG NAVIGATION SYSTEM
Shinya Hayami, Masaki Ueno, Yoshinobu Shigekawa,
Shunsuke Yamaguchi, Masaji Tani, Manabu Kawai,
Seiko Hirono, Ken-ichi Okada, Motoki Miyazawa and
Hiroki Yamaue
Wakayama Medical University, Japan
Introduction: In performing hepatectomy for hepatocel-
lular carcinoma, anatomical resection is desirable to
control intrahepatic metastasis or to reduce postopera-
tive complications. Recently, near-infrared fluorescence
(NIRF) imaging under indocyanine green (ICG) injec-
tion and contrast enhancement intraoperative ultraso-
nography (CEIOUS) were provided and progressed the
intraoperative imaging diagnosis.Using advantages of
these techniques, we aimed to develop a novel naviga-
tion system for anatomical liver resection.
Method: Previously, 22 HCC patients underwent ana-
tomical hepatectomy using this navigation system
(lobectomy (n = 4), segmentectomy (n = 6), sub-seg-
mentectomy (n = 12)). Navigation of anatomical liver
resection was performed as follows: 1) under ligation of
the glisonian pedicle where flows the planned liver
resection area, ICG was intravenously injected and
observed the demarcation area using NIRF imaging
system (PDE, Hamamatsu photonics, Japan) (counter
perfusion method). 2) Immediately after ultrasound
guided injection of ICG to the glisonian pedicle where
flows the planned liver resection area, NIRF image was
observed (direct perfusion method).
Results: The planned resection area was detected
clearly as a non-fluorescent area by the counter per-
fusion method (Figure 1) and as a fluorescent area
by the direct perfusion method (Figure 2). The resec-
tion volume was statistically correlated with the esti-
mated volume by 3D-CT volume analysis. There
were no adverse effects related to our new navigation
system.
Conclusions: We demonstrated hear that the navigation
system using NIRF imaging is a novel and reliable
technique for anatomical hepatic parenchyma resection.
PO21-03
CLASSICAL VERSUS ROBOT-ASSISTED
LAPAROSCOPIC LIVER RESECTION: A
MATCHED-PAIR COMPARATIVE
STUDY
Hadrien Tranchart1, Cecillia Ceribelli1, Alberto Patiriti2
and Ibrahim Dagher1
1Antoine Beclere Hospital, France; 2San Matteo degli
Infermi Hospital-Spoleto, Italy
Introduction: Only a few series have demonstrated the
safety of robot-assisted laparoscopic liver resection
(RLLR) and the benefits of this approach. This report
describes the results of a pair-matched comparative
study between classical laparoscopic liver resection
(CLLR) and RLLR performed in two European surgi-
cal centers.
Method: Patients were retrospectively matched in pairs
for the following criteria: sex, age, severity of liver dis-
ease, tumor size, type of liver tumor and type of resec-
tion. A total of 28 patients undergoing RLLR were
compared with patients undergoing CLLR during the
same period. Operative and postoperative outcomes
were compared.
Results: The mean duration of surgery was similar in
the two groups (p = 0.15). Despite matching more
tumors were localized in posterior segments (IVa, VII,
VIII and I) in the RLLR group (39.3% vs. 10.7%;
p = 0.008). Conversion rate was superior in the RLLR
group (14.3 vs. 7.1%; p < 0.0001). Mean blood loss
was similar in the two groups (p = 0.56). Transfusion
was required for four patients (14.3%) in the RLLR
group and one patient (3.6%) in the CLLR group
(p < 0.0001). Global morbidity was inferior in the
RLLR group (17.8 vs. 21.4%; p = 0.02). Mortality was
nil in both groups. Mean hospital stay was similar in
the two groups (p = 0.68).
Conclusions: In selected patients, RLLR could lead to
a lower morbidity rate. However this approach seems
to be associated with a more important conversion rate
compared with the CLLR.
PO21-04
IPAD GUIDED RIGHT
HEMIHEPATECTOMY WITH A NEW
APPLICATION DESIGNED
SPECIFICALLY FOR NAVIGATION
SURGERY: INITIALLY CLINICAL
EXPERIENCE FOR PERIHILAR
CHOLANGIOCARCINOMA
Ryusei Matsuyama1, Ryutaro Mori1, Koichi
Taniguchi1, Kazunori Nojiri1, Seigo Hiratani1,
Kazuhisa Takeda1, Kuniya Tanaka1, Alexander K€ohn2,
Andrea Schenk2 and Itaru Endo1
1Yokohama City University, Japan; 2Fraunhofer,
Germany
Introduction: Liver has complicated and variable anat-
omy of the hepatic vein, portal vein and hepatic artery.
Precise anatomical understanding for liver is necessary
for curative and safe hepatectomy. We have reported
the utility of 3D-CT image in hepatobiliary surgery.
We herein report a new iPad application designed spe-
cifically for liver surgery using augmented reality (AR)
technology.
Method: 11 patients with perihilar cholangiocarcinoma
who underwent right hemihepatectomy with caudate-
lobectomy between November 2012 and August 2013
were enrolled in this study. The 3D reconstructed tri-
adgraphy was obtained from preoperative computed
tomography data. A new iPad application “Mobile
Liver Explore” offers the possibility to check detailed
anatomical information in the operative field by finger-
tip and confirm surgical plan. An AR mode enables an
overlay of the camera view of the liver with the 3D vas-
cular image (hepatic artery, portal vein, hepatic vein,
and bile duct). We check the branches of middle hepa-
tic vein and marking it to the liver surface under an
augmented reality mode.
Results: All eleven patients were performed hepatec-
tomy safely with iPad guided. Ten of eleven patients
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were performed combined resection of portal vein and
reconstruction. Mean time of operation was 681.5 min.
and mean time of hepatectomy was 45.9 min. Mean
blood loss in hepatectomy was 227.1 mL. Only 3 of ele-
ven patients required a RCC transfusion. Morbidity
occurred in only two of eleven patients (Clavien-Dindo
Grade III<, abdominal abscess).
Conclusions: iPad with specialized AR application seem
to be suitable for clinical use in open liver navigation
surgery. Intraoperative demonstration of branches of
hepatic vein may improve the safety and accuracy of
operations.
PO21-05
USABILITY OF 3-DIMENSIONAL
VIRTUAL RECONSTRUCTION
SOFTWARE (DR. LIVER) FOR PRE- AND
INTRAOPERATIVE DETERMINATION
OF LIVING DONOR LIVER
TRANSECTION AND VASCULAR
RECONSTRUCTION
Wanjoon Kim, Shin Hwang, Gi-Won Song, Tae-Yong
Ha, Dong-Hwan Jung, Hee-Chul Yu, Hee-Cheon Yu
and Sung-Gyu Lee
Asan Medical Center, Ulsan University, Korea
Introduction: In living donor liver transplantation,
accurate assessments of liver graft volume and anatom-
ical variation are mandatory for the preoperative plan-
ning of safe donor hepatectomy and successful
recipient implantation. The aim of this study was to
assess the usability and accuracy of 3-dimensional vir-
tual reconstruction software in living-donor liver trans-
plantation.
Method: We used commercial 3-dimensional virtual
reconstruction software, ‘Dr. Liver’ for preoperative
evaluation of living donor anatomy and volumetrics by
using computed tomography images in consecutive 50
cases of adult living donor liver transplantation. The
predicted liver resection volumes revealed a significant
correlation with the conventional manual volumetry
and the actual value (all p < 0.01). The drainage area
by the individual branches of the middle, right and
inferior right hepatic veins was quantified to achieve
reconstruction of the corresponding venous branch.
This 3-dimensional virtual reconstruction software reli-
ably predicted accurate liver graft volume and the
drainage volume of hepatic vein branches.
Results: This software may contribute to the preopera-
tive planning of safe donor hepatectomy and implanta-
tion with satisfactory graft viability. Accurate
preoperative assessments of hepatic volumetrics are
needed for surgeons to risk stratify and properly select
patients for major hepatic resections including donor
hepatectomy.
Conclusions: The software ‘Dr. liver’, which was devel-
oped by Korean liver surgeons, represents a reliable
step towards a greater accuracy in hepatic volumetrics
and improved safety in liver surgery.
PO22-01
SURGICAL TREATMENTS OF 3151 HCC
PATIENTS IN THREE DECADES; THE
CHANGE OF TREATMENT PLAN AND
OUTCOME ANALYSIS
Ming-Chin Yu, Chao-Wei Lee, Yann-Sheng Lin, Wei-
Chen Lee, Miin-Fu Chen and Kun Ming
Chang Gung memorial hospital, Linkou branch, Taiwan
Introduction: HCC were always an important health
issue in Taiwan. The change of surgical planning was
seldom presented. Here we offered a single experience
of HCC in northern Taiwan medical center.
Method: Of 3151 HCC patients from 1983 to 2012,
three cohorts were grouped in decades: 187, 1293, and
1671 were collected in era 1, 2, and 3 respectively. The
data were analyzed with AJCC staging system and 4.1,
49.5, 18.4, 5.1, 7.4, and 2.2% were stage I, II, IIIA,
IIIB, IIIC, and IV, respectively. The overall complica-
tion rate was 21.8% and surgical mortality rate was
4.8%.
Results: The patients selection were change in the dec-
ades; less patients were HBV positive, less Child B or C
status, less tumor rupture, less vascular invasion, less
satellite nodules. The tumor size was also decreased
(p < 0.05). The presence of cirrhosis is 50%. The dis-
ease free and overall survival at 5 and 15 years were
51.8% and 36.6%, 25.8% and 23.7% respectively. The
surgical outcome was significantly improved at era 3 by
stage I and IIIB. Treatment of postoperative recurrence
was improved by TACE.
Conclusions: The data showed surgical treatment still
had important role in HCC. To improve long-term out-
come, delicate surgical technique, detailed anatomy
concept in transection, and aggressive recurrence treat-
ment should be addressed.
PO22-02
PREDICTION OF HEPATOCELLULAR
CARCINOMA RECURRENCE
FOLLOWING HEPATECTOMY BASED
ON OPERATIVE FACTORS AND
TUMOR CHARACTERISTICS
Shozo Mori, Junji Kita, Takayuki Shiraki, Masato
Kato, Mitsugi Shimoda and Keiichi Kubota
Dokkyo Medical University, Japan
Introduction: Recurrence of hepatocellular carcinoma
(HCC) occurs at high rates, resulting in dismal out-
comes, despite curative liver resection (LR). Therefore,
establishment of a simple and useful predictive model
of recurrence would help improve survival rates.
Method: A total of 438 patients with HCC who under-
went LR as the initial curative treatment were enrolled
between April 2000 and March 2012. The preoperative,
operative, and pathological variables of these patients
were analyzed to generate a predictive model of recur-
rence after LR.
Results: HCC recurred in 285 (65%) patients. Univari-
ate analysis showed that 10 independent factors
affected recurrence and could be used as predictive
measures. Further, a prediction formula for recurrence
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based on the results of multivariate discriminant analy-
sis was established: D = 0.517 (outside the Milan crite-
ria) + 0.564 (alpha-fetoprotein > 10 ng/mL) + 0.349
(non-anatomical LR) + 0.431 (blood loss > 240 mL).
By applying this formula, patients were categorized
into low-, standard-, and high-risk groups (Groups 1,
2, and 3, respectively). Two of 18 patients (11%) in
Group 1, 135 of 224 (60%) in Group 2, and 148 of 196
(76%) in Group 3 developed HCC recurrence. Accord-
ingly, this formula had a discrimination rate of 64%
for predicting the development of recurrence. One- and
five-year recurrence rates were 6% and 14% in Group
1, 20% and 64% in Group 2, and 41% and 89% in
Group 3, respectively (p < 0.001, log-rank test).
Conclusions: We developed a model for predicting
HCC recurrence during the follow-up period after LR
based on operative factors and tumor characteristics.
This model clearly discriminated those patients with an
elevated risk of recurrence, who would require addi-
tional monitoring during postoperative care.
PO22-03
IMPACT OF THE MACROSCOPIC
GROSS TYPE CLASSIFICATION FOR
SMALL HEPATOCELLULAR
CARCINOMA
Satoshi Katagiri, Shun-Ichi Ariizumi, Yoshihito
Kotera, Yutaka Takahashi, Akiko Oomori, Shingo
Yamashita, Godai Yoneda, Hirohito Egawa and
Masakazu Yamamoto
Tokyo Women’s Medical University, Japan
Introduction: In the recent years, the treatment options
for Hepatocellular Carcinoma (HCC) less than 3 cm in
diameter is selected the hepatectomy or the local abla-
tion. We inquired paying attention to the macroscopic
gross type of surgical specimens for small HCC.
Method: We enrolled 942 na€ıve patients with HCC less
than 3 cm in diameter who were treated with hepatec-
tomy at our hospital between 1986 and 2011. Statistical
analysis was made of the histopathological evidence of
portal and hepatic vein invasion, intrahepatic metasta-
sis and cumulative and disease-free survival rates by
the macroscopic gross type of the general rules for the
clinical and pathological study of primary liver cancer
from Liver Cancer Study Group of Japan. The macro-
scopic gross type is classified into five types, small nod-
ular type with indistinct margin (SNIM), simple
nodular type (SN), confluent multinodular type (CM),
simple nodular type with extranodular growth (SNEG)
and infiltrative type (IF).
Results: Of 942 patients with small HCC examined for
the microscopic portal vein invasion of surgical speci-
mens, 0, 9.2, 40.6, 28.5 and 32.1% had SNIM, SN,
CM, SNEG and IF, respectively. For the macroscopic
intrahepatic metastasis, 0, 8.3, 29.7, 30.2 and 14.3%
had SNIM, SN, CM, SNEG and IF, respectively. Of
869 patients with curative resection, the 5-year survival
rates were 77, 69, 71 and 61% in patients with SNIM,
SN, CM and SNEG, respectively. The 5-year disease
free survival rates were 41, 33, 36 and 27% in patients
with SNIM, SN, CM and SNEG, respectively. There
were a significant difference between SNEG and other
types in 5-year survival and disease free survival rate.
Conclusions: These results suggest the possibility that
simple nodular type with extranodular growth of HCC
less than 3 cm in diameter has a high grade of malig-
nancy. The treatment to such type HCC requires cau-
tions.
PO22-04
CLINICOPATHOLOGIC FEATURE AND
PROGNOSIS OF COMBINED
HEPATOCELLULAR-
CHOLANGIOCARCINOMA WITH STEM
CELL FEATURE
Hwakyung Jung, Sungsu Yoon, Dongshik Lee and
Hongjin Kim
Yeungnam University Medical Center, Korea
Introduction: Combined hepatocellular-cholangiocarci-
noma (cHCC-CC) is rare subtype of primary liver can-
cer, and generally the prognosis is known to be worse
than HCC. The purposes of this study were to evaluate
the clinicopathologic feature and prognosis of the
cHCC-CC.
Method: From January 2000 to December 2012, 33
patients were diagnosed with cHCC-CC who under-
went hepatectomy for liver malignancy. The clinico-
pathologic and follow-up data were evaluated
retrospectively, and compared the data of HCC and
ICC patient.
Results: 33(8.51%) patients of the 388 patients who were
initially diagnosed with HCC were diagnosed with
cHCC-CC after surgery from January 2000 to December
2012. Mean age was 57.85  11.39 and Male:Female
ratio was 20:13. Mean ICG R15 was 15.74  10.98%
and Child-Pugh class of all patients were A. 20 patients
(60.6%) had HBV viral infection, 3 (9.1%) patients had
HCV viral infection. 10 patients (30.3%) didn’t have
viral hepatitis. The mean value of preoperative serum-
AFP was 4398.86  14763.43 (1~77249). cHCC-CC was
classified with 2010 WHO classification, 2 patients
(6.1%) were classical subtype, 1 patient (3.0%) was typi-
cal subtype, 6 patients (18.2%) were intermediate type, 3
patients(9.1%) were cholangiolocellular type. 21 patients
were unclassified. Lymph node metastasis was present in
4 patient (12.1%) and 2 patient (1%) for cHCC-CC and
HCC, respectively. The cumulative 1, 3and 5 year dis-
ease-free survival rates after hepatectomy were 64.4%,
37.9%, and 0% in cHCC-CC patients, and 80.9%,
62.6%, 52.0% in HCC patients. The cumulative 1, 3 and
5 year survival rates were 72.1%, 46.5% and 31.0% in
cHCC-CC patients, and 78.0%, 56.4%, 46.0% in HCC
patients. But, after adjusted by stage, there was no signif-
icant difference in overall survival and disease-free sur-
vival.
Conclusions: cHCC-CC has a clear pattern of HCC,
but it has also some aspect of CCC, such as lymph
node metastasis. Survival difference may be related to
higher rate of lymph node metastasis and advanced
stage of cHCC-CC.
© 2014 The Authors
HPB © 2014 Americas Hepato-Pancreato-Biliary Association HPB 2014, 16 (Suppl. 2), 258–316
300 Poster Oral Representation
PO22-05
FACTORS AFFECTING THE
OUTCOMES OF THE SURGICAL
TREATMENT OF BREAST CANCER
LIVER METASTASES
Vladislav Treska, Monika Cerna, Vaclav Liska, Tomas
Skalicky and Ilona Zednikova
University Hospital, Medicine Faculty, Czech Republic
Introduction: The results of the surgical treatment of
breast cancer liver metastases (BCLM) may be affected
by a number of factors. The aim of this study was to
specify the risk factors of the surgical treatment of
BCLM.
Method: Twenty one female BCLM patients were trea-
ted with liver resection or radiofrequency ablation
(RFA). We studied the effects of patients age, time
interval between the breast cancer and BCLM surgery,
the type of surgical procedure, histopathological find-
ings of the primary tumor, the number and overall
diameter of BCLMs, the presence of resectable extra-
hepatic metastases, and local tumor recurrence after
breast cancer surgery on patients′ overall (OS) and pro-
gression-free survival (PFS).
Results: The long-term results did not differ between
liver resection and RFA. Patient age <50 years and the
interval between breast and liver surgery were risk fac-
tors for OS (HR 4.163, CI 1.146–15.118, p < 0.02; and
HR 4.738, CI 1.287–17.441, p < 0.01, respectively) and
for PFS (HR 4.303, CI 1.056–17.531, p < 0.01; and HR
5.088, CI 1.496–17.303, p < 0.01, respectively). The
presence of extra-hepatic metastases was a risk factor
for OS (HR 5.078, CI 1.437–17.949, p < 0.005). An
overall diameter of BCLM ≥3.5 cm and a negative sta-
tus of both ER and PR in the primary tumor were risk
factors for PFS (HR 9.999, CI 1.257–79.513, p < 0.009;
and HR 21.475, CI 1.907–241.843, p < 0.0003, respec-
tively).
Conclusions: The risk factors for BCLM surgery are
patient′s age <50 years, the presence of extrahepatic
metastases, hormon negative receptors in the primary
tumor and an overall BCLM diameter ≥3.5 cm.
PO23-01
CLINICO-PATHOLOGICAL FEATURES
AND SURVIVAL OUTCOMES OF
BRCA1/2-ASSOCIATED PANCREATIC
CANCERS: THE ONTARIO
EXPERIENCE
Siong-Seng Liau1, Emily Whelan2, Hassan Shoushtari1,
Spring Holter2, Kanji Zaheer2, Serra Stefano1,
Mohammad Akbari3, Cleary Sean1 and Gallinger
Steven1
1Toronto General Hospital, Canada; 2Mount Sinai
Hospital, Canada; 3University of Toronto, Canada
Introduction: Germline BRCA1/2 mutation carriers
represent the most common subgroup of hereditary
pancreatic cancer. BRCA1/2 mutations lead to
impaired DNA damage repair and predispose to a
‘mutator’ phenotype in cancers. Hypothetically, the
cumulative mutations are stochastic, leading to varying
tumour phenotype. This study aimed to analyze the
baseline clinicopathologic characteristics of BRCA1/2-
associated pancreatic cancers, and to explore possible
differences in clinical outcomes.
Method: We reviewed the tumour characteristics and
survival of 33 BRCA1/2 carrier patients with pancreatic
adenocarcinoma (8 BRCA1, 25 BRCA2). All patients
had sequence confirmation of germline BRCA1 and
BRCA2 mutation status.
Results: The most common germline mutations were
c.185delAG (38% of BRCA1 group) and c.6174delT
(48% of BRCA2 group). BRCA1 and BRCA2 muta-
tion carriers did not differ in age (62  11 vs.
61  12), symptomatology at diagnosis and other
clinicopathologic features. BRCA1 carriers tended to
be males of Jewish descent, and with a family history
of pancreatic cancer. Surgical resectability rates were
37.5% and 32% for BRCA1 and BRCA2 carriers
respectively. In the surgically resected group, the med-
ian survivals were 25.9 months and 31.1 months for
BRCA1 and BRCA2 carrier patients, respectively. The
actuarial 1-, 3- and 5-year survivals for the resected
patients were 100%, 33.3% and 0% for BRCA1 carri-
ers and 80%, 40% and 20% for BRCA2 carriers. For
unresectable or metastatic disease, the median survivals
for BRCA1 and BRCA2 were 15.9 months and
12.0 months respectively. A small group of outliers
(12%; n = 4/33, 1BRCA1, 3BRCA2) were identified
with longer survival (>3 years).
Conclusions: This series confirms the generally poor
survival of BRCA1 and BRCA2 carriers with pancre-
atic cancer. There is heterogeneity in the survival out-
comes with longer survival biased by a small group of
outliers. This ‘survival outlier’ phenomenon may repre-
sent a biologically-distinct group with potential for
longer survival and warrants further characterization.
PO23-02
RESECTION OF LOCALLY ADVANCED
PANCREATIC CANCER AFTER
NEOADJUVANT CHEMOTHERAPY
WITH MODIFIED FOLFIRINOX: A
PROSPECTIVE PHASE II STUDY
Enrico Vasile, NelideDe Lio, Mario Antonio
Belluomini, Francesca Costa, Carla Cappelli, Daniela
Campani, Alfredo Falcone and Ugo Boggi
University of Pisa, Italy
Introduction: Up to 30% of the patients diagnosed with
pancreatic ductal adenocarcinoma (PDAC) are denied
resection because of local tumor growth in the absence
of metastasis. These patients could be still be consid-
ered for resection, if responsive to neaodjuvant chemo-
therapy (NACT). We report the results of a phase-II-
clinical-trial, coupling high-dose-multi-drug-NACT
with aggressive surgery.
Method: All patients enrolled were selected by a multi-
disciplinary workgroup, when PDAC was staged as T4
(according to the UICC), ECOG PS was 0–1, and age
was 18–75 years. A modified-FOLFIRINOX regimen
was used. Tumor response was evaluated according to
RECIST. The opportunity to add a local treatment,
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either surgery or radiation-therapy, was evaluated after
every CT follow-up.
Results: Between 11/2010–07/2013, 35 patients were
enrolled: 9/35 celiac axis involvement, 18/35 superior
mesenteric artery (SMA), 6/35 celiac axis and SMA.
Fourteen patients had a partial response (40%), 19 sta-
ble disease, two progressed. Twenty-three patients were
selected for surgical exploration, and 19 underwent
potentially curative resection: four pancreaticoduoden-
ectomy, 14 total-splenopancreatectomy, one distal
splenopancreatectomy. Multivisceral resection was nec-
essary in six patients. Seventeen patients needed resec-
tion of at least one peripancreatic vessel: superior
mesenteric vein (SMV) in six patients, SMV plus SMA
in 5 patients, and hepatic artery/celiack trunk plus
SMV in four patients. Two patients required the simul-
taneous resection of three vessels. Mean-operative-time
was 456.8 minutes. In-hospital-mortality was 4.3%,
and overall-postoperative-morbidity 43.4%. Mean-hos-
pital-stay was 16.4 days. 19/19 resections were R0. The
mean number of examined lymph nodes was 72.3, and
the mean number of positive nodes three. Quite inter-
estingly, 75% of veins and 87.5% of SMA were tumor-
free at pathology. Overall-progression-free-survival was
14 months, resected-patient-progression-free-survival
17.8 months, out-of-surgery-patient-progression-free-
survival 10.3 months, median-overall-survival
24.2 months.
Conclusions: Modified-FOLFIRINOX protocol in T4
PDAC allows resection in a relevant percentage of
patients, most of whom with histological downstaging,
achieving survival results similar to primary-resectable-
patients.
PO23-03
LONG AND SHORT TERM SURVIVAL
AFTER PROXIMAL PANCREATIC
RESECTION-EXPERIENCE OF A
SINGLE UNIT
Andrew Healey, Sanjay Pandanaboyana, Mark
Duxbury, R Ravindran, James Powell, Steve Wigmore,
O. James Garden and Rowan Parks
Royal Infirmary of Edinburgh, United Kingdom
Introduction: Pancreatic resection has traditionally been
associated with significant morbidity and mortality
rates. Advances in pre-operative imaging, surgical tech-
nique and perioperative management in specialist units
have reduced morbidity and mortality rates. The aim
of this study was to assess the short and long-term out-
come in patients undergoing major proximal pancreatic
surgery in a tertiary referral unit.
Method: All patients undergoing a Whipple/PPPD pro-
cedure from 1988 to 2011 were reviewed. Survival data
was obtained through the national Information Ser-
vices Division of NHS Scotland. Survival data was
processed as Kaplan Meier plots using GraphPad
Prism software.
Results: 532 Whipples procedures were performed,
(292 males, 240 females). The mean age of patients was
62.8 years, (range 5–132 years). Tumour site was as fol-
lows: 39% head of pancreas, 26% ampullary, 13% dis-
tal common bile duct and 7% duodenum. Post
operative histology was benign in 10%. Mean follow
up was 6.75 years, (range 1–23 years). Postoperative
mortality at 30 and 60 days was 2.6 and 3% respec-
tively. Overall 1, 3 and 5-year survival was as follows
77%, 54% and 33%. Median survival was 531 days.
Conclusions: This large single institutional series illus-
trates excellent short and long-term survival data fol-
lowing pancreatic resection for presumed pancreatic
malignancy. The data is consistent with that published
by other specialist HPB units.
PO23-04
VARIATIONS IN MEDICAL ONCOLOGY
UTILIZATION PRACTICES BY
PANCREATIC CANCER PATIENTS IN A
SINGLE PAYER HEALTH CARE
SYSTEM
Scott Hurton, Geoff Porter, Mark Walsh and Michele
Molinari
Dalhousie University, Canada
Introduction: Population based studies in the USA
have shown that pancreatic cancer (PC) has one of the
lowest rates of cancer directed therapy among solid
organ malignancies. Socio-economic factors, referral
patterns and unequal access to health-care might be
responsible. There is a lack of data on PC patients liv-
ing in regions where health care is uniformly available.
The main aim of this study was to assess PC-directed
therapy in a cohort of patients diagnosed with PC in
Nova Scotia (Canada).
Method: A cohort of 1129 patients with PC was identi-
fied using the Provincial Cancer Registry over a 10-year
period (2001–2010). Demographic, clinical and socio-
economic data were extracted from the linkage of mul-
tiple administrative databases. Predictors of medical
oncology healthcare utilization in PC patients were
explored by multivariate regression analyses.
Results: Curative resection was performed in 163
patients (14.4%) and palliation in 996 (85.6%). Of all
resected patients, 45% had a medical oncology visit for
adjuvant therapy. In addition, only 34.4% of all
resected patients visited medical oncology within
10 weeks. Among the unresected patients, 31% were
referred for palliative chemotherapy. There was greater
attrition between referral to medical oncology and
actual visit to medical oncology in resected patients
versus unresected patients (14.1% vs. 4.6%). Upon
multivariate analysis, only advanced age (p = 0.0092)
and presence of comorbidities (p = 0.0029) were the
only significant factors predictors for failure of PC
directed therapy. Socioeconomic status and rural resi-
dence were not significant predictors of medical oncol-
ogy visit for chemotherapy consideration.
Conclusions: The majority of patients with PC did not
receive cancer directed therapy, despite the universal
availability of healthcare services. Socioeconomic char-
acteristics and distance to medical centers did not have
a significant effect in utilization of adjuvant or pallia-
tive oncological treatments.
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PO23-05
DIFFERENT FACTORS INFLUENCE
SURVIVAL IN DIVERSE AGE GROUPS
FOLLOWING SURGERY FOR
PANCREATIC CANCER
Antanas Gulbinas, Kestutis Urbonas,
Giedrius Barauskas and Juozas Pundzius
Lithuanian University of Health Sciences, Lithuania
Introduction: Current overviews show that pancreato-
duodenectomy can be safely performed for patient’s
age 70 years and over in terms of postoperative compli-
cations and mortality though it is challenging and
highly depends on multidisciplinary team approach.
Despite increasing age of patients there is a lack of
data on deeper analysis of factors influencing long term
survival in elderly.
Method: The data of 251 patients who underwent
major surgery for adenocarcinoma of the head of the
pancreas was prospectively collected and analyzed. Val-
ues of results were presented as means +/-SD and as
medians. Survival rates were summarized using the
Kaplan-Meier method, and the log-rank test was used
to compare differences in survival between different age
groups. Cox proportional hazard model was applied to
indentify prognostic factors that were independently
associated with survival.
Results: The median overall survival of 14.9 month
was observed. Median survival of group <70 years was
16.2 month and 13.8 month for group 70 years and
over. Multivariate analysis revealed that R1 resection
(HR 1.76; CI 1.16–2.67), poor tumor differentiation
grade (G3-G4) (HR 1.48; CI 0.96–2.28) were factors
associated with worse survival for group <70 years.
Lymphonode metastases (HR 4.89; CI 2.49–9.56) and
perineural spread (HR 2.73; CI 1.48–5.06) were inde-
pendent factors negatively influencing survival in age
group >70 years.
Conclusions: Different factors influence survival in
diverse age groups following surgery for pancreatic
cancer: elderly patient’s survival is mainly influenced by
tumor outspread, whereas tumor characteristics are the
main prognosticators in younger patients.
PO24-01
PANCREATIC ANASTOMOTIC
LEAKAGE AFTER
PANCREATICODUODENECTOMY. RISK
FACTORS, CLINICAL PREDICTORS
AND PATIENTS OUTCOMES
Ehab El-Hanafy and Waleed Askr
Mansoura university, Egypt
Introduction: Postoperative pancreatic fistula (POPF)
after pancreaticoduodenectomy PD remains a challenge
even at high volume centers. This study was designed
to analyze perioperative risk factors for POPF after PD
and evaluate the factors that predict the extent and
severity of leak.
Method: We retrospectively studied all patients who
underwent PD in our Center, from January 2001 to
June 2012.
Demographic data, preoperative, intraoperative, post-
operative variables were collected. The amylase of
serum and drainage fluid was measured on postopera-
tive day (POD) 1, 3, and 5. Blood picture and Liver
functions were measured on POD 1, 5.
Results: A total of 471 consecutive patients underwent
PD in our center. Fifty seven patients (12.1%) devel-
oped a POPF of any type. 21 patients (4.5%) had a fis-
tula type A, 22 patients (4.7%) had a fistula type B
and the remaining 14 patients (3%) had a POPF type
C. Cirrhotic liver (p = 0.05), BMI >25 kg/m2
(p = 0.0001), soft pancrease (p = 0.04), pancreatic duct
diameter <3 mm (p = 0.0001), pancreatic duct located
<3 mm to the posterior border (p = 0.02) significantly
associated with POPF. with the multivariate analysis
both BMI and pancreatic duct diameter were demon-
strated to be independent factors. The hospital mortal-
ity in this series was 11 patients (2.3%), the
development of POPF type C was associated with a
significantly increased mortality (7/14 patients). POD 1,
5 a drain amylase level > 4000 IU/L, WBC, pancreatic
duct diameter, pancreatic texture were predictors for
clinical evident POPF using (ROC) curve
Conclusions: Cirrhotic liver, BMI, soft pancrease, pan-
creatic duct diameter <3 mm, pancreatic duct near pos-
terior border are risk factors for development of
POPF. POD 1, 5 a drain amylase level, WBC, pancre-
atic duct diameter, pancreatic texture may be predictors
for POPF B,C.
PO24-02
PROSPECTIVE CONSECUTIVE
ANALYSIS ON THE AMOUNT OF
DIETARY INTAKE AFTER
PANCREATICODUODENECTOMY; IS
PPPD INFERIOR TO SSPPD IN
POSTOPERATIVE ORAL INTAKE
TOLERANCE?
Yasutoshi Kimura, Masafumi Imamura, Makoto
Meguro, Tatsuya Itoh, Toshihiko Nishidate, Masayuki
Ishii, Takayuki Nobuoka, Toru Mizuguchi and Koichi
Hirata
Sapporo Medical University, Japan
Introduction: Fast-tracking surgery is demanded in
patients underwent with pancreaticoduodenectomy
(PD). Several potential factors associating with the pro-
longation of postoperative hospital stay have been dis-
cussed, such as the type of PDs, reconstruction
methods and other complications.
A prospective consecutive study was conducted to eval-
uate the postpancreaticoduodenectomy (PD) oral
intake tolerance. The occurrence of delayed gastric
emptying (DGE) and the amount of dietary intake
were analyzed. The relative merits for oral intake toler-
ance between PPPD and SSPPD were additionally
determined.
Method: Between 2004 and 2012, 146 consecutive
patients underwent PDs. Perioperative data were pro-
spectively collected in all patients, and the patient’s
postoperative dietary intake was recorded for all meals
until discharge. We introduced the total amount of die-
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tary intake (TDI, Akizuki E, Kimura Y, et al., Ann
Surg 2009) as an indicator of early postoperative oral
intake tolerance (day 1 to 21). The postoperative out-
comes were compared between PPPD and SSPPD.
Multivariate analysis for factors associated with low
TDI was performed.
Results: The occurrence of DGE as defined by ISGPS
was 18.5% (27/146; A/B/C = 7/5/15) in all patients,
and there was no difference between PPPD (15.9%)
and SSPPD (22.4%). The daily dietary intake was
gradually recovered in patients with both types of PDs;
however, the value was significantly better in PPPD
patients after POD 14 (p < 0.05). The median TDI
value in patients with PPPD (6.4) was superior to that
with SSPPD (4.5) (p = 0.007). Multiple regression
analysis revealed that the type of PDs (PPPD vs.
SSPPD, regression coefficient = 0.180, p = 0.045) and
DGE (regression coefficient = 0.423, p < 0.001) were
associated with TDI values.
Conclusions: TDI values provided detailed information
for analyzing postoperative oral intake tolerance,
although the ISGPS definition of DGE seemed avail-
able for recent postoperative patient-care. The risk fac-
tors for low oral intake tolerance after PDs proved to
be the type of operation (SSPPD) and DGE.
PO24-03
THE 2 LAYERS PANCREATICO-
JEJUNOSTOMY DECREASE THE RISK
AND GRAVITY OF PANCREATIC
FISTULA AFTER
PANCREATICODUODENECTOMY
Beatrice Aussilhou, Safi Dokmak, Fadhel Samir
Fteriche, Olivier Farges, Jacques Belghiti and Alain
Sauvanet
Beaujon Hospital, France
Introduction: The best type of pancreatic anastomosis
after pancreaticoduodenectomy (PD) at lower risk and
gravity of pancreatic fistula (PF) is not well defined.
Our aim was to compare our experience with two types
of pancreatico-jejunostomies (PJ) performed in a ter-
tiary centre by a single surgeon.
Method: From January 2009 to August 2012, 100
patients underwent PD by a single surgeon (BA) at two
consecutives periods of time and data were studied ret-
rospectively from a prospective maintained database
and divided in two groups: Group A1 (n = 50) with a
PJ in one layer and group A2 (n = 50) with a PJ in
two layers. These two groups were compared in term
of mortality, rate and gravity (B and C) of pancreatic
fistula and hospital stay. PF rate and gravity were
defined according to ISGPF. A1 was compared to A2.
Results: There was no significant difference between
the two groups regarding age, sex, BMI, underlying
pathology, texture of the pancreas and the size of the
main pancreatic duct. The mortality was 0% and 2%,
respectively (NS). The rate of PF (42% vs. 12%;
p < 0,01), grade B (62% vs. 33%; p < 0.01) and grade
C (5% vs. 2%; NS) was significantly more important in
the group A1. the duration of hospital stay was signifi-
cantly longer in the group A1 (23 vs. 15 days,
p < 0,0001).
Conclusions: This study showed that the PJ in two lay-
ers is associated with decreased rate and gravity of pan-
creatic fistula and should be the anastomosis of choice
after pancreaticoduodenectomy.
PO24-04
SMA-FIRST APPROACH THROUGH
THE TREITZE LIGAMENT IN
LAPAROSCOPIC
PANCREATICODUODENECTOMY
Yorihiko Muto, Akihiro Cho, Hiroshi Yamamoto,
Osamu Kainuma, Nobuhiro Takiguchi, Yoshihiro
Nabeya, Hiroo Yanagibashi, Takahito Masuda,
Mamoru Sato and Matuo Nagata
Division of Gastroenterological Surgery, Chiba Cancer
Center Hospital, Japan
Introduction: Although minimally invasive surgery has
been widely spread, laparoscopic resection for invasive
pancreatic ductal adenocarcinoma (PDAC) is still not
universally accepted as an alternative approach for open
surgery. On the other hand, the technical aspects of this
complex operation continues to fascinate surgeons and
this has been resulted in a number of modifications.
Method: 14 patients with PDAC underwent laparo-
scopic pancreaticoduodenectomy (LPD) using SMA-
first approach through the Treitze ligament in our insti-
tution.
Surgical technique: With the transverse colon lifted
upward, the Treitze ligament is opened, and the pancre-
atic head and the duodenum are freed from the ante-
rior surface of the IVC. The origin of the SMA
covered with loose connective tissue is identified and
taped cephalad to the left renal vein. Dissection of the
nerve plexus around the SMA proceeds from the origin
to the branching point of the IPDA. The IPDA is orig-
inating from the first jejuna artery or directly from the
SMA. A counterclockwise rotation of the SMA facili-
tates isolation and ligation of the IPDA arising from
the posterior surface of the SMA.
Results: In all patients, SMA-first approach through
the Treitze ligament and early ligation of the IPDA
could be successfully performed, as planned.
Conclusions: The present procedure is safe, feasible,
and useful in LPD for PDAC.
Conflict of Interest: We have no conflicts of interest or
financial ties to disclose.
The present procedure is safe, feasible, and useful in
LPD for PDAC.
PO24-05
DEFINING THE OPTIMAL EXTENT OF
VASCULAR RESECTION AT
PANCREATICODUODENECTOMY (PD):
SYSTEMATIC ASSESSMENT OF
OUTCOME FROM RESECTION
INCORPORATING THE SUPERIOR
MESENTERIC ARTERY (SMA)
Mahmoud Abdel Dayem, Santhalingam
Jegatheeswaran and Ajith Siriwardena
Manchester Royal Infirmary, United Kingdom
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Introduction: PD is the treatment of choice for non-
metastatic, localised cancers of the head of the pancreas
in patients without major co-morbidity. Technically,
resection can be prevented when tumour progression
involves the portal/superior mesenteric vein or the
SMA. Although venous resection is increasingly
accepted, SMA resection remains unestablished. Given
the rarity of SMA resection in any given series, this
study undertakes an analysis of pooled data on arterial
resection in order to assess outcome.
Method: Medline and embase were searched for the
period 2000–2013 selecting only articles in English
which provided complication profile, outcome and sur-
vival data allocatable to patients undergoing arterial
resection at PD.
Results: During this period four manuscripts provided
information on 25 patients undergoing PD with SMA
resection. Reconstruction (available for 17) was by flap
rotation of the splenic artery in nine (53%), graft in six
(35%) and primary end-end anastomosis in 2 (12%).
Median (range) operating time was 820 (441–
1190) min., blood loss 6650 (2400–15,900) mL and 30-
day mortality was three (12%). Median survival was 11
(0–29) months.
Conclusions: The addition of SMA resection to PD
produces a lengthy operative procedure with high
reported blood loss but acceptable 30-day mortality. As
the median survival is similar to that for non-operated
pancreatic cancer, SMA resection at PD should only be
undertaken in the context of national clinical trials with
mandatory reporting of quality of life measures.
PO25-01
LIGAMENT OF TREITZ APPROACH IN
LAPAROSCOPIC MODIFIED RAMPS
Hiroki Sunagawa, Kanako Ogura, Tomoro BaBa,
Toshio Harumatsu, Shogo Kinjyo, Tomohumi
Orokawa, Yasuaki Mayama, Susumu Inamine, Tetsuo
Toyama and Naoto Oshiro
Nakagami Hospital, Japan
Introduction: Laparoscopic distal pancreatectomy (Lap-
DP) is regarded as a safe and effective procedure for
low malignant potential pancreatic tumors. Lap-DP for
pancreatic cancer is being applied with increasing fre-
quency in selected cases. However, the use of this pro-
cedure for pancreatic cancer is still controversial. The
main goals of pancreatic cancer surgery are to obtain
an R0 and sufficient regional lymph nodes. Radical an-
tegrade modular pancreatosplenectomy (RAMPS) was
introduced to obtain a higher rate of R0 and a higher
lymph node count. However, there is no standard lapa-
roscopic technique for left-sided pancreatic cancer.
Method: We started the procedure by dissecting the lig-
ament of Treitz. We entered and spread the anterior
space of the aorta and IVC where the left renal vein
was exposed. We also dissected the lymph nodes of the
root of SMA, and following RAMPS was performed.
Results: The technique was used in three patients who
had pancreatic cancer within the pancreas. The median
length of the operation was 417 min, the median blood
loss was 75 ml, the median number of retrieved lymph
nodes was 31 and all three patients underwent an R0.
Two patients began to receive adjuvant chemotherapy
by POD 14.
Conclusions: The ligament of Treitz approach in lapa-
roscopic modified RAMPS offered R0 resection and
the resection of sufficient regional lymph nodes. The
procedure also allowed adjuvant chemotherapy to be
started early in the postoperative course.
PO25-02
THE HAMMERSMITH LAPAROSCOPIC
PANCREATICOGASTROSTOMY: A
NOVEL LAPAROSCOPIC PANCREATIC
ANASTOMOSIS DURING CENTRAL
PANCREATECTOMY
Tamara Gall, Mikael Sodergren, Adam Frampton and
Long Jiao
Hammersmith Hospital, United Kingdom
Introduction: Central pancreatectomy (CP) is preferred
to distal pancreatectomy (DP) for the excision of
benign tumours at the neck or body of the pancreas, in
order to preserve pancreatic parenchyma and the
spleen. However, the pancreaticoenterostomy is techni-
cally difficult to perform laparoscopically and the post-
operative pancreatic fistula (POPF) rate is high. Thus
there are few reported series of laparoscopic CP. We
present the Hammersmith Laparoscopic Pancreaticoga-
strostomy (HLPG) technique, a novel method for
reconstruction of the pancreatic stump during CP. This
method is technically easier to perform than standard
techniques.
Method: From March 2012 to July 2013, four patients
underwent HLPG during a laparoscopic CP. This
involves creating a sleeve gastric tube for an end-to-end
anastamosis between the distal pancreatic stump and
the stomach. Operative outcomes were reviewed pro-
spectively.
Results: Two males and two females with a median age
of 49 years had a CP with HLPG. The total operative
time was 437.4  12 mins (mean  sd) and the time
taken for reconstruction of HLPG anastomosis was
37.6  7.6 min. (mean  sd). After a median follow-up
of 27.5 months there was no mortality. One patient
had a grade A postoperative pancreatic fistula (POPF)
requiring no medical or surgical treatment.
Conclusions: The HLPG is technically easy to construct
laparoscopically. It is a feasible operation which may
reduce operative time and POPF rate. A larger series in
the future will fully evaluate the operative outcomes.
PO25-03
THE PANCREATICO-JEJUNOSTOMY
(PJ) IN TWO LAYERS SEEMS TO
DECREASE THE RISK OF PANCREATIC
FISTULA AND THE GRAVITY OF
PANCREATIC FISTULA
Beatrice Aussilhou, Safi Dokmak, Alain Sauvanet,
Olivier Farges and Jacques Belghiti
Beaujon Hospital, France
Introduction: The type of pancreatic anastomosis after
Whipple procedure is not well defined to decrease the
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rate of pancreatic fistula and their gravity. Our aim
was to compare two types of pancreatico-jejunostomies
performed in the same center.
Method: From January 2009 to August 2012, 100
patients underwent a Whipple procedure, including two
groups: A1 (n = 50) with a pancreatico-jejunostomy in
one layer and A2 (n = 50) with a PJ in two layers. The
two groups were similar in terms of age, sex, BMI,
diagnosis including adenocarcinoma (n = 24 in group
A1 and n = 22 in group A2), neuroendocrine tumor
(n = 5 in group A1 and n = 3 in group A2), ampullo-
ma (n = 6 in group A1 and n = 5 in group A2), cho-
langiocarcinome (n = 0 in group A1 and n = 7 in
group A2) and IPMN (n = 8 in group A1 and n = 0 in
group A2), texture of the pancreas and height of the
pancreatic duct. These two groups were compared in
term of rate of pancreatic fistula and its gravity, dura-
tion of hospital stay and mortality.
Results: The mortality was nil in the group A1 and 2%
(one patient) in the group A2. The rate of pancreatic
fistula was significantly more important in the group
A1 (42% vs. 12%, p < 0,01) with 62% versus 33% of
grades B and 5% versus 2% of grades C. the duration
of hospital stay was significantly longer in the group
A1 (23 versus 15 days, p < 0,0001).
Conclusions: This study showed that the PJ in two lay-
ers is associated to a decreased rate of pancreatic fistula
and a shorter duration of hospital stay.
PO25-04
A NOVEL U-SUTURE TECHNIQUE FOR
END-TO-END INVAGINATED
PANCREATICOJEJUNOSTOMY
FOLLOWING
PANCREATICODUODENECTOMY
Xiao-ping Chen, Zhi-yong Huang, Josef WY Lau,
Bi-xiang Zhang, Zhi-wei Zhang, Yi-fa Chen,
Wan-guang Zhang and Peng Zhu
Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology, China
Introduction: Internationally, POPF remains a leading
cause of morbidity and mortality after pancreaticoduo-
denectomy (PD). In order to reduce the POPF inci-
dence, a number of technical modifications for
pancreato-enteric anastomosis after PD have been pro-
posed. In 1995, we established a new technique with
transpancreatic transverse U-sutures for end-to-end
invaginated pancreaticojejunostomy after a PD (Chen’s
U-Stitch technique), and the preliminary results were
quite encouraging. This study aims to review a new sur-
gical approach, the Chen’s U-Stitch technique, for end-
to-end invaginated pancreaticojejunostomy (PJ), and to
evaluate the effectiveness of this approach with reduc-
ing the incidence of postoperative pancreatic fistula
(POPF) formation.
Method: To evaluate this new approach, during 2002
to 2012, 264 patients who received the new Chen’s U-
Stitch technique after a PD were included in this study.
The postoperative morbidity and mortality including
the POPE incidence were analyzed.
Results: The postoperative morbidity was 22.3% (22/
264) and mortality was 0% (0/264). The POPF rate
was 3.4% (9/264) for Grade A, 0.8% (2/264) for Grade
B, and 0% (0/264) for Grade C.
Conclusions: This new surgical technique (Chen’s U-
Stitch) which involves an end-to-end invaginated pan-
creaticojejunostomy with 2–4 transpancreatic transverse
U-sutures provides excellent outcomes at reducing the
POPF incidence after PD. This technique is a simple
approach that is time-saving and can also be safely
applied in patients with soft pancreas and/or small pan-
creatic ducts.
PO25-05
PANCREATICODUODENECTOMY IN
PATIENTS WITH CHRONIC LIVER
DISEASE
Ippei Matsumoto, Sachiyo Shirakawa, Makoto
Shinzeki, Sadaki Asari, Tadahiro Goto, Taro Okazaki,
Masahiro Kido, Tetsuo Ajiki, Takumi Fukumoto and
Yonson Ku
Kobe University Graduate School of Medicine, Japan
Introduction: Surgery in patients with chronic liver dis-
ease (CLD) is at high risk of postoperative morbidity
and mortality. We retrospectively investigated short-
and long-term outcomes after pancreaticoduodenecto-
my (PD) in CLD patients.
Method: We reviewed consecutive 260 patients who
had undergone PD in our institution from 2003 until
2011 and identified 21 patients (8%) with CLD,
included 16 in Child-Turcotte-Pugh (CTP) class A, four
in B, and one in C. Outcomes were compared to 21
matched control patients in age-, sex-, disease- and
UICC-stage.
Results: Preoperatively, significantly higher serum cre-
atinine and international normalized ratio, and lower
serum albumin were noted in CLD group. There was
no significant difference between the two groups in
operative time, blood loss, and the rate of blood trans-
fusion, although higher use of fresh frozen plasma
(FFP) was found in CLD group. Postoperative morbid-
ities were significantly higher in CLD group than those
in non-CLD group (100% vs. 38%, p < 0.001), whereas
no inhospital mortality occurred in both groups. Some
CLD patients experienced severe complications (refrac-
tory ascites and sepsis) and required intensive manage-
ment: prolonged course of antibiotics; use of diuretics
and FFP; and enteral nutrition including BCAAs. The
2-year disease free survivals for CLD and non-CLD
group were 70% and 75% (p = 0.95), and overall sur-
vivals were 57% and 84% (p = 0.09), respectively.
Three of CLD patients died from causes other than
cancer. Nine patients with CLD were administered
additional drugs for liver disease postoperatively as
daily medication. Postoperative adjuvant chemotherapy
(AC) was indicated for 11 CLD and 14 non-CLD
patients. However, only 6 (55%) CLD patients received
AC, whereas 13 (93%) non-CLD patients received AC
(p = 0.04).
Conclusions: In CLD patients, high rate of complica-
tions associated with hepatic decompensation were
identified in early postoperative course. And late wors-
ening liver dysfunction after PD may increase liver
related death.
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PO26-01
STEREOTACTIC RADIOTHERAPY PLUS
SURGICAL RESECTION FOR LARGE
HEPATOCELLULAR CARCINOMA: A
CASE SERIES AND PATIENTS
OUTCOME
Chin-cheung Cheung and Kong-ling Ting
Tuen Mun hospital, Hong Kong, China
Introduction: Currently there is no consensus on the
management of large inoperable hepatocellular carci-
noma (HCC) (more than 10 cm). Therefore, we evalu-
ated the clinical outcomes of patients received surgical
resection after stereotactic radiotherapy (SRT) for large
HCC in a regional hospital in Hong Kong.
Method: A registry database of 160 patients treated
with stereotactic radiotherapy for inoperable HCC
between 2009 and 2012 were analysed retrospectively.
Six patients were found to have large HCC with an
average size of 14.6 cm (10.4–23.5 cm) and suboptimal
remnant liver volume (RLV) with child-Pugh class A
cirrhosis .They were treated with TACE once and fol-
lowed by SRT. The effect of SRT was reviewed by
computer tomographic scan 2 months after receiving
SRT. Liver resection was done for patients with opti-
mal RLV while extrahepatic metastases were excluded.
Results: All six patients received pre-operative SRT
with significant tumour shrinkage and compensatory
hypertrophy of the normal liver tissue which markedly
improved RLV. Open right hemi-hepatectomy were
performed afterwards. Intra-operative radiation related
adhesions over diaphragm, retroperitonium and inferior
vena cava nearby regions were encountered and tack-
led. All patients had no surgical related complications;
prolonged operative time or increased blood loss was
reported. Post-operatively, there was no radiation
induced liver disease or liver failure noticed. One of
them showed complete necrosis and resolved of main
portal vein tumour thrombosis after the SRT and he
remained disease free for four years after operation.
Conclusions: Pre-operative SRT combined with liver
resection, may be effective in treating large HCC with
acceptable radiation toxicity. Further assessment of
down-staging efficacy of SRT, optimal time interval
between SRT and resection, and survival benefit will be
evaluated by further randomised controlled study.
PO26-02
EFFICACY OF SORAFENIB AS
ADJUVANT THERAPY TO
HEPATOCELLULAR CARCINOMA
PATIENTS AFTER HEPATECTOMY
Zhao Gang, Hao Xi-shan and Song Tian-qiang
Tianjin Medical University Cancer Institute and
Hospital, China
Introduction: High reccurence rate is a major negative
factor for the prognosis of hepatocellular carci-
noma patients, and many factors, especially vascular
invasion (including macroscopic and microscopic) have
been proven to be related with postoperative high rec-
curence rate. Sorafenib is the only one drug that can
improve the prognosis to the advanced patients. But
until now, there are few researches about the effect
about Sorafenib in adjuvant treatment. So the aim of
our study is to evaluate whether HCC patients can get
benefit after hepatectomy through Sorafenib.
Method: There were 55 HCC patients who underwent
operation. For the patients with high risk recurrence fac-
tors, we recommend Sorafenib 400 mg po bid as adju-
vant therapy. All the patients were followed up each
3 months. Clinical data were collected and analyzed.
Results: In those 55 patients, there were 34 patients
with macroscopic vascular invasion (MaVI) and 21
patients with microscopic vascular invasion (MiVI) and
satellite lesion. And there were 24 patients (14 with
MaVI and 10 with MiVI) as adopted Sorafenib and 31
patients (20 with MaVI and 11 with MiVI) as control
group. The median follow-up time was 20.33 months
(range, 2.73–38.57). The recurrence free survival time
(month, mean  standard deviation) of the Sorafenib
Group and Control Group in the whole patients,
patients with MaVI and patients only with MiVI &
satellite were: 16.76  2.42 versus 6.83  1.31 (p =
0.000), 12.56  2.64 versus 6.31  1.90 (p = 0.037) and
20.88  3.39 versus 7.78  1.40 (p = 0.002) respec-
tively. The overall survival time (month, mean  stan-
dard deviation) of the Sorafenib Group and Control
Group in the whole patients, patients with MaVI and
patients only with MiVI & satellite lesion were:
28.04  1.88 versus 19.97  2.78 (p = 0.002),
26.02  2.85 versus 15.20  2.56 (p = 0.028) and
29.52  1.60 versus 23.52  4.35 (p = 0.037) respec-
tively.
Conclusions: This study showed that using Sorafenib as
adjuvant therapy could prevent recurrence and improve
prognosis. This maybe a potential evidence to use So-
rafenib after operation. But we should need a multicen-
ter large number randomized controlled trial to prove.
PO26-03
SEQUENTIAL TRANSCATHETER
ARTERIAL CHEMOEMBOLIZATION
AND PORTAL VEIN EMBOLIZATION
FOR HCC RESECTION IN CIRRHOTIC
PATIENTS IMPROVES OUTCOME AND
INCREASES TUMOR NECROSIS: A
CASE MATCHED CONTROL STUDY
Daniele Sommacale1, Tullio Piardi1, Yohann Renard1,
Alexandra Heurgue1, Thomas F Baumert2, Jacques
Marescaux2, Reza Kianmanesh1 and Patrick Pessaux2
1DUNE POLE, France; 2Pole Hepato-digestive-
Hopitaux Universitaires of Strasbourg-Univesity of
Strasbourg, France
Introduction: Portal vein embolization (PVE) alone or
sequential transcatheter arterial chemoembolization
(TACE) and PVE were proposed before hepatocellular
carcinoma (HCC) resection. The aim of this study was
to compare the early post-operative course of these two
therapeutic strategies.
Method: Between January 2012 to June 2013, 12
patients underwent a sequential TACE + PVE (group
1). This group of patients was matched to 12 control
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patients who underwent HCC resection after PVE
alone (group 2) from historical database. The two
groups were matched for: age, sex, number and size of
HCC, volume of FRL, Child score.
Results: Baseline patient and tumor characteristics
were similar in the two groups. In all patients the
radiological treatment was well tolerated. The mean
increase of FLR volume was 10% in group 1 and 7%
in group 2 (P = n.s). All patients underwent a subse-
quent hepatic resection: in group 1, 10 major hepatic
resections were performed versus 12 in group 2
(P = n.s.). The post-operative incidence of hepatic fail-
ure (HF) was higher in the group 2 (41.6%, 5/12) than
in the group 1 (8.3%, 1/12). Among five patients
(group 2), only one died for HF at postoperative day-9.
Major complications (Dindo≥III) was 25% (n = 3) in
group 1 and 33.3% (n = 4) in group 2 (P = n.s.). Post-
operative day-60 mortality rate was 8.3% (n = 1) in
group 1 and 25% (n = 3) group 2 (P = n.s). The mean
hospitalisation stay in ICU was statistically higher in
group 1 (3.25 days; range: 1–16 days) than in group 2
(18.5 days; range: 3–67) (P = 0.03). The incidence of
tumour necrosis was significantly higher in the group 1
(11/12 vs. 3/12, p = 0.002)
Conclusions: Sequential TACE and PVE before HCC
resection increases the rate of FLR with a better post-
operative course and increases the rate of tumor necro-
sis.
PO26-04
EFFECTS OF TACE/PVE
COMBINATION BEFORE MAJOR LIVER
RESECTION FOR HCC IN CIRRHOTIC
PATIENTS – THE SAINT-ANTOINE
EXPERIENCE
Lilian Schwarz, Olivier Scatton, Julien Cazejust,
Dominique Wendum, Francois Cauchy, Fabiano
Perdigao, Ailton Sepulveda, Denis Bernard and Olivier
Soubrane
Hopital St Antoine, France
Introduction: Preoperative transarterial chemoemboliza-
tion/portal vein embolization combination (TACE/
PVE-c) has been proposed before major hepatectomy
for large HCC in cirrhotic patients. The aim of this
study was to assess its impact both on tumor and FLR.
Method: From November 2009 to April 2013, 27
patients with HCC and insufficient FLR underwent
TACE/PVE combination. The median time interval
between TACE and PVE was 28 [15–68] days. Com-
puted tomography assessed liver volume 3 weeks after
PVE. Data on clinical and pathological features, and
survival outcomes were retrospectively analyzed.
Results: Median age was 60 [46–79] years and 25
(93%) patients were male. The median tumor size was
60 mm [18–180], and 15(55%) patients had a single
tumor. According to the BCLC classification, 5 patients
(18%) were BCLC 0-A, 16 (60%) BCLC B, and 6
(22%) BCLC C. Twenty-two (81%) patients had cir-
rhosis. TACE and PVE morbidity rate were both 18%,
and contraindicated surgery in 1 (3.7%) patient. Three
other patients were not candidates for resection because
of tumoral progression (n = 1), and portal hypertension
(n = 2). The median pre-, post-TACE/PVE FLR, and
liver hypertrophy were 28% [13–57], 39% [14–66], and
11% [6–33], respectively. Resection was performed in
23 cases including 17 (74%) right hepatectomies, 3
(13%) right hepatectomies extended to middle hepatic
vein and 3 (13%) right trisectionectomies. Associated
controlateral liver tumorectomy/ablation was per-
formed in 5(22%) cases. Pure laparoscopic approach
was used in 6 (26%) cases. Postoperative liver failure
occurred in 5 (22%) cases. Mortality rate was 4%. On
pathological analysis, tumor necrosis ranged from 50 to
90% in 9 (39%) cases and exceeded 90% in 10 (43%)
cases. After a median follow-up of 17 months, 20
patients were alive (7 without recurrence). Fifteen
patients experienced recurrence after a median interval
of 15[4–40] months.
Conclusions: In this series, TACE/PVE allowed for
both hypertrophy of FLR and pathological response of
HCC. Further investigations are required to confirm its
potential neoadjuvant role before surgical resection of
HCC.
PO26-05
NEOADJUVANT TRANSCATHETER
ARTERIAL EMBOLIZATION AND
PORTAL VEIN EMBOLIZATION
BEFORE MAJOR HEPATECTOMY FOR
SINGLE HEPATOCELLULAR
CARCINOMA NO LARGER THAN 10 CM
LOCATED IN RIGHT LIVER
DongHwan Jung, SungGyu Lee, Shin Hwang,
KiHun Kim, ChulSoo Ahn, TaeYong Ha,
GiWon Song, GilChun Park, YoungIn Youn and
WanJoon Kim
Asan Medical Center, Ulsan University, Korea
Introduction: There are several kinds of liver resections
for singe hepatocellular carcinoma (HCC) located in
right liver. The aim of this study was to evaluate the
survival impact of sequential neoadjuvant transcatheter
embolization (TACE) and portal vein embolization
(PVE) for single HCC no larger than 10 cm located in
right liver.
Method: Between January 1997 and December 2010,
70 patients with single HCC underwent right hepatec-
tomy after sequential neoadjuvant TACE and PVE
(Neoadjuvant group). 230 patients with single HCC
underwent right hepatectomy without TACE and PVE
(Classic group).
Results: There were no differences in sex, age, tumor
differentiation, vascular invasion, satellite lesion, and
preoperative AFP level between two groups. Tumor
size was significantly larger in the Classic group
(p = 0.005, 5.70 cm vs. 4.75 cm). Resection margin was
significantly wider in the Neoadjuvant group
(p = 0.005, 2.89 cm vs. 2.03 cm). The 5-year overall
survival and disease-free survival rates in the Neoadju-
vant group were 85.0% and 61.2%, respectively, both
of which were significantly better than the 66.3% and
42.7% seen in the Classic group (p = 0.008 and
p = 0.013, respectively). Better effects of the Neoadju-
vant group on both overall and disease-free survival
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were seen in patients having HCC 5 cm or less in diam-
eter. However, no significant difference in either overall
or disease-free survival was seen in patients having
HCC larger than 5 cm in diameter.
Conclusions: Neoadjuvant TACE and PVE before right
hepatectomy for singe HCC no larger than 5 cm leads
to longer overall and disease-free survival than right
hepatectomy without TACE and PVE.
PO27-01
ELEVATION OF PORTAL VEIN
PRESSURE PREDICTS
POSTHEPATECTOMY LIVER FAILURE
FOLLOWING RIGHT LOBECTOMY
Hiroya Iida, Tsukasa Aihara, Shinichi Ikuta and Naoki
Yamanaka
Meiwa hospital, Japan
Introduction: We usually decide an extent of hepatic
resection according to a level of ICGR 15 in Japan.
However, AP-shunt and constitutional ICG excretory
defect modified value of ICGR 15. Therefore we use in-
traoperative portal pressure for an additional tool of
evaluation of hepatic function reserve. The aim of this
study is to evaluate the usefulness of measuring intra-
operative portal pressure as predicting posthepatectomy
liver failure (PHLF).
Method: We retrospectively analyzed outcomes of 35
patients who underwent measurement of intraoperative
portal pressure prior and posterior to right lobectomy
between April 2004 and August 2012. We divide the
patients according to post operative course uncompli-
cated group (n = 22) and PHLF group (n = 13). Grade
B or C according to International study group of liver
surgery (ISGLS) criteria was applied to PHLF in the
present study. Patient background, intraoperative
bleeding, operation time and elevation of portal pres-
sure were compared between the two groups.
Results: There was significant difference in preopera-
tive white blood count, intraoperative bleeding and ele-
vation of portal pressure in univariate analysis
(p < 0.05). Elevation of portal pressure was indepen-
dent risk factor in multivariate analysis. In addition,
elevation of portal pressure more than 3cmH20 was
associated with PHLF with 69.2% sensitivity and
90.9% specificity.
Conclusions: Elevation of portal pressure more than
3 cm H2O after right lobectomy is a risk of PHLF. If
the elevation of portal pressure more than 3 cm H2O is
observed following clamp of the right branch of portal
vein, we should consider reducing the extent of resec-
tion.
PO27-02
COMPARISON OF REMNANT-TO-
TOTAL VERSUS REMNANT-TO-
STANDARD LIVER VOLUME RATIO AS
PREDICTOR OF POSTOPERATIVE
HEPATIC DYSFUNCTION AFTER LIVER
RESECTION
Hee Joon Kim, Choong Young Kim, Young Hoe Hur,
Yang Seok Koh, Jung Chul Kim, Chol Kyoon Cho
and Hyun Jong Kim
Chonnam National University Medical School, Korea
Introduction: The future liver remnant (FLR) is usually
calculated as a ratio of remnant liver volume (RLV) to
total functional liver volume (RLV/TFLV). In liver
transplantation, It is generally accepted that a ratio of
graft volume to standard liver volume (SLV) need to
be at least 30% to 40% to fit the hepatic metabolic
demand of the recipient. Aim of this study was to com-
pare RLV/TFLV versus RLV/SLV as a predictor of
postoperative liver function and liver failure.
Method: CT volumetric measurements of RLV were
obtained retrospectively in 74 patients who underwent
right hemihepatectomy for malignant tumor from
January 2010 to May 2013 at Chonnam National Uni-
versity Hwasun Hospital. RLV and TFLV were
obtained using CT volumetry, and SLV was calculated
using Yu’s formula: SLV (ml) = 21.585 9 body weight
(kg)0.732 9 Height (cm)0.225. RLV/SLV ratio was com-
pared with RLV/TFLV as a predictor of postoperative
hepatic function.
Results: Postheptectomy liver failure (PHLF), morbid-
ity, serum total bilirubin level at postoperative day 5
(POD 5) were increased significantly in group RLV/
SLV ≤ 30% compared with group RLV/SLV > 30%
(p = 0.002, p = 0.004, and p < 0.001, respectively). But
RLV/TFLV was not correlated with PHLF and mor-
bidity (p = 1.000 and 0.798, respectively). RLV/SLV
showed more strong correlation with serum total biliru-
bin level than RLV/TFLV (RLV/SLV vs. RLV/TFLV,
R = 0.706 vs. 0.499, R2 = 0.499 vs. 0.239).
Conclusions: RLV/SLV was more specific than RLV/
TFLV in predicting postoperative course after right
hemihepatectomy. To determine safe limit of hepatic
resection, more large scaled, prospective study is needed.
PO27-03
IMPACT OF ESSENTIAL STRATEGY
FOR EARLY NORMALIZATION AFTER
SURGERY WITH PATIENT’S
EXCELLENT SATISFACTION AFTER
HEPATECTOMY FOR LIVER TUMORS
Morihiko Ishizaki, Masaki Kaibori, Kosuke Matsui,
Hideyuki Matsushima, Tatsuma Sakaguchi, Richi
Nakatake, Kentaro Inoue and A-Hon Kwon
Kansai Medical University, Japan
Introduction: We have revised Enhanced Recovery
After Surgery (ERAS) program of the Europe dispatch
into Japanese perioperative program (ESsential Strat-
egy for Early Normalization after Surgery with
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patient’s Excellent satisfaction; ESSENSE). We have
introduced the ESSENSE program in liver surgery.
Method: We compared the seven items between ES-
SENSE program (ESSENSE group; n = 80) and usually
perioperative management (control group; n = 78). The
examined seven items was as follows: (1). Abolition of
preoperative colon preparation using purgative, (2).
Abolition of preoperative long-term stopping of drinking
and meal, (3). Exclusion of postoperative detention of
gastric tube, (4). Exclusion of postoperative detention of
abdominal drain, (5). Resumption of meal postoperative
day 1, (6). Change of intraoperative interval of antibiot-
ics from 3 hours to 4 or 7 hours, and postoperative days
prescribed of antibiotics for four days to two days, (7).
Introduction of prehabilitation. A hepatocellular carci-
noma (HCC) patients with liver cirrhosis was treated
with BCAA granules preoperative for 1 month and
drunken with rehydration solution (total dose:
1000~1500 ml) until 3 hours before surgery. We started
these changes as ESSENSE program from November,
2011 through a transition period.
Results: There were no differences between the two
groups with respect to diagnosis and surgical proce-
dure. The postoperative improvement of insulin resis-
tance was recongnized in the HCC patients of
ESSENSE group. Introduction of perioperative exercise
therapy was resulted in extension of walk distance
immediately after operation. There were no differences
between ESSENSE and control groups on postopera-
tive complications outcomes (9/78 vs. 6/80; p = 0.39).
Postoperative hospital stays were an average of 15 days
and 19 days (p = 0.04) in the ESSENSE and control
groups, respectively.
Conclusions: The ESSENSE program on liver surgery
was effective for management of hepatic resection for
liver tumors.
PO27-04
HEPATIC MICROCIRCULATION
DURING LIVER RESECTION
Jan Nilsson, Sam Eriksson, Per-Jonas Blind, Roland
Andersson and Christian Sturesson
Clinical Sciences, Lund University, Sweden
Introduction: The aim of this study was to assess hepa-
tic microcirculation before and immediately after resec-
tion of liver tumors using sidestream dark-field (SDF)
imaging and to correlate changes with size of resection
and early postoperative liver function.
Method: Hepatic microcirculation was measured intra-
operatively on 40 patients undergoing liver resection
for tumors. SDF imaging allowed assessment of func-
tional sinusoidal density (FSD), sinusoidal diameter
(SD) and sinusoidal red blood cell velocity (RBCV).
Results: Baseline microcirculatory parameters before
resection was (mean  SEM) FSD = 21.6  0.4
mm/mm2, SD = 12.4  0.2 mm and RBCV =
188  16 mm/s. Minor resections (<3 Couinaud’s seg-
ments) caused no change in microcirculation parame-
ters. Major resections (≥3 Couinaud’s segments)
resulted in an increase in RBCV by 74% (p < 0.001),
whereas both FSD and SD remained constant. In
(extended) right-sided hemihepatectomies, there was a
negative linear correlation between increase in RBCV
and serum bilirubin levels on postoperative day 3
(Pearsons r = 0.79, p = 0.002).
Conclusions: For the first time in human subjects it
was shown that increased liver blood perfusion after
major liver resections, on the level of microcirculation,
are due to an increase in RBCV. Intraoperative sinusoi-
dal hyperperfusion after major liver resections is a mar-
ker of early postoperative liver function.
PO27-05
PERI-OPERATIVE N-ACETYLCYSTEINE
DOES NOT MODIFY BIOCHEMICAL OR
CLINICAL PARAMETERS OF
OUTCOME AFTER LIVER SURGERY
Saurabh Jamdar, Santhalingam Jegatheeswaran, Paul
Shuttleworth, Aali Sheen and Ajith Siriwardena
Manchester Royal Infirmary, United Kingdom
Introduction: Liver ischaemia-reperfusion (IR) injury
associated with hepatectomy is an important cause of
morbidity. N-acetylcysteine (NAC) protects against oxi-
dative injury in experimental models of liver IR but
there are no clinical trials evaluating NAC in hepatec-
tomy. This study evaluates the effect of peri-operative
infusion of NAC in patients undergoing liver resection.
Method: 117 liver resections (in 113 patients) during
the period January 2009 to December 2010 constitute
the study population. 87 (74%) underwent major resec-
tion (defined as 2 or more sections using Brisbane 2000
nomenclature). During this period, we employed a
selective policy for use of NAC with continuous infu-
sion (dose of 10 g/24 hour) commenced within 24 hour
of hepatectomy until normalisation of liver function.
NAC was given in 64 (55%) resections [no-NAC in 53
(45%)].
Results: The NAC group had a median (range) age of
62 (24–86) years compared to No-NAC group 66 (31–
79) years (p = 0.68). In the NAC group there were 49
major/15 minor resections compared to 39 major/14
minor in the no-NAC group (Yates corrected chi
square p = 0.87). Day 1 post-op ALT in NAC group
was 276 (11–2213) U/l compared to 178 (10–2341) in
non-NAC p = 0.006 (reference range 5–40). Day 3
ALT in NAC was 184 (13–1104) compared to 149 (11–
2368) in non-NAC p = 0.56. There was no difference in
length of stay (p = 0.23). There was 1 (0.8%) postoper-
ative death.
Conclusions: This is the largest reported experience of
the use of NAC to modify liver IR after hepatectomy.
The distribution of major and minor resections was
similar groups. NAC does not appear to modulate
post-operative enzymatic liver function or benefit out-
come.
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PO28-02
METHODS TO DECREASE BLOOD
LOSS DURING LIVER RESECTION
Constantinos Simillis1, Tianjing Li2, Jessica Vaughan1,
Lorne Becker3, Brian Davidson1 and Kurinchi
Gurusamy1
1University College London, United Kingdom; 2Johns
Hopkins Bloomberg School of Public Health, USA;
3SUNY Upstate Medical University, USA
Introduction: The optimal treatment strategy for liver
resection is not known.
Method: We searched the Cochrane Library, MED-
LINE, EMBASE, and Science Citation Index
Expanded until July 2012 to identify the randomised
clinical trials (irrespective of language, blinding, or
publication status) where the method of vascular occlu-
sion, parenchymal transection, and management of the
cut surface were clearly reported, and where patients
were randomly assigned to different treatment strate-
gies. Two review authors identified trials and collected
data independently. We conducted a Bayesian network
meta-analysis in WinBUGS. We calculated the odds
ratios (OR) with 95% confidence intervals (CI) for the
binary outcomes and mean differences (MD) with 95%
CI for the continuous outcomes using fixed-effect
model or random-effects model according to model-fit.
Results: We included a total of 496 participants rando-
mised to seven different treatment strategies from seven
trials in a network meta-analysis. All the trials were of
high risk of bias. There was no significant difference in
mortality, proportion of people transfused or hospital
stay between the different strategies. Any reductions in
blood loss and transfusion requirements were modest.
There was significant increase in the proportion of peo-
ple with serious adverse events (SAE) when surgery
was performed using radiofrequency dissecting sealer
(RFDS) compared to the standard clamp-crush method
(OR 7.13; 95% CI 1.77–28.65). Quality of life and
return to work were not reported in any of the trials.
Conclusions: There is currently no evidence to recom-
mend any specific technique of liver parenchymal resec-
tion. Liver resection using RFDS appears to increase
the serious adverse events and should be evaluated in
further randomised clinical trials before routine use.
Methods of liver resection using no special equipment
seem to be as safe and effective as more complex meth-
ods requiring special equipment.
PO28-03
RISK FACTORS FOR ORGAN/SPACE
SURGICAL SITE INFECTION AFTER
HEPATECTOMY FOR
HEPATOCELLULAR CARCINOMA
Seikan Hai, Yuji Iimuro, Shogo Tanaka, Nobukazu
Kuroda, Tadamichi Hirano, Toshihiro Okada,
Yasukane Asano, Kazuhiro Suzumura, Yuichi Kondo
and Jiro Fujimoto
Hyogo College of Medicine, Japan
Introduction: Recently, advances in surgical techniques
and perioperative management have allowed hepatec-
tomy to be performed more frequently and safely,
which has reduced the mortality rate to 1.4–2.6%.
However, the postoperative morbidity rate is still high,
and surgical site infection (SSI), particularly organ/
space SSI, is a common cause of major morbidity after
hepatectomy for hepatocellular carcinoma (HCC).
Method: The clinical data from 448 patients who
underwent hepatectomy for HCC in our department
between January 2001 and December 2011 were retro-
spectively reviewed, and risk factors for organ/space
SSI were analyzed.
Results: Organ/space SSI occurred in 48 patients
(10.7%). The most common pathogens for infection were
Staphylococcal bacteria. Patients with organ/space SSI
needed significantly longer postoperative hospital care
than the patients without organ/space SSI (median: 49
versus 23 days). The postoperative mortality rate was
significantly higher in the patients with organ/space SSI
(6 of 48 patients, 12.5%) than in those without organ/
space SSI (9 of 400 patients, 2.25%). Multivariate analy-
sis revealed repeat hepatectomy, blood transfusion and
hypoalbuminemia (≦3.7 g/dl) to be independent risk fac-
tors for occurrence of organ/space SSI.
Conclusions: Organ/space SSI is closely related to pro-
longed postoperative hospital care and hospital death.
Preoperative nutritional care and prevention of exceed-
ing intraoperative blood loss are important to reduce
the occurrence of organ/space SSI after hepatectomy
for HCC.
PO28-04
WHETHER STEM CELLS ENHANCE OR
INHIBIT THE GROWTH OF
HEPATOMA CELLS?
Kuo-Shyang Jeng, Hsin-I Hsiau, Fang-Yu Chang and
Ming-Che Yu
Far Eastern Memorial Hospital, Taiwan
Introduction: Stem cells have an ability to perpetuate
themselves through self-renewal and to generate mature
cells through differentiation. Some reported that stem
cells enhance growth and metastasis of colon cancer
cells and also pancreatic cancer cells. Whereas, Wang
Y found stem cells inhibit the tumorigenicity of esopha-
geal carcinoma cells. Whether stem cells enhance or
inhibit growth and invasion of hepatoma cells remains
unknown. We conduct this study to elucidate whether
stem cells play as weapons or dangers for liver cancer
treatment.
Method: RLE cells were derived from 10-d-old suck-
ling Fisher (F344) rats. Separate coculture of rat hepa-
toma cells (H4-II-E-C3) with the isolated fresh RLE
without any cell-to-cell contact using a cell culture
insert. Comparisons of effects of growth, apoptosis and
migration of H4-II-E-C3 cells among the ratio of RLE
cells: H4 cells 1:5, 1:1 and 5:1 respectively. Total RNA
isolation, RT, RNA isolation and real-time PCR to
compare SHH pathway factors, Bcl-2, Bax, p53, IL-12,
VEGF and SCF.
Results: RLE cells had an ability of promoting apopto-
sis of H4-II-E-C3. With the increment of RLE cells,
the migration of H4-IIE-C3 cell decreased and the ratio
of H4:RLE 1:5 was statistically significant (p = 0.029).
The significant change of the main factors of SHH
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pathway include SHH (p = 0.029) and GLI-1
(p = 0.002). The other factors are Bax (p = 0.000) p53
(p = 0.005) and stem cell factor (p = 0.061, borderline).
Conclusions: From this study, the progenitor cells sig-
nificantly increase the apoptosis and inhibit the growth
and migration of rat hepatoma cells (H4-II-E-C3). The
affecting factors include SHH, GLI-1, p53 and Bax. It
may be helpful in further strategy for hepatoma treat-
ment.
PO28-05
BLOCKING CD47 PROMOTES
PHAGOCYTOSIS OF HUMAN
HEPATOCELLULAR CARCINOMA
CELLS
William Chapman1, Z. Xiao1, K. Ott1, C. Chen1,
Y. Lin1, L. Lin1, W. Frazier1, M. Kumar1 and
P. Manning2
1Washington University in St Louis, USA; 2Vasculox,
Inc, USA
Introduction: CD47 is a novel therapeutic target in
solid cancers, however, no data support the role of
CD47 in HCC. CD47 allows cancer cells to disguise
themselves from the host immune system by blocking
SIRPa on macrophages. We postulated that CD47 anti-
bodies could promote phagocytic clearance. The aim of
this study was to determine expression of CD47 on
HCC tumors and to evaluate the ability of blocking
CD47 monoclonal antibodies (CD47mAbs) in promot-
ing phagocytosis.
Method: CD47 expression was determined in 10 HCC
tumor samples and 6 normal livers by immunohisto-
chemistry and in human primary hepatocytes and
HepG2 cell line by flow cytometry. Toxicity of
CD47mAbs for HepG2 cells was determined by MTT
assay. Peritoneal macrophages were isolated from
NOD/SCID/ᵞ (NDG) mice and co-cultured with
HepG2 cells to assess phagocytosis under the following
conditions: (1) untreated, (2) IgG control, (3) non-
blocking CD47mAb control 2D3, (4) blocking
CD47mAb 400.
Results: Immunofluorescence staining high expression
of CD47 on HCC tissues, but not in normal liver.
HCC demonstrated CD47 immunofluorescence inten-
sity of 88.8  2.50, while normal liver had an intensity
of 18.0  0.50. CD47 expression was also high in the
HepG2 HCC cell lines, but low or absent in isolated
human hepatocytes. HepG2 cells incubated overnight
with CD47 mAbs did not induce cell death. Phagocyto-
sis of HCC cells was significantly increased by the
blocking CD47mAb 400 compared to control mAbs
(p < 0.05). The phagocytic index of the anti-CD47400
was 71.1  1.08 whereas for the IgG it was
11.5  0.36 and for 2D3 was 9.6  0.61.
Conclusions: CD47 is highly expressed in primary HCC
tumors and on HepG2 cells but not in normal hepatic
tissue. Blockade of CD47 markedly increased macro-
phage phagocytosis of HCC cells suggesting that block-
ade of CD47 may be beneficial in the management of
HCC.
PO29-01
MINIMALLY INVASIVE RAMPS IN
WELL-SELECTED LEFT-SIDED
PANCREATIC CANCER WITH YONSEI
CRITERIA: LONG-TERM (>MEDIAN
3 YEARS) ONCOLOGIC OUTCOME
Sung Hwan Lee, Chang Moo Kang, Ho Kyoung
Hwang, Sung Hoon Choi and Woo Jung Lee
Yonsei University College of Medicine, Korea
Introduction: Though minimally invasive techniques for
distal pancreatectomy with or without splenectomy
have been regarded as a feasible and safe treatment for
benign and borderline malignant lesions of pancreas, it
is still debatable in management of left-sided pancreatic
cancer in terms of feasibility and oncologic safety.
Method: From June 2007 to November 2010, 12 patients
underwent laparoscopic or robotic radical antegrade
modular pancreatosplenectomy (RAMPS) for well-
selected left-side pancreatic cancer. Yonsei criteria for
selecting patients included following tumor condition;
pancreas-confined tumor, intact fascia layer between the
distal pancreas and left adrenal gland and kidney, tumor
apart more than 1 or 2 cm from celiac axis. We com-
pared the clinicopathologic factors and oncologic out-
comes of minimally invasive surgery (MIS) group and
open group for treating left-sided pancreatic cancer.
Results: In MIS group, mean of tumor size was
2.75  1.32 cm and retrieved lymph nodes were
10.5  7.14. The resection margins were confirmed to
negative for malignancy in all patients. In comparison
with open group (n = 24), there were statistically signif-
icant factors in terms of tumor size (2.75  1.32 vs.
3.93  1.50 cm, p = 0.028), hospital stay (12.25  6.79
vs. 21.83  13.76 days, p = 0.008). In survival analysis,
MIS group had better overall survival (OS) periods
than the open group (60.0 vs. 30.7 months, p = 0.046).
In order to overcome the heterogeneity of subject
between the MIS and open group, we divided the open
group into two groups depending on Yonsei criteria.
There were no significant difference of median overall
survival periods between the MIS group and the open
group within Yonsei Criteria (60.00 vs. 60.72 months,
p = 0.495).
Conclusions: Minimally invasive RAMPS is not only
technically feasible but also oncologically safe in well
selected left-sided pancreatic cancer. Yonsei Criteria for
selecting minimally approach need to be validated
based on large volume experiences.
PO29-02
USEFULNESS OF LOW POWER CUSA
IN LAPAROSCOPIC ENUCLEATION OF
PANCREATIC TUMOR LOCATED
CLOSE TO THE MAIN PANCREATIC
DUCT
Masahiro Minagawa, Kazuyasu Takizawa, Masakazu
Nitta, Kabuto Takano, Jun Sakata, Takashi Kobayashi
and Toshifumi Wakai
Niigata University Graduate School of Medical and
Dental Sciences, Japan
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Introduction: Injury of the main pancreatic duct
(MPD) is problematic in pure laparoscopic enucleation
of pancreatic tumor close to the MPD as well as open
surgery. In order to avoid MPD injury in laparoscopic
enucleation, our group has been testing to use minimal-
powered CUSA (Cavitron Ultrasonic Surgical Aspira-
tor) which enables to expose peripheral vessels without
bleeding. We herein introduce our technique and show
the results so far.
Method: The power setting of CUSA was reduced to
the minimal level before use. The surface of the pan-
creas was transected using laparosonic coagulating
shears (LCS). Low power CUSA was used in dissection
of the deep part of the pancreas near the MPD. To
confirm no leakage from the MPD, indigo carmine
injection from endoscopic naso-pancreatic tube inserted
preoperatively was performed after tumor removal.
Three of 6 patients who had a pancreatic tumor (5 ins-
ulinomas and 1 nonfunctional neuroendocrine tumor)
located within 3 mm from the MPD underwent pure
laparoscopic enucleation by this procedure. Several
clinical data were compared between three cases using
CUSA (CUSA group) and the other three cases not
using CUSA (no CUSA group).
Results: There was no injury of the main pancreatic
duct in all cases. Although the amount of bleeding
showed no significant difference between two groups,
the average of the time required to manage hemosta-
sis was shorter in CUSA group than no CUSA
group (166  70 seconds vs. 646  382 seconds). The
mean operation time was 328  54 min. in CUSA
group and 238  74 min. in no CUSA group respec-
tively. Pancreatic fistula (ISGPF Grade B) occurred
in 1 patient.
Conclusions: Gentle dissection using low power
CUSA can keep a dry operative field during enucle-
ation of pancreatic tumor. This technique may
become one of useful procedures for laparoscopic
pancreas surgery.
PO29-03
SHOULD WE BE RELUCTANT TO
PERFORM
PANCREATICODUODENECTOMY IN
PATIENTS WITH LIVER CIRRHOSIS?
Young-dong Yu, Dong-Sik Kim, Sung-Won Jung and
Sung-Ock Suh
Korea University Anam Hospital, Korea
Introduction: Despite recent advances in surgical proce-
dures and postoperative management, pancreaticoduo-
denectomy (PD) still implies mortality and high
morbidity rate. Liver cirrhosis with or without portal
hypertension has been found to be a major risk factor
for intra-operative bleeding and postoperative ascites
following extra-hepatic surgery. The high mortality rate
of elective extra-hepatic surgery in cirrhotic patients
with portal hypertension leads some surgeons to con-
sider liver cirrhosis a contraindication for PD. The aim
of this study was to present our results of PD in cir-
rhotic patients.
Method: We retrospectively reviewed the medical
records of patients who underwent pancreaticoduoden-
ectomy from January 2002 to December 2012. Patient
data and clinical outcomes were collected and entered
into a database. Patients with preoperative liver cirrho-
sis were compared with patients without liver cirrhosis.
Results: There were 133 patients who received pancrea-
ticoduodenectomy. Among these patients, 18 patients
were diagnosed with liver cirrhosis preoperatively. Liver
cirrhosis was due to hepatitis B (n = 8), hepatitis C
(n = 1), alcohol (n = 5) but was also cryptogenic
(n = 4). Most patients were child A with only one
patient child B. The mean MELD score was 4. The
morbidity rate was 22.2% and the immediate postoper-
ative mortality rate was 11.1%. There was no signifi-
cant difference in operation time, blood loss, hospital
days and postoperative outcome between the cirrhosis
group and non-cirrhosis group.
Conclusions: We believe that PD can be safely per-
formed in patients with Child A liver cirrhosis and
should not be systematically considered as a contraindi-
cation.
PO29-04
POSTOPERATIVE BETA CELL
FUNCTIONS CORRELATE WITH THE
REMNANT PANCREATIC VOLUME
AFTER MAJOR PANCREATIC
RESECTION
Kenichiro Uemura, Tuguka Shiwa, Yoshiaki
Murakami, Takeshi Sudo, Yasushi Hashimoto, Naru
Kondo, Kazuhiro Kobuke, Masayasu Yoneda and
Shuhei Nakanishi
Graduate School of Biomedical and Health Sciences,
Hiroshima University, Hiroshima, Japan
Introduction: There is few data concerning the beta cell
function after major pancreatic resection. The aim of
this study was to clarify beta cell function and the
pathogenesis of postoperative DM after major pancrea-
tectomy using glucagon stimulation test (GST), and the
correlation between beta cell function and pancreatic
parenchyma volume (PV).
Method: A total of 52 patients who underwent major
pancreatic resections, 33 patients with pancreaticoduo-
denectomy (PD) and 19 patients with distal pancreatec-
tomy (DP) were enrolled. The beta cell functions were
evaluated by GST before and after surgery. Fasting
serum C-peptide levels (F-CPR) and stimulated serum
C-peptide values (6 min.-CPR) were used to assess the
beta cell function. The PVs were measured with 64-row
multi-detector computed tomography.
Results: Median values of F-CPR and 6 min.-CPR sig-
nificantly decreased after pancreatectomy (F-CPR: 1.8
vs. 1.5 ng/mL, p < 0.001, 6 min.-CPR: 4.5 vs. 2.7 ng/
mL, p < 0.001). Median value of PV was also signifi-
cantly decreased after pancreatectomy (49.7 vs.
19.5 cm3, p < 0.001). In the patients after DP, the val-
ues of HbA1c (6.3 vs. 5.5%, p < 0.05), fasting plasma
glucose levels (129 vs. 109 mg/dL, p < 0.01), and the
incidence of DM (67% vs. 33%, p < 0.05) are signifi-
cantly higher than that after PD, while, postoperative
6 min-CPR levels (3.25 vs. 2.55 ng/mL, p < 0.05) and
postoperative PV (30.8 vs. 16.8 cm3, p < 0.05) in the
patients after DP, are significantly higher than those
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after PD. Both basic and stimulated serum CPR levels
in the postoperative period were significantly correlated
with postoperative PVs (F-CPR: r = 0.509, p < 0.001,
6 min.-CPR: r = 0.641, p < 0.001).
Conclusions: The incidence of postoperative DM is sig-
nificantly higher in the patients with DP than that after
PD, in spite of the significantly better beta-cell func-
tion. Postoperative beta cell functions correlate with
the remnant pancreatic parenchymal volume after
major pancreatic resection.
PO29-05
TOTAL PANCREATECTOMY FOR
PANCREATIC PEOPLASMS
Shuji Suzuki, Takashi Hatori, Akira Kimijima, Nana
Oshima, Ryuji Suzuki, Wataru Izumo and Masakazu
Yamamoto
Tokyo Women’s Medical University, Japan
Introduction: Total pancreatectomy (TP) is sometimes
performed to treat pancreatic neoplasms that are
spreading to the entire pancreas. However, TP impairs
quality of life, due to the resulting loss of pancreatic
exocrine and endocrine function. However, the out-
come after TP is improved so much recently. We ana-
lyzed postoperative early and late outcomes after TP.
Method: A total of 79 patients who underwent TP
including total excision of the remnant pancreas
(TERP) for the pancreatic neoplasms from 2000 to
2012 were examined retrospectively. Clinicopathological
background, morbidity, and survival data were col-
lected and analyzed.
Results: 43 patients were male and 36 patients were
female. The mean age was 66.5 years (range, 47–
83 years). There were 50 patients with intraductal pap-
illary mucinous neoplasm (IPMN), 22 patients with
pancreatic ductal adenocarcinoma (PDAC), 4 patients
with multiple pancreatic metastases from renal cell car-
cinoma, two patients with intraductal tubulopapillary
neoplasm (ITPN) and two patients with multifocal Pa-
nIN-3. 62 patients underwent primary TP and 17
patients underwent TERP. Only four patients under-
went conventional TP and remaining 75 patients under-
went organ-preserving TP (pylorus preserving TP
(PPTP) 51, subtotal stomach-preserving TP (SSPTP)
12, duodenum-preserving TP (DPTP) 11). Mortality
rate was 0%, and morbidity rate was 12% (10). Mor-
bidity consisted of five patients with delayed gastric
emptying, three patients with lymphatic leak, 1 patient
with bile duct stenosis, and one patient with ileus. Only
a patient was received of re-operation for ileus. They
needed to use insulin from 14 to 48 units. They con-
trolled HbA1c level from 6.1 to 8.6%. Megadose pan-
creatic enzyme replacement therapy was required in all
patients. Complete rehabilitation was achieved in 76
patients (96%).
Conclusions: TP, especially organ-preserving TP is fea-
sible to treat pancreatic neoplasms that are spreading
to the entire pancreas.
PO30-01
CO-TRANSPLANTATION WITH BONE
MARROW DERIVED MSCS IN THE
INTRAMUSCULAR ISLET
TRANSPLANTATION
Gumpei Yoshimatsu1, Naoaki Sakata1, Haruyuki
Tsuchiya1, Masahiko Fukase1, Tatsuo Hata1, Yu
Katayose2, Shinichi Egawa3 and Michiaki Unno1
1Tohoku Universtiy Graduate School of Medicine,
Japan; 2Tohoku University Hospital, Japan; 3Tohoku
University, Japan
Introduction: Intramuscular islet transplantation is con-
sidered as safe and easy in procedure, however the
transplant efficiency was worse than intraportal trans-
plantation which has been performed in clinical. Mes-
enchymal stem cells (MSCs) have many useful roles for
cotransplanted cells such as preventing apoptosis and
inflammation and promoting neovascularization. We
attempted to improve the efficiency of intramuscular
transplantation by cotransplantation of bone marrow
derived MSCs using the rodent model.
Method: Islets and MSCs were acquired from BALB/c
mice (9-12w, male). In vitro study, we performed cul-
ture of islets (50 islet eqivalents) with and without
MSCs (1 9 105 cells) for 96 hs, and evaluated the
residual rate of islets (ratio of residual islet numbers
and islet numbers at 0 h), viability of islets (ratio of
viable cells and total cells in islet) and insulin releasing
function (ratio of released insulin volume at high and
low concentration of glucose stimulations: stimulation
index). In vivo study, we performed syngeneic intramus-
cular islet (500 islet equivalents) with and without MSC
(5 9 105 cells) cotransplantation to diabetic mice and
evaluated blood glucose levels, plasma C-peptide, body
weight, and change of blood glucose level after glucose
stimulation (glucose tolerance test).
Results: While there was no significant difference in
residual rate, stimulation index was significantly higher
in islets with MSCs group. Blood glucose level of islets
with MSCs group tended to be lower than islet without
MSCs group. In the glucose tolerance test at 1 month
after transplantation, the pattern of blood glucose
change was better in islets with MSCs group, especially
at the 90 and 120 min. after glucose stimulation.
Conclusions: Co-transplanted of MSCs can improve
the islet graft function and glucose tolerance in intra-
muscular transplantation.
PO30-02
PANCREAS TRANSPLANT AT TAIPEI
VETERANS GENERAL HOSPITAL
Yi-Ming Shyr and Shin-E Wang
Taipei Veterans General Hospital, Taiwan
Introduction: Type 1 diabetes eventually leads to
nephropathy, neuropathy, retinopathy and angiopathy
after 10–30 years. Currently, pancreas transplant is the
treatment of choice in tight control of blood sugar for
IDDM patients, and further to stabilize, prevent or
even to reverse the diabetic complications. We will
present our experience in pancreas transplant which
was initiated on September 19, 2003.
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Method: From September 2003 to December 2012,
there were 79 pancreas transplants performed for 75
patients at Taipei Veterans General Hospital, with 29
SPK, 8 PAK, 37 PTA and 5 PBK.
Results: Most (82.3%) of our pancreas transplants
were for IDDM patients. The blood sugar usually
returned to normal level within 5 hours (median) after
revascularization of the pancreas grafts. The fasting
blood sugar maintained within normal range thereafter
throughout the whole clinical course in most cases.
There were two surgical mortality. The technical suc-
cess rate was 94.9%. Excluding the four cases with
technique failure, overall 1-year pancreas graft survival
is 98.5% and 5-year is 94.1%, with 100% 1-year for
SPK, 97.1% 1-year for PTA, 100% 1-year for PAK
and 100% 1-year for PBK.
Conclusions: Pancreas transplant provided an ideal
insulin-free solution for DM, especially IDDM. Pan-
creas transplant could be performed with similar suc-
cessful rate irrespective of the type of pancreas
transplant at our hospital.
PO30-03
EFFECT OF EARLY ENTERAL
NUTRITION ON POSTOPERATIVE
NUTRITIONAL STATUS AND IMMUNE
FUNCTION FOLLOWING
PANCREATICODUODENECTOMY
Hitoshi Inoue, Jota Watanabe, Takaaki Takebayashi,
Tetsuya Mizumoto, Hajime Sato, Syoichi Kageyama,
Akihiro Takai, Taiji Tohyana, Fumiki Kushihata and
Yasutugu Takada
Ehime University, Japan
Introduction: To explore the effect of early enteral
nutrition (EN) on postoperative nutritional status,
intestinal permeability, and immune function in
patients following pancreaticoduodenectomy.
Method: Total of 34 patients with malignant tumor
who underwent pancreaticoduodenectomy in our hospi-
tal from April 2011 to May 2013 were enrolled in this
study. They were prospectively divided into EN group
(n = 15) and total parenteral nutrition (TPN) group
(n = 16) based on the nutrition support modes. The
body weight, average hospital stay, complications and
mortality after the surgery were recorded and analyzed.
Peripheral blood samples were collected on the days 1,
3, 5, 7 and 14 after surgery. The plasma diamine oxi-
dase (DAO) activity was determined to assess the intes-
tinal permeability. The postoperative blood levels of
inflammatory cytokines were determined using enzyme-
linked immunosorbent assay (ELISA).
Results: After the surgery, complications were less in
the EN group than those in the TPN group. The DAO
activity were significantly higher in the EN group than
those in the TPN group on POD 5 and 14 (all
p < 0.05). In addition, the EN group had higher IL-10
levels than the TPN group.
Conclusions: Early EN after surgery can effectively
improve the postoperative course, protect intestinal
mucosal barrier.
PO30-04
IMPAIRED PANCREATIC PERFUSION
IN SPLENIC VEIN THROMBOSIS
FOLLOWING LAPAROSCOPIC
SPLENECTOMY
Sung Hwan Lee, Chang Moo Kang, Yong Eun Chung,
Ho Kyoung Hwan, Sung Hoon Choi and
Woo Jung Lee
Yonsei University College of Medicine, Korea
Introduction: Despite of significant incidence of splenic
vein thrombosis after laparoscopic splenectomy, there
are few researches about the clinical significance of
splenic vein thrombosis (SVT) following laparoscopic
splenectomy. Especially, the relationship between SVT
and pancreatic perfusion has never been reported.
Method: We retrospectively analyzed the record of
patients who underwent laparoscopic splenectomy from
August 2006 to August 2011. Patients who were per-
formed abdominal CT scan before and after laparoscopic
splenectomy were enrolled in this study. We measured the
Hounsfield scale (HU) of each part of pancreas divided
into three parts (Head, Body and Tail), and then analyzed
the difference between preoperative values and postoper-
ative values, SVT group and no-SVT group.
Results: Thirty-four patients were enrolled in this study,
and 21 patients (61.8%) were found to have SVT in rem-
nant splenic vein after laparoscopic splenectomy. In
comparison of pancreatic perfusion between preopera-
tive and postoperative phase, significant reduction of
Hounsfield scale was observed in late arterial phase of
CT scan regardless of location (Tail: 107.56  14.53 vs.
94.33  16.99, p-value = 0.000 & Body: 109.17  16.59
vs. 100.40  16.19, p-value = 0.002 & Head:
107.67  17.49 vs. 101.62  13.77, p-value = 0.026). In
comparison of postoperative pancreas perfusion between
SVT and no-SVT group, significant difference was noted
at tail portion in late arterial phase (89.58  17.25 vs.
101.98  13.94, p-value = 0.037).
Conclusions: Impaired pancreatic perfusion was
observed postoperatively in each parts of pancreas at
late arterial phase of CT scan. Especially, significantly
reduced perfusion of distal part of pancreas was
observed in SVT group after laparoscopic splenectomy
compared with non-SVT group. Well-designed prospec-
tive study is necessary to assess the clinical impact of
impaired pancreatic perfusion on development of post-
operative pancreatic fistula in laparoscopic distal pan-
creatosplenectomy.
PO30-05
EARLY ENDOSCOPIC
CYSTOGASTROSTOMY IN GRADE III
PANCREATIC TRAUMA TREATED
INITIALLY WITH NON-OPERATIVE
MANAGEMENT – IS IT SAFE?
Vasu Pillai Letchumanan and Manisekar Subramaniam
Hospital Sultanah Bahiyah, Alor Star, Malaysia
Introduction: In pancreatic trauma, integrity of the
main pancreatic duct is the most important factor in
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determining the outcome of patients. Severe pancreatic
injury is mainly managed with surgical intervention.
This case series describes successful initial non-opera-
tive management of Grade III pancreatic injury fol-
lowed by endoscopic cystogastrostomy within 3 weeks
post trauma.
Method: Ten patients who had Grade III pancreatic
trauma were managed with non-operative management
from August 2010 till August 2013. Repeat CT scan
done at 2 weeks post trauma. If pseudocyst identified,
endoscopic cystogastrostomy was done as early less
than 3 weeks under general anaesthesia or sedation.
Using ERCP scope, needle knife was used to puncture
the selected point. D-J stents were inserted draining the
fluid. The stents were removed one month post proce-
dure after reassessed with imaging during follow up.
Results: The patients presented within 1 to 27 days
post trauma. 90% of the patients noted to have
thrombocytosis before the procedure. In our series of
10 patients, 8 of the patients underwent endoscopic cys-
togastrostomy; one underwent percutaneous drainage
of pseudocyst and one patient noted to have spontane-
ous resolution of pseudocyst. Four of the patients
underwent endoscopic cystogastrostomy within 3 weeks
post trauma. Among the endoscopic cystogastrostomy
patients, there was one failure; one patient needed 2nd
endoscopic cystogastrostomy and another patient
underwent percutaneous drainage and subsequently ret-
roperitoneal necrosectomy for another collection. Two
patients noted to have residual pseudocyst (3 cm) on
follow up but they were asymptomatic. No immediate
post procedure complications. There was no mortality
recorded.
Conclusions: Non operative management of severe pan-
creatic injury with early endoscopic cystogastrostomy is
feasible and yields good results with low morbidity. It
preserves the pancreas. Early endoscopic cystogastros-
tomy, within 3 weeks in pancreatic pseudocyst is safe.
However, long term follow up required looking for
long term morbidity.
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